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properties through cAMP/PKA-dependent mechanisms in the Pars Intercerebralis (PI) neurons of the
brain. Its actions are independent of the mushroom body, which we have also shown to be an important
sleep regulating structure in the fly. This understanding of the anatomical circuitry driving wakefulness in
the fly paves the way for finer dissection of the cellular and molecular mechanisms underlying sleep.

Degree Type
Dissertation

Degree Name
Doctor of Philosophy (PhD)

Graduate Group
Neuroscience

First Advisor
Amita Sehgal

Keywords
Octopamine, Norepinephrine, Sleep, Drosophila, Arousal, Circadian Rhythms

Subject Categories
Behavioral Neurobiology | Systems Neuroscience

This dissertation is available at ScholarlyCommons: https://repository.upenn.edu/edissertations/1561

CIRCUITRY UNDERLYING SLEEP IN DROSOPHILA
MELANOGASTER: ANATOMY AND THE ROLE OF
OCTOPAMINE.
Amanda Crocker
A DISSERTATION
In
Neuroscience
Presented to the Faculties of the University of Pennsylvania
in Partial Fulfillment of the
Requirements for the Degree of Doctor of Philosophy
2010

___________________________
Amita Sehgal, Ph.D.
John Herr Musser Professor of Neuroscience
Supervisor of Dissertation
Deptartment of Neuroscience

___________________________
Rita Balice-Gordon, Ph.D.
Professor of Neuroscience
Neuroscience Graduate Group Chairperson
Committee members:
Allan Pack, M.B.Ch.B. Ph.D.; John Miclot Professor of Medicine
Max Kelz, MD Ph.D.; Assistant Professor of Anesthesiology and Critical Care
Irwin Levitan, Ph.D.; Professor & Chair of Deptartment of Neuroscience, Jefferson Univ.
Thomas Jongens Ph.D., Associate Professor of Genetics

Circuitry Underlying Sleep in Drosophila Melanogaster: Anatomy
and the Role of Octopamine.

Copyright
2010
Amanda Jean Crocker

ii

Acknowledgements
I would like to thank the past and present members of the Sehgal lab for
all of their help and support since I first rotated in 2004. Their insights and
discussions have helped me immensely in understanding both my project and my
future interests. Without them my science understanding would not be what it is.
I would like to especially thank Bill Joiner, Sam Johnson (Xiangzhong Zheng),
Kyunghee Koh, Eliot Friedman, Mark Wu, Karen Ho, Susan Harbison, Wenfeng
Chen, Justin DiAngelo, Terry Dean, Zhefeng Yue, Kiet Luu, Dechen Chen,
Shailesh Kumar, Renske Erion, Nooreen Dabbish, Wenyu Luo, Yanshan Fang,
Alexis Gerber, and Sue Kelchner for discussions, listening, help with
experiments, and advice beyond the lab. I will be forever grateful. I would also
like to thank my mentor, Dr. Amita Sehgal. When I was choosing a lab to join, I
was told Amita was a great choice because she not only does great science, but
is also a wonderful person. Having been here for almost 6 years I agree whole
heartedly with that statement. She has provided an excellent environment in
which to foster my own ideas and explore questions of interest while providing
guidance along the way. She has provided an excellent model for the type of
scientist I would like to become.
I would also like to thank Dr. Bob Kalb and Dr. Ted Abel for giving me the
opportunity to work in their labs for a semester and learn many of the molecular
biology techniques I currently use. I also had many excellent discussions with
them on my projects after I joined the Sehgal Lab.
iii

I would like to thank Dr. Irwin Levitan and Dr. Mohammad Shahidullah for
providing excellent experiments and data, without which, my project would be not
be complete. I would also like to thank Dr. Tom Scammell and Dr. Clif Saper,
without whom I would not be interested in sleep. They also provided great
advice on choosing graduate programs, mentors, and life as a scientist. I would
like to thank Tom, specifically who hired me as a technician and giving me my
own project, truly convincing me that I wanted to pursue a science career.
I would also like to thank my committee members, Dr. Allan Pack, Dr. Tom
Jongens, Dr. Max Kelz, and Dr. Irwin Levitan for all of their advice over the years.
Their comments and insights greatly improved my projects and for that I am
grateful.
Lastly, I acknowledge my wonderful family and friends, without whom I
would not be here.

iv

ABSTRACT
CIRCUITRY UNDERLYING SLEEP IN DROSOPHILA
MELANOGASTER: ANATOMY AND THE ROLE OF
OCTOPAMINE.
Amanda Crocker
Thesis Advisor: Amita Sehgal

Almost 20 years ago, the gene underlying fatal familial insomnia was
discovered, first suggesting the concept that a single gene can regulate sleep. In
the two decades since, there have been many advances in the field of behavioral
genetics, but it is only in the past 10 years that the genetic analysis of sleep has
emerged as an important discipline. Major findings include the discovery of a
single gene underlying the sleep disorder narcolepsy, and identification of loci
that make quantitative contributions to sleep characteristics. The sleep field has
also expanded its focus from mammalian model organisms to Drosophila,
zebrafish, and worms, which is allowing the application of novel genetic
approaches. This thesis picks up on current sleep research to understand sleep,
using Drosophila as our model organism. In Drosophila we have the unique
opportunity to study at a single neuron level, how it regulates sleep and by doing
this try to understand why we sleep. This work is devoted primarily to the
neurotransmitter octopamine, which is the invertebrate homolog of
norepinephrine. We show that octopamine is a wake-promoting signal in the fly,
v

as is its counterpart in mammals. Behavioral changes in the animal are seen
with modifications of a single octopamine-producing cell and this effect is used to
understand both the anatomical and cellular pathways involved in this signal. We
find that octopamine exerts its arousal properties through cAMP/PKA-dependent
mechanisms in the Pars Intercerebralis (PI) neurons of the brain. Its actions are
independent of the mushroom body, which we have also shown to be an
important sleep regulating structure in the fly. This understanding of the
anatomical circuitry driving wakefulness in the fly paves the way for finer
dissection of the cellular and molecular mechanisms underlying sleep.

vi

TABLE OF CONTENTS
Acknowledgements

iii

Abstract

v

Table of Contents

vii

List of Figures

ix

List of Tables

x

Chapter I: Introduction and Overview

1

Chapter II: Octopamine regulates sleep through PKA-dependent
mechanisms in Drosophila

47

Abstract

48

Introduction

48

Methods

50

Results

56

Discussion

65

Figures and Tables

71

Chapter III: Novel neural circuitry mediates effects of octopamine on
sleep in Drosophila

91

Abstract

92

Introduction
vii

92

Methods

95

Results

103

Discussion

113

Figures and Tables

119

Chapter IV: Effects of octopamine on metabolism in Drosophila
143
Abstract

144

Introduction

145

Methods

148

Results

149

Discussion

153

Figures and Tables

156

Appendix

160

Part 1: The mushroom body regulates sleep in Drosophila

161

Part 2: Caffeine changes global levels of cAMP

192

Summary and Perspectives

References

viii

196

203

List of Figures
CHAPTER I
Figure 1-1. Brain regions in the fly important for sleep–wake regulation. 43
CHAPTER II
Figure 2-1. The octopamine biosynthesis pathway and its distribution in the fly
brain
71
Figure 2-2. Baseline sleep phenotype of Tdc2 RO54 mutants, which have
decreased levels of octopamine and tyramine. 72
Figure 2-3. Baseline sleep phenotype of TβH nm18 mutants, which have
decreased levels of octopamine and increased levels of tyramine. 74
Figure 2-4. Baseline sleep phenotype produced by depolarizing Tdc2-positive
neurons. 76
Figure 2-5. Baseline sleep phenotype produced by hyperpolarizing Tdc2positive neurons. 78
Figure 2-6. Total sleep in Tdc1-Gal4 female flies expressing UAS-NaChBac. 80
Figure 2-7. Overexpression of Tdc2 causes decreases in sleep. 81
Figure 2-8. Oral administration of octopamine decreases sleep in Iso31 flies
and TβH nm18 mutant flies. 82
Figure 2-9. Dose response curve for effects of octopamine on sleep and
tyramine on sleep. 85
Figure 2-10. Effects of octopamine are mediated by PKA and independent of
the Mushroom Body. 87
CHAPTER III
Figure 3-1. MARCM methods 119
Figure 3-2. Cells in the medial protocerebrum mediate wake-promoting effects
of octopamine. 121
Figure 3-3. Octopamine signals through cells in the pars intercerebralis (PI)
123
Figure 3-4 Expressing PkaR in Dilp2 neurons consolidates sleep. 125
Figure 3-5. Sleep is altered by manipulations of the electrical activity of PI
neurons. 127
Figure 3-6. Octopamine modulates the outward potassium current in PI
neurons 128
Figure 3-7. Octopamine increases cAMP signaling in PI neurons. 130
Figure 3-8. Molecular analysis of the OAMB and OctB2R receptors. 132
Figure 3-9. Mutations in the OAMB receptor affect sleep levels. 134
Figure 3-10 The OAMB receptor is expressed in Dilp2 neurons. 135
Figure 3-11. The OAMB mutant shows an attenuated response to octopamine.
136
CHAPTER IV
Figure 4-1. Triglyceride levels in different sleep mutants. 156
Figure 4-2. Baseline sleep in flies with altered insulin signaling. 158
Appendix
ix

Figure A-1. Expression of PKA in various regions of the fly brain affects sleep
differentially. 170
Figure A-2. Localization of GAL4-dependent brain expression. 172
Figure A-3. Expression patterns of eight GAL4 drivers within the MB peduncle.
173
Figure A-4. Expression of constitutively active PKA with the 238Y or 30Y. 176
Figure A-5. Inducible expression of PKA in the MBs leads to decreased sleep
bout duration and accumulation of sleep debt. 177
Figure A-6. Sleep architecture of animals expressing PKA under the control of
c309 and 201Y drivers. 180
Figure A-7. MBSwitch/UAS-mc* female flies show homeostatic rebound sleep
following 12 hours of mechanical sleep deprivation that is similar in
magnitude to PKA-induced rebound. 182
Figure A-8. Decreasing and increasing excitability in a subset of MB neurons
have opposite effects on sleep. 184
Figure A-9 Decreasing excitability in a subset of MB neurons using the EKO
transgene increases sleep. 186
Figure A-10 Ablation of mushroom bodies with hydroxyurea leads to increased
activity and decreased rest. 187
Figure A-11 Model of sleep-regulating circuitry involving MBs. 189
Figure A-12 Caffeine reduces Epac1-camps FRET
195

List of Tables
CHAPTER I
Table 1-1. Terms commonly used to describe sleep. 44
Table 1-2. Genes implicated in homeostatic regulation of sleep through
genetic studies across species. 45
Table 1-3 Theories for sleep function. 46
CHAPTER II
Table 2-1 Sleep and activity in flies mutant for the octopamine pathway. 89
Table 2-2 Sleep bout analysis in flies mutant for the octopamine pathway. 90
CHAPTER III
Table 3-1 Sleep data for flies generated through MARCM. 138
Table 3-2 Effects of octopamine on sleep in different fly lines. 139
Table 3-3 Sleep in octopamine receptor mutants and in flies with altered
excitability of Dilp2 neurons. 140
CHAPTER IV
Appendix
Table A-1 The GAL4 drivers used are listed alongside their published
expression patterns. 190
x

CHAPTER I:
INTRODUCTION AND OVERVIEW

This introduction consists of two main parts. The first is an overview of
sleep research and the use of genetics to understand sleep, and the second is a
more in-depth introduction to the invertebrate neurotransmitter octopamine, the
major subject of this thesis. The first part was published as a review in 2010
(Crocker and Sehgal, 2010).

Part 1: Genetics of Sleep
Sleep is one of the great mysteries of science. It is a fundamental
phenomenon with no known molecular function despite the fact that it spans
genetically diverse eukaryotes, from higher order phyla such as mammals, to
lower phyla such as arthropods (Tobler, 2005). Within individual species many
characteristics of sleep are tightly regulated. These include, but are not limited
to, the timing of sleep onset, depth of sleep, and average duration. Since all
these organisms show regulation of the same sleep-associated processes, the
thinking is that conserved genetic mechanisms underlie sleep across species
(Allada and Siegel, 2008).
The recognition that sleep may be regulated by conserved genetic
mechanisms has not yet led to a unified understanding of it. A closely related
process- the generation of circadian rhythms- is now explained on the basis of a
universal model, largely because of mechanistic studies done in phylogentically
1

very diverse organisms. Studies of sleep have been primarily descriptive,
consisting of lesion studies that have identified relevant anatomic areas in
mammals, and pharmacological data that have pinpointed effects of different
neurochemicals. However, even these have not provided specific loci/foci to the
extent known for the circadian field, perhaps because these do not exist for
sleep. For instance, there is still no specific anatomical area that can be lesioned
to completely eliminate sleep. Likewise, if there is a specific neurotransmitter for
sleep, it is still hypothetical. Thus, sleep does not appear to be controlled by a
single locus or dedicated genes. It is better understood as a broad system wide
phenomenon.
Hypotheses for sleep include somatic theories (healing of the body and
other endocrine functions), cellular metabolic theories (removal of reactive
oxidative species and energy replenishment), brain specific functions such as
synaptic plasticity (in adults, this would underlie memory consolidation) or
synaptic downscaling. One needs to be careful with some of these hypotheses
since they are often based on detrimental effects of sleep deprivation, which is
both a cellular and organismal stress due to the fact that it exceeds our normal
physiological time awake. Given that wake-promoting pathways are involved in
other biological functions excess activity of these pathways could produce effects
independent of sleep. Also, the sleep field is split between those who want to
associate sleep function with specific aspects of the electroencephalogram
(EEG) (described below) and those who want to understand what happens to the
brain when it is offline, independent of the EEG.
2

Genetics provides a new way to address the function of sleep. While for
the past 20 years genetics has been used primarily to verify lesion and
pharmacological studies through targeted gene approaches, it can now be used
to probe more intricate questions in sleep. Thus, forward genetic screens,
inducible and anatomical specific genetic mutations, genetic alterations in
synaptic signaling and excitability, genetic lesioning of cells, microarrays and
other genetic manipulations can be employed to identify novel mechanisms
underlying sleep, and also to test specific hypotheses for sleep function.
The first part of the sleep introduction focuses on the use of genetic and
molecular techniques in model organisms to understand sleep. The first section
provides the basic background of sleep research and introduces the study of
sleep from a genetic perspective. The second section focuses on the heritability
of sleep traits and the genes underlying these traits. The third describes the use
of genetic manipulations in model organisms to understand the neurochemistry
of sleep. The introduction ends with a discussion of recent studies designed to
identify novel sleep-regulating genes, all of which have the ultimate goal of
identifying sleep function.

Background:
The Definition of Sleep
In the broadest sense, sleep is defined as a period of inactivity. This
period is accompanied by an increase in arousal threshold, often in a
stereotypical body position, and, if disrupted, is followed by a period of sleep
3

rebound (Hendricks et al. 2000; Huber et al. 2004). This definition is applied to
organisms as genetically simple as Caenorhabditis.elegans as well as to more
complex organisms such as mice and even humans.
To understand sleep, two distinct aspects of it must be addressed. These
are the timing of sleep and the length/quality of sleep (Borbely, 1982). Both are
maintained to be approximately the same from day to day. The timing of sleep is
well established as a function of the circadian system in the brain. The circadian
system is important for driving many aspects of behavior and physiology with a
~24 hour period through a set of molecular oscillators. How our body knows how
much sleep we need is less understood. Based upon the rebound, or
compensatory sleep, that follows sleep deprivation, sleep is thought to be an
essential process whose amount is controlled by a homeostatic system
(Dauvilliers et al., 2005).
In mammals, sleep is identified empirically by physiological markers. In
humans, as well as monkeys, rats and mice, changes in brain activity during
sleep and wakefulness can be monitored using an electroencephalograph
(EEG), and different stages of these behavioral states have come to be identified
by characteristic EEG patterns (wave forms) (Table 1-1) (Allada and Siegel 2008;
Ambrosius et al. 2008). These patterns are best defined in humans where a
typical sleep EEG consists of 1-3 NREM (non-rapid eye movement) stages and a
rapid eye movement (REM) stage (Table 1-1). Stage 1N is characterized by the
transition from faster oscillations in the 8-13 Hz range during wakefulness to
oscillations in the 4-7Hz range. Stage 2N is characterized by sleep spindles (fast
4

oscillations in the 12-14 Hz range) on top of the slower oscillations. Stage 3N is
the deepest stage of sleep and is composed of at least 20% slow, large
amplitude oscillations in the 0-4 Hz range known as delta waves; at its deepest
points this stage of sleep could consist of >50% delta waves. (Aeschbach and
Borbely, 1993; Dumermuth et al., 1983). Depth of sleep is often characterized by
the term “delta power” which refers to the frequency and amplitude of the delta
waves produced. Delta power is hypothesized to be a readout of the homeostatic
drive, so the higher the delta power the greater the sleep pressure in the animal
(Tobler and Borbely, 1986; Webb and Agnew, 1971). In other mammals the
sleep stages are less well defined, and generally fall into the categories of
NREM, REM or wakefulness (Tobler and Borbely, 1986).

Genetic Approaches to the Study of Sleep
The first clue that human sleep could be genetically regulated came from
twin studies conducted in the 1930s (Reviewed in (Dauvilliers et al., 2005)).
These studies showed that monozygotic twins are more likely to have similar
sleep amounts and sleep onset times than dizygotic twins. After the invention of
the EEG it was found that monozygotic twins also show similarities in their EEG
spectrum. Despite the fact that there is great variation in EEG spectrum from
individual to individual, within monozygotic twins it is highly correlated
(Ambrosius et al., 2008; Anokhin et al., 1992; Steinlein et al., 1992; van
Beijsterveldt and Boomsma, 1994). As discussed below more recent studies
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have validated the genetic basis of the EEG pattern and even identified genetic
loci that underlie these traits.
Mice have approximately 85 % genetic similarity to humans and so
provide an excellent model for the genetic analysis of sleep (Church et al., 2009).
They display similar EEG traces, and periods of sleep that are regulated by the
same homeostatic and circadian mechanisms as in humans (Allada and Siegel,
2008). However, there are several drawbacks to using a mouse model: They
have a long generation time. They are likely to show compensation or
redundancy in genes critical for the survival of the mouse, many of which may be
important for sleep. Also, until recently, genetic tools were not available to alter
the expression of genes over time or spatially within the mouse brain (Rossant
and McMahon, 1999).
Simpler organisms such as C.elegans, Drosophila melanogaster (fruit fly),
and Danio rerio (zebrafish) are all also proving to be excellent models for sleep
(Allada and Siegel, 2008; Cirelli, 2009). They share the advantage that they are
all genetically tractable, and have relatively simple genomes (the worm and the
fly also have very short generation times). In addition they all have the ability to
generate both simple and complex behaviors (Sokolowski, 2001). Lower
redundancy of the genome in these organisms makes it easier to identify genes
important for sleep. Research in these model organisms has also seen a
burgeoning of genetic tools that can be used to probe sleep, ranging from
technology that allows for precise temporal and spatial control of genes to
reagents that can bypass the need for electrophysiology.
6

While the utility of the model organisms listed above is unquestionable, it
is important to note that the genetics of sleep is not restricted to these organisms.
Family-based linkage studies and genome wide association studies are
pinpointing sleep genes in humans (Hallmayer et al., 2009; Winkelmann et al.,
2007). In addition, advances in the genetics of sleep have sometimes come from
unexpected systems. For instance, a dog model for narcolepsy led to the
identification of a gene underlying this disorder and a circadian rhythm mutation,
tau, was found fortuitously in a hamster (Lin et al., 1999; Ralph and Menaker,
1988).
Genetic analysis of Sleep Traits:
Natural Variations in Sleep Traits.
While earlier work focused primarily on wake EEG, more recent studies
have examined EEGs during sleep (Ambrosius et al., 2008; De Gennaro et al.,
2008). De Gennaro et al. (2008) showed recently that frequencies of 8-16 Hz
during NREM sleep show a high amount of heritability, regardless of sleep-need
or intensity. Despite these studies, very little familial linkage work has been done
on EEG sleep traits.
Large scale mapping studies of genetic differences in sleep architecture
between inbred mouse strains (QTL mapping) has allowed researchers to isolate
genes that underlie subtle differences across strains (O'Hara et al., 2007). One
study focused on theta oscillations, which vary in frequency across inbred
strains, but very little within a strain. Tafti et al. (2003) looked specifically at the
difference between the Balb/cByJ mice which have “slow” theta frequencies on
7

the EEG and c57Bl/6J which have “fast” theta rhythms (Tafti et al., 2003). In
mice, hippocampal-derived theta rhythms in the 6-10 Hz range are seen during
REM sleep and exploratory behavior, including wheel running. This is different
from the cortical theta rhythms seen in humans in stage N1 of sleep that are in
the 4 to 7Hz range. Tafti et al. (2003) were able to narrow down the region of
interest to a single gene on chromosome 5 known as Acads (short chain acylcoenzyme A dehydrogenase). They found that Balb/cByJ mice have a deficiency
in Acads, which underlies the slowing of the theta rhythm.
Another successful QTL study identified a gene on chromosome 14, Rarb,
that contributes to the 1-4hz delta frequency in mice (Maret et al., 2005). Taking
a reverse genetic approach to specifically target the Rarb gene, Maret et al.
(2005) showed that retinoic acid signaling (the pathway Rarb functions in) is
important for modulating cortical synchrony during NREM sleep.
Later in this review we will touch on some of the ion channels that have
been mutated to alter the EEG pattern. Since the channels probably account
more directly for the oscillatory bursting of the sleep EEG, they may be regulated
by some of the genes discussed above. However, while these studies are
important for the insights they provide regarding the genetic control of the sleep
EEG, they do not reveal the significance of these waves. Nor, for that matter, do
they allow association of EEG patterns with sleep function.

Circadian influences on sleep

8

As mentioned above, the circadian regulation of sleep is much better
defined than the homeostatic regulation. In addition, the molecular basis of
circadian control is quite well understood, as a result of cross-disciplinary
approaches which included organisms as simple as cyanobacteria and
Neurospora (Sehgal, 2004). Molecular mechanisms of the circadian clock are
indeed conserved from cyanobacteria to humans. From Drosophila to humans,
the molecules are also largely conserved and have even been implicated in
human circadian disorders. The mammalian molecular clock mechanism
described below does not do justice to the current state of knowledge in this field;
its brevity can be attributed to the fact that it has been covered in countless other
reviews, and to the need to focus this writing on the homeostatic regulation of
sleep.
The circadian system in mammals and invertebrates involves molecular
feedback loops within cells that can maintain a ~24 hour rhythm (Siepka et al.,
2007). In all these organisms, the core components of the clock are broken into
positive and negative regulators. In mammals, BMAL1 and NPAS2 /CLOCK are
the positive regulators that drive the transcription of Per (Period) and Cry
(Cryptochrome), which feed back and inhibit the transcription of BMAL1 and
CLOCK/NPAS2, thereby forming the negative regulators. Following degradation
of the negative regulators, a new cycle begins. Mice mutant for any of these
genes, or combinations of these genes, generally display aberrant rest: activity
patterns although redundancy often results in weaker phenotypes than predicted.

9

As one would expect, the circadian system is important in determining the
timing of sleep. This is best demonstrated in a disorder known as Familial
Advanced Sleep Phase Syndrome (FASPS) which results in very early sleep and
wake times. Genetic studies have identified a mutation in the Casein kinase 1
delta gene in one family afflicted with FASPS and a mutation in the period gene,
which affects its interaction with Casein kinase 1, in yet another family (Toh et al.,
2001; Xu et al., 2005). Remarkably both these genes were first identified in
Drosophila as part of the circadian clock, thereby attesting to the conservation of
molecular mechanisms (Kloss et al., 1998; Konopka and Benzer, 1971).
Interestingly the Tau mutation in the hamster which causes a very short period is
an allele of Casein Kinase 1 epsilon. (Lowrey et al., 2000)
The FASPS mutations do not change the overall length of any of the sleep
parameters or homeostat but do alter (advance) the timing of sleep onset. The
same phenotype is produced when either Per2 or Casein kinase 1 delta is
mutated in the mouse, but in flies the equivalent mutation in Casein kinase 1
delta results in a phase delay (Xu et al., 2005). Thus, this particular amino acid is
also important in flies, although the regulation may be somewhat different.
Naturally occurring polymorphisms in circadian clock genes do not cause
extreme phenotypes like FASPS, but can have effects on the timing of sleep.
Indeed, several studies have attempted to correlate such polymorphisms with
preferences for early wake-up times (seen in “morning” types or “larks”) or late
sleep times (“evening” types or “owls”) (Archer et al., 2003; Carpen et al., 2005;
Carpen et al., 2006; Viola et al., 2007). The C allele of the T2434C polymorphism
10

in Per1 is associated with morningness and disruptions in sleep timing (Carpen
et al., 2006).
It is clear that circadian genes affect the timing of sleep. What still
remains debatable is whether they have a role in the homeostatic regulation of
sleep i.e. in determining seep amount. There is some evidence to this effect.
Mice with mutations in some core circadian genes such as CLOCK, BMAL and
Cry, as well as other circadian regulators, show changes in sleep amount. Clock
mutant mice sleep on average 2 hours less than their wild-type littermates
(Naylor et al., 2000). The BMAL knockout mice and the CRY1/CRY2 double
knockout mice both show increases in their total sleep time (Laposky et al., 2005;
Wisor et al., 2002). A knockout of Prokineticin 2, which is a possible output
signal from the SCN (suprachiasmatic nucleus, center for circadian rhythms in
mammals), shows reduced total sleep and attenuated sleep rebound following a
period of deprivation (Hu et al., 2007). Likewise, mutations in some circadian
genes in fruit flies also have disruptions in the sleep homeostat (Chung et al.,
2009; Donlea et al., 2009; Hendricks et al., 2003; Shaw et al., 2002) .
A recent study implicated yet another circadian gene in the regulation of
sleep length. Dec2, a basic helix loop helix (bHLH) protein, is thought to function
in the clock as a repressor of Clock/Bmal1 (Honma et al., 2002). The recent
study found a point mutation in the Dec2 gene in a family of short sleepers (He et
al., 2009). These people fall asleep at a normal time, unlike people with
advanced phase syndrome, discussed above, but wake up early so that their
average amount of sleep is about 6 hours (He et al., 2009). In mice, knockout of
11

Dec2 did not result in a decrease in sleep like the point mutation found in
humans. But, when the specific point mutation was introduced into the mouse, it
decreased sleep time, without affecting circadian period, suggesting that it has a
dominant effect. Interestingly, a role for Dec2 is conserved in flies (Lim et al.,
2007).
Flies generated to express the mouse Dec2 gene carrying the P385R
mutation showed a sleep phenotype similar to that seen in mammals (He et al.,
2009).
Even with these effects of circadian genes on sleep amount, it remains
unclear as to whether the circadian clock affects sleep homeostasis. For one,
the effects are small. For another, they have not been reported for all clock
genes. Finally, for the genes that have been implicated, the sleep phenotypes
could reflect pleiotropic or non-circadian effects of these genes.

The Genetics of Sleep Neurochemistry:
The first book on the anatomy of sleep was published in the 1840s
(Edelson, 1992). Since that time, most of our understanding of sleep
neurochemistry has relied on physiological and pharmacological studies. But
over the past 10-20 years, genetics has emerged as a major tool to investigate
sleep neurochemistry as well as the circuitry associated with it. Indeed, much of
the earlier physiological/pharmacological work in mammals is now supported by
genetic approaches and has been summarized in many excellent reviews and
anatomical maps (Andretic et al., 2008; Saper et al., 2005). More recently there
12

has been a surge of genetic studies identifying sleep-regulating areas and
neurochemicals in the fly brain (see Figure 1-1).
The neurochemical analysis of sleep has involved characterization and
manipulation of the major neurotransmitter systems, as well as their receptors.
Genetic approaches have classically created and/or characterized targeted
knockouts of candidate molecules and identified new roles or confirmed old roles
for many of these in sleep. We provide below a brief outline of how genetic
modifications in the biosynthetic or signaling pathways of different
neurotransmitters have provided insights into sleep neurochemistry. A list of
these neurotransmitters, as well as other genes, that affect sleep across species
is provided in Table 1-2.

Hypocretin/Orexin:
The discovery of the orexin, also known as hypocretin, gene represents
one of the most significant advances in sleep research in the past 20 years. Its
role in narcolepsy was discovered independently by two labs, one studying
canine narcolepsy and the other studying feeding behavior. The focus of Dr.
Mignot’s group at Stanford University (Lin et al. 1999) was on cloning the
narcolepsy gene. Using a breed of dogs afflicted with narcolepsy, they were able
to map the relevant mutation to the gene encoding the hypocretin receptor
(hcrtrt2) (Lin et al., 1999). Dr. Yanagisawa’s group at University of Texas
Southwestern (Chemelli et al. 1999), on the other hand, had identified ligands of
orphan G-protein coupled receptors and in studying the phenotype of a knockout
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mouse lacking one of these ligands, orexin, found that it showed narcoleptic
behavior (Chemelli et al., 1999). It became clear from these and subsequent
studies that orexin plays a critical role in stabilizing sleep and wake cycles, by
influencing both wake-promoting and sleep-promoting areas of the brain
(Mochizuki et al., 2004; Saper et al., 2005). Its major role is as a wake-promoting
signal; in its absence, animals have trouble maintaining wakefulness and lapse
rapidly into REM sleep. People with narcolepsy typically lack orexin-producing
neurons for reasons that may have to do with altered immune function
(Hallmayer et al., 2009).
Orexin has also been studied in zebrafish, but its role there is slightly more
controversial, with conflicting studies reporting insomnia-like phenotypes of both
the over-expression as well as knockout models (Prober et al., 2006; Yokogawa
et al., 2007). There is also controversy over the projection pattern of orexin
neurons and the localization of the fish orexin receptor (Kaslin et al., 2004;
Yokogawa et al., 2007). Further studies in zebrafish will be needed to tease apart
the role of orexin.
Flies do not have orexin, but it is hypothesized that Pigment Dispersing
Factor (PDF), which is released from central clock neurons, is the fly equivalent
of orexin. Some of these neurons (the large cells) play an important role in
promoting wakefulness in the fly in the early morning and this is done through
PDF (Donlea et al., 2009; Parisky et al., 2008; Shang et al., 2008; Sheeba et al.,
2008a) (Figure 1-1). It is hypothesized that PDF acts much as orexin does in
mammals, as a stabilizer of sleep and wake. Flies that lack PDF signaling, either
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by disruption of the PDF gene, ablation of PDF neurons, or lack of the PDF
receptor, show defects in their ability to respond to the ‘lights on’ transition and
thus have reduced activity levels at the beginning of their day (Chung et al.,
2009; Shang et al., 2008). They also show increases in overall sleep amounts
with increased transitions from wake to sleep. Some of this action appears to be
mediated through GABAergic inputs onto PDF neurons (Chung et al., 2009;
Parisky et al., 2008). Additionally, flies with hyperexcitable PDF neurons show
lower levels of sleep (Shang et al., 2008; Sheeba et al., 2008a; Sheeba et al.,
2008b). Thus, the effect of PDF on sleep levels and consolidation is similar to
that of orexin in mammals.

Acetylcholine:
Genetic analysis of acetycholine has been difficult in most organisms due
to the many biologically essential functions of this neurotransmitter. In addition
there are a very large number of nicotinic and muscarinic acetylcholine receptors
and receptor subtypes. Thus, the role of acetylcholine in sleep has, to date,
been better studied using pharmacological approaches, which indicate that
acetylcholine is part of the arousal system critical for the waking EEG and REM
sleep. For the few nicotinic receptor mutants analyzed for sleep, only minor
changes in sleep architecture have been reported (Fonck et al., 2005; Lena et
al., 2004). On the other hand, a mutation in the muscarinic acetylcholine
receptor M3 results in a decrease in REM sleep (Goutagny et al., 2005).
Targeted genetic disruption of the acetylcholine receptor subtypes within small
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populations of neurons, such as with RNAi technology or genetically designed
viruses, may be more informative. It is also possible that acetylcholine does not
actually regulate sleep, but that sleep stages regulate acetylcholine, as
suggested by (Gais and Born, 2004).

The Biogenic Amines:
The role of norepinephrine, dopamine, serotonin and histamine in sleep
has been covered exhaustively (Berridge, 2008; Cirelli, 2009; Dzirasa et al.,
2006; Monti and Monti, 2007; Monti et al., 2008; Saper et al., 2005). For this
reason we have limited our discussion of these neurotransmitters. In brief,
targeted genetic disruptions in the biogenic amines, specifically norepinephrine,
dopamine, and histamine, have confirmed the wake-promoting action of these
neurotransmitters suggested by lesion and pharmacological approaches
(Hunsley et al., 2006; Hunsley and Palmiter, 2003; Monti and Monti, 2007;
Ouyang et al., 2004; Popa et al., 2005; Qu et al., 2008; Vallone et al., 2002;
Waddington et al., 2005; Wisor et al., 2001). Serotonin on the other hand has
had a more complicated history since it may have different effects on REM
versus NREM sleep. It is clear from genetic and pharmacological studies that it
inhibits REM sleep (Boutrel et al., 1999; Boutrel et al., 2002), but it may actually
promote NREM sleep (Jouvet, 1968).
One area in which genetic targeting studies have provided novel insight is
in the role of histamine in narcolepsy. Mice carrying a mutation in histamine
decarboxylase (HDC) show altered levels of sleep-hypersomnolence-and are
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unable to maintain wakefulness during times of normally high vigilance, such as
light transitions and cage changes (Parmentier et al., 2002). This phenotype is
similar to that of narcolepsy and, in fact, a role of histamine in this disease is
being investigated. Both orexin knockout mice and HDC knockout mice show
sleep fragmentation and increased REM, but the HDC knockout mice show
increased REM during the light phase when mice normally sleep (Anaclet et al.,
2009), whereas orexin mutants display REM during waking hours. In support of
the role histamine may play in narcolepsy, patients with narcolepsy have
decreased levels of histamine in their cerebral spinal fluid (Nishino et al., 2009).
These data begin to underscore the more complicated aspects of sleep-wake
regulation.
Many environmental cues and inputs can promote wakefulness, and
similarly there appear to be many neurotransmitter systems important for the
response to each of those cues. Mice have periods of wakefulness following
introduction to a novel environment such as new cages or new lighting, as well
as increased arousal during and following locomotor tasks. Histamine may play
a critical role in the EEG spectrum of sleep during the day when mice sleep, as
well as in arousal induced by novel environments (Anaclet et al. 2009). Orexin
on the other hand is connected to the wakefulness seen during the night (the
mouse’s active period) and is necessary to maintain arousal during and after
locomotor tasks (Anaclet et al. 2009).
Unfortunately, both pharmacological studies and genetic studies
conducted to date suffer from potential drawbacks. For one, pharmacological
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studies rely on injections that may not be very specifically targeted. In addition,
an agonist or antagonist can often have extraneous effects. On the other hand,
genetic deletions, particularly those that occur during development, are
frequently compensated by the animal. Also, since molecules can have different
functions in different regions, analysis of global knockouts typically does not yield
clear cut results. Perhaps for this reason, sleep phenotypes of genetic knockouts
are often complicated, and sometimes controversial (Alexandre et al., 2006;
Boutrel et al., 1999; Boutrel et al., 2002; Frank et al., 2002; Hedlund et al., 2005;
Monti and Monti, 2007; Waddington et al., 2005; Wisor et al., 2003) . In order to
address the role of each receptor in sleep inducible and anatomically specific
knockouts need to be generated. Moreover, to control for redundancy it may be
necessary to generate animals lacking multiple receptors.
Interestingly virtually all these neurotransmitters, e.g. dopamine, serotonin
and octopamine (invertebrate counterpart of norepinephrine), regulate sleep in
other model organisms such as the fly (Chang et al., 2006)(Yuan et al., 2006)
(Andretic et al., 2008b; Crocker and Sehgal, 2008; Crocker et al., 2010; Kume et
al., 2005; Lebestky et al., 2009; Wu et al., 2008) (Chapter 2,3 of this thesis)
(Figure 1-1). While the work on dopamine and octopamine has confirmed that
they constitute wake-promoting signals as they do in mammals, serotonin in the
fly provides a sleep-promoting signal (Yuan et al. 2006). In general, analysis in
the fly is simplified because, thus far, only one sleep state is known, there are
fewer receptors for each neurotransmitter, and there is also less compensation
and redundancy. It is also possible to map sleep-regulating effects of a molecule
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to specific subsets of neurons through an unbiased genetic approach. Not only
does this provide anatomical information, it also allows visualization of
phenotypes produced by manipulation of just those cells. Using this approach
we recently showed that only a subset of octopamine-producing cells is
responsible for its wake-promoting signal (Crocker et al. 2010)(Chapter 3).
Although wake-promoting neurotransmitters are clearly important in
determining sleep amount, there is much more interest in sleep-promoting
molecules since these could more directly be part of the sleep homeostat. At the
very least, they are required for implementation of sleep drive.

Known sleep-

promoting neuromodulators are discussed below.

GABA:
GABA is a major sleep-promoting neurotransmitter that, when released
from the ventral preoptic area (VLPO) in mammals, inhibits wake-promoting
areas (Gong et al., 2004a). In addition, release of GABA from the nucleus
reticularis of the thalamus, and its action on other thalamic nuclei, promotes the
transition from a wake to a sleep EEG (Cope et al., 2005). While pharmacological
studies have implicated GABA-A receptor in sleep generation, genetic mutants of
the pathway show minimal phenotypes. Mice carrying a point mutation in the
GABA-A receptor, a1-a3, show no changes in sleep amount (Kopp et al., 2003;
Kopp et al., 2004; Tobler et al., 2001). The GABA-A receptor a3 subunit
knockout mice display normal sleep amounts, but have reduced spindle activity
(10-15Hz range during NREM-REM transitions) (Winsky-Sommerer et al., 2008).
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The knockout of the GABA-A receptor d subunit has only been examined after
drug treatment and it shows normal EEG patterns (Winsky-Sommerer et al.,
2007). The role of the GABA-A receptor b3 subunit has been more controversial
with conflicting results on whether there is an effect on sleep and delta power
(Laposky et al., 2001; Wisor et al., 2002a). Redundancy in the GABA signaling
pathway likely accounts for these questionable phenotypes.
In summary, genetic analysis of neurotransmitters that are widely
distributed and necessary for life, such as GABA and glutamate, has proven to
be very difficult in mammals. However, the Drosophila, C.elegans and recently
zebrafish models have provided insight into how these systems are involved in
sleep and its underlying circuitry. For instance, GABA is a major sleep-promoting
signal in flies . Recent work shows that the wake-promoting large central clock
cells, mentioned above, are the primary recipients of the GABA signal relevant
for sleep (Agosto et al. 2008; Parisky et al. 2008; Chung et al. 2009). This
creates a system similar to that seen in mammals, where the sleep-promoting
neurons become active and shut down the wake-promoting centers of the brain.

Somnogens
Very early in sleep research, researchers showed that cerebral spinal fluid
from a sleep-deprived animal could induce sleep in a rested animal (Legendre
and Peiron, 1913). Since those early experiments the hunt has been on for a
specific circulating somnogen that tells your body to go to sleep. Many found the
idea that it could be adenosine very intriguing. The thinking goes that as one
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uses more energy during the day, more and more of the body’s ATP is converted
to adenosine, signaling a need for sleep, which then restores energy levels
(Benington and Heller, 1995).
The data on the role of adenosine are complicated. Mice that carry
mutations in either the A2A or the A1 adenosine receptor do not show profound
changes in sleep (Bjorness et al., 2009; Huang et al., 2005; Stenberg et al.,
2003; Urade et al., 2003). This has been problematic for the field since caffeine
is thought to promote arousal by blocking the A2A receptor (Huang et al., 2005).
To date, the best evidence for a sleep-promoting effect of adenosine comes from
pharmacological studies. However, recently mice expressing a dominant
negative SNARE protein (this blocks the release of neuroactive molecules) in
astrocytes were found to have reduced cortical slow wave oscillations,
characteristic of NREM, and also decreased sleep pressure following periods of
deprivation (Fellin et al., 2009; Halassa et al., 2009). This reduction was thought
to be due to decreased ATP release from astrocytes, and thereby attenuated
build up of extracellular adenosine. The idea is that typically adenosine would
act through the A1 receptor to suppress synaptic transmission and promote slow
wave activity (Fellin et al. 2009). These studies did not map the site of
adenosine action, but they provide a basis for further investigation of a function
for adenosine in sleep.
Caffeine action has also been studied in the fruit fly where it acts through
the cAMP pathway, rather than the adenosine receptor, to promote wakefulness.
In addition, using a cAMP reporter expressed in all neuronal tissue in the fly, Wu
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et al. (2009) found that the effect of caffeine was quite global and not restricted to
a specific region (Wu et al., 2009). Thus, while pharmacological treatment of
flies with an adenosine agonist was shown to promote sleep (Hendricks et al.,
2000a), there are as yet no genetic data to support a role of adenosine in fly
sleep.
Interestingly, cAMP phosphodiesterase (PDE) is a known target of
caffeine, but had been excluded as a possible mechanism to explain effects of
caffeine on sleep in mammals because of the relatively lower affinity of caffeine
for PDE. However, in light of a report indicating that effects of caffeine on
immune function in mammals are mediated by PDE inhibition, as well as the
recent fly data, it is worth re-exploring a role for PDE (Horrigan et al., 2006; Wu
et al., 2009). This is particularly important given that the adenosine receptor
knockouts have little to no sleep phenotype, and cAMP signaling is clearly
involved in sleep regulation (see below). It should also be noted that the fly
experiments involved chronic treatment with caffeine while the mammalian
studies usually deliver it acutely. There may be differences in the mechanisms
used under these different conditions.

Identification of Genes required for sleep homeostasis:
The big question remains -why do we sleep? There is also now the
growing sense that the function of sleep may fall out of its molecular analysis.
Since few sleep-regulating molecules are known, studies are under way to
identify novel genes required for sleep. These studies include forward genetic
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screens and genetic manipulation of candidate genes required for sleep, by
focusing on changes in sleep amount as a readout of sleep homeostasis. In
some cases, the candidate genes are based upon hypothesized sleep functions,
so as to assess how loss or gain of a specific function affects sleep quantity.
(See also Table 1-3).

Genes based upon somatic theories of sleep function
Sleep and the immune response
Is sleep necessary for normal body function such as the immune response
and balanced metabolic activity (Van Cauter et al., 1997)? The idea that immune
modulators like cytokines promote sleep has anecdotal support, since the
mounting of an immune response by the body usually results in fatigue and
sleepiness. Researchers have focused mainly on two cytokines, interleukin -1B
(IL-1B) and tumor necrosis factor -α (TNF-a) as sleep-promoting molecules.
Mice lacking IL-1B show decreased NREM sleep during their active time while
mice lacking TNF-a show decreased NREM during their sleep time (Fang et al.,
1998; Krueger et al., 1998). In addition, double knockouts lacking both IL-1B and
TNF-a show a greater magnitude of slow wave delta power following sleep
deprivation (Baracchi and Opp, 2008). From these data though, one cannot
conclude a causal relationship between the immune system and sleep drive.
These mutant animals still sleep and the lowered NREM may just reflect an
overlap in immune and sleep circuitry.
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Expression profiles undertaken to identify genes whose expression
changes with sleep state have also identified genes in the immune response
pathway (Cirelli et al., 2005b; Williams et al., 2007). In Drosophila, NFKappa B
(Relish) and other immune response genes have been identified in such screens
and are upregulated during wakefulness and prolonged wakefulness. In addition,
flies with decreased levels of Relish have reduced nighttime sleep (Williams et
al., 2007). In the rat cortex also, expression of genes in the immune response
pathway is upregulated during wakefulness, as indicated by microarray studies.
These include lysozyme, COX-2, and I-kappaB α (Cirelli et al., 2005b). However,
while the microarray studies support the genetic mutant data, they also do little to
address causality. They are nevertheless useful for identifying associations
between gene expression profiles and behavioral states.

Sleep and metabolism
There have long been theories that sleep is important for metabolism
(Benington and Heller 1995). This is supported by the potential role for
adenosine and by reports showing associations between glycogen levels and
sleep (Kong et al., 2002). In addition, there appears to be anatomic overlap in
the regulation of sleep and metabolism. For instance, the mammalian
hypothalamus is an important control structure for both processes. Recent work
in the fly also implicates its major hormonal and metabolic center as an important
place for the regulation of sleep (Crocker et al., 2010; Foltenyi et al., 2007)
(Chapter 3) (Figure 1-1).
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Epidermal growth factor receptor (EGFR), a receptor important for cell
proliferation and growth through different signaling pathways, is implicated in
sleep regulation in Drosophila and in C.elegans (Foltenyi et al., 2007; Van
Buskirk and Sternberg, 2007). Foltenyi et al. (2007) found that increased
signaling of the EGFR pathway results in increased sleep. Signaling was
increased through gain of function mutations of the EGFR ligands in an area of
the fly brain homologous to the hypothalamus, known as the Pars Intercerbralis
(PI) (Figure 1-1), and was correlated with changes in downstream ERK signaling.
Our own recent work shows that wake-promoting effects of octopamine are
mediated by insulin-producing cells in the fly brain, which are also located in the
PI.(Crocker et al., 2010)(Chapter 3).
The EGFR pathway is also implicated in C. elegans sleep. The C.
elegans model for sleep focuses on a developmentally regulated state of
quiescence, called lethargus, that occurs in conjunction with larval molts.
Interestingly, lethargus is regulated by the worm homolog of the circadian gene
per, and is associated with synaptogenesis (a hypothesized function of sleep),
suggesting that it represents a primordial sleep-like state (Raizen et al., 2008;
Van Buskirk and Sternberg, 2007). Over-expression of lin-3 (ligand for EGFR)
induces lethargus-like behaviors (Van Buskirk and Sternberg, 2007). The
receptor Let-23 (EGFR) is found in only a handful of neurons, of which the ALA
neurons are responsible for the effect of lin-3 on lethargus (Van Buskirk and
Sternberg, 2007). These neurons are neuroendocrine in nature, similar to the
neurons through which EGF affects sleep in flies. Thus, in the mouse, the fly and
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in the worm, metabolic and endocrine functions appear to be tied to sleep.
Whether it is just an anatomical overlap or a functional overlap still needs to be
addressed.
Many mouse mutants with altered metabolic function also show changes
in sleep. For instance, mouse knockouts of the ghrelin gene show a slight
increase in sleep (Laposky et al., 2008). Correspondingly, leptin deficient mice
have a decrease in NREM sleep and increased fragmentation (Szentirmai et al.,
2007). Mice that do not make growth hormone releasing hormone (GHRH) and
its receptor show significantly less NREM sleep, whereas mice overexpressing
growth hormone sleep more (Obal et al., 2003; Obal et al., 2001). Unfortunately
these studies do not address the fundamental question of whether increased
hunger in these animals overrides the sleep signal.
More recently genes important for dealing with cellular stress have been
implicated in sleep regulation. Through both differential expression profiles and
targeted gene approaches, the gene Bip is implicated as a sleep-promoting
factor. Bip is important for the unfolded protein response in the ER and is
upregulated following periods of sleep deprivation in mice (Cirelli et al., 2005b).
In addition, flies with altered Bip levels show changes in their homeostatic
response to sleep deprivation (Naidoo et al., 2007).

Genes Important for Synaptic Modulation:
One of the current hypotheses for why we sleep is that it allows for or
even promotes synaptic downscaling (Tononi and Cirelli, 2006). This hypothesis
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is based upon the presumption that during wakefulness interaction of animals
with their environment leads to the strengthening of some synapses while others
remain the same. It postulates that synaptic downscaling during sleep promotes
efficiency in terms of energy and space while maintaining the relative ratios of the
strength of synapses. This hypothesis has been supported in recent years by
differential expression studies of genes whose expression changes with
sleep/wake state. Many immediate early genes and genes that regulate synaptic
strength were identified in these studies. These include NARP and Homer1a in
the awake rat cortex (Cirelli et al., 2005b). In addition, knockouts of c-Fos
(another immediate early gene marking neuronal activity) and Gria3 (AMPAreceptor GluR3 subunit) in mice show alterations in their sleep (Shiromani et al.,
2000; Steenland et al., 2008). The c-Fos null animals have more wakefulness
and reduced slow wave sleep and the Gria3 animals show dampened EEG
powers across waking and NREM sleep but no changes in total sleep amount
(Shiromani et al. 2000; Steenland et al. 2008). The Homer1a gene was also
identified in QTL analysis as a strong candidate for a gene underlying sleep
homeostasis and magnitude of delta power (Mackiewicz et al., 2008; Maret et al.,
2007). More recent work by Gilestro et al. (2009) monitored genes known to
target the synapse and used them to monitor changes in synapses following
across normal sleep wake stages as well as periods of sleep deprivation. They
found sleep was necessary for declining synaptic marker strength (Gilestro et al.,
2009).
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While these results are tantalizing, it may be premature to conclude that
synaptic downscaling is a function of sleep. In order to definitively address this
question, genetic tools that allow one to better visualize circuitry and synapses
need to be employed. Zebrafish provide an ideal model organism for such
approaches since they are translucent and thus allow one to visualize changes in
synapses.

Ion Channels and Channel-Regulating Molecules
Forward genetic screens in the fruit fly have identified sleep-regulating
genes that are important for K+ channel activity. The Minisleep (mns) fly line,
isolated in a genetic screen, carries a mutation in the Shaker K+ channel (Cirelli
et al., 2005a). Based upon the mns phenotype, a mutation in the β subunit of
Shaker, hyperkinetic, was tested and also found to reduce sleep (Bushey et al.,
2007). An independent genetic screen isolated a short sleeping mutant known as
sleepless which also affects activity of the Shaker K+ channel (Koh et al.,
2008)(Wu et al., 2010). Both the sleepless and the Shaker mutants sleep very
little at night. Interestingly neither of these mutations has been rescued in a
specific area of the fly brain, suggesting that a global change in synaptic
properties underlies sleep.
These mutants have other phenotypes as well, such as shorter lifespan,
ether sensitivity and in the case of Shaker a learning and memory deficit (Bushey
et al., 2007; Koh et al., 2008). In the case of sleepless it was found that the ether
sensitivity could be rescued independent of the sleep phenotype (Koh et al.
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2008). It would be interesting to know whether lifespan can also be rescued
independently.
In mice the large number of ion channels, subunits and distribution has
made it difficult to identify the role these play in sleep. Indeed, based upon the
redundancy of K+ channels in mammals, it is unlikely that mutations in these
would have been found through forward genetic screens since such screens
typically require strong phenotypes. However, reverse genetic approaches have
allowed the detection of subtle sleep phenotypes in mice mutant for Shaker-like
channels (Douglas et al., 2007; Espinosa et al., 2004; Espinosa et al., 2008;
Vyazovskiy et al., 2002). In addition, mice lacking an N-Type calcium channel α
1b subunit have a sleep phenotype. This subunit is important in many of the
major anatomical regions important for arousal including the locus coeruleus and
the dorsal raphe (Beuckmann et al., 2003). Accordingly, mice lacking this
subunit show hyperactivity (increased consolidation of REM and increased
NREM to Wake transitions). These mice also show decreased power during
NREM sleep, implying decreased sleep drive. When the α 1G subunit of the Ttype Ca++ channel is knocked out globally in mice they display decreased NREM
cortical EEG oscillations, due to the inability of thalamical relay neurons to go into
a bursting mode, and increased fragmentation of sleep (Anderson et al., 2005;
Lee et al., 2004). The same phenotype is observed when this subunit is knocked
out specifically in the thalamus, thereby verifying lesion studies which implicate
the thalamus in arousal and in the generation of the sleep EEG (Anderson et al.
2005). Along the same lines, mice lacking the SK2 channel (a K+ channel
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specific to the dendrites of the nucleus reticularis of the thalamus) show
weakened delta waves and spindles in the EEG, which results in very
fragmented sleep (Cueni et al., 2008). This K+ channel couples with the T-type
Ca+ channels described above. These animals provide an ideal model to
determine how specific electrical attributes of cortical neurons correlate with
sleep EEG.

Genes Involved in Learning and Memory
In both mice and flies many genes important for learning and memory
have been targeted for sleep analysis. These include but are not limited to
CREB, Protein Kinase A (PKA), cAMP, ERK, cGMP and some of the ion
channels listed above.
Manipulations of CREB, a transcription regulator, influence total sleep and
NREM in mice (Graves et al., 2003b). Thus mice lacking either one of two CREB
isoforms in the entire brain show altered sleep. These animals spend less time
awake and have longer bouts of NREM sleep. They also have altered memory
formation and reduced long term potentiation (Graves et al., 2002). The effect on
long term potentiation (LTP) and hippocampal-dependent memory formation is
similar to what is seen following a period of sleep deprivation (Graves et al.,
2003a). More recently, effects of sleep deprivation on LTP were rescued by an
inhibitor of a specific phosphodiesterase, supporting the idea that effects of sleep
on hippocampal plasticity are mediated by cAMP signaling (Vecsey et al., 2009).
Another molecule implicated in learning and memory and sleep is brain derived
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neurotrophic factor (BDNF) (Monteggia et al., 2004). Levels of BDNF increase
with increased exploratory behavior which also increases the depth of delta
power during sleep (Huber et al., 2007). The role of BDNF may not be
independent of CREB since BDNF is a major target of CREB.
The mammalian work linking sleep with learning and memory genes has
been largely limited to analysis of BDNF and CREB. In the fly this is not the
case. There are many tools available to fly researchers that allow one to probe
very specific parts of these pathways. Two important intracellular pathways
implicated in sleep are the cAMP-PKA pathway and the ERK pathway (Foltenyi
et al., 2007; Hendricks et al., 2001; Joiner et al., 2006). It is thought that the
cAMP pathway provides a wake-promoting signaling pathway, whereas the ERK
pathway, at least within a subset of neurons, is sleep-promoting. Mutants and
transgenic flies carrying manipulations of these different signaling pathways have
also helped to locate anatomical regions important for sleep regulation. In the
case of cAMP and PKA, an area known as the mushroom body is important
(Joiner et al., 2006; Pitman et al., 2006) (Figure 1-1). The mushroom body is
similar to the hippocampus in mammals in that it is involved in memory formation
(Heisenberg, 2003).
Bushey et al. (2007) correlated short sleep with short term memory deficits
in flies (Bushey et al., 2007). They specifically looked at hyperkinetic flies and
variations of the Shaker mutation and found that regardless of other behaviors,
the sleep phenotype (short sleep) and decreased memory are associated. It is
currently unknown whether short sleep causes a memory deficit or vice versa.
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Following a period of sleep deprivation learning is impaired, but the converse has
also been argued (Cirelli, 2009). Genetically manipulating the mushroom body in
the fly, as described above, can produce either short or long sleepers depending
on the region targeted. In addition flies exposed to an enriched environment
sleep more (Donlea et al., 2009; Ganguly-Fitzgerald et al., 2006). This increase
in sleep is dependent on cAMP presumably because it involves memory
consolidation, and can be rescued within the central clock cells in the fly (Donlea
et al. 2009) (Figure 1-1).
As in flies and mammals, cyclic nucleotide pathways affect lethargus in
worms.. Worms deficient in egl-4 (cGMP-dependent kinase) have reduced
periods of quiescence, whereas gain of function mutants of egl-4 show enhanced
quiescence (Raizen et al., 2008). Similar sleep phenotypes are observed in flies
that have alterations in PKG (similar to egl-4) (Raizen et al. 2008). Also a mouse
conditional brain knockout of cGMP-dependent protein kinase type 1 causes
increased sleep fragmentation, exaggerated delta rebound following deprivation
and reduced REM sleep (Langmesser et al., 2009). Thus a role for cGMP in
sleep is conserved across evolution. cGMP protein kinase mutants also have
defects in learning and memory, in both mice and flies (Feil et al., 2009).
While the analysis of genetic mutants may not have provided major
breakthroughs in our knowledge of sleep up to this point, it has been critical in
many respects. First, even where the studies have been purely confirmatory,
they have served to unequivocally establish a particular mechanism or a role for
a specific molecule in sleep. This extends also to genes underlying diseases
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associated with sleep problems: Sleep disturbances have been reported in
people with Angelman syndrome and Fragile X syndrome, and in both cases
knockout f the relevant gene in mice and/or flies has produced a circadian/sleep
phenotype (Dockendorff et al., 2002; Wu et al., 2008; Zhang et al., 2008). In
many cases, genetic mutants have helped to resolve controversies. Moreover,
forward genetic screens in model organisms are already identifying new
molecules and will likely also lead to paradigm-shifting findings. Such screens
immediately associate gene with function and importantly, they are done in a
completely unbiased fashion which arguably is the best approach for a process
about which little is known. Finally, the anatomic studies conducted in
invertebrates are already indicating overlap between sleep and other aspects of
physiology e.g. metabolism. These findings could be invaluable for what they
suggest about sleep function. Importantly, they can be easily followed up with
experiments designed to address specific hypotheses
The future potential of genetic approaches is also tremendous, given the
rapid development of novel genetic tools and technology. For example the use
of optogenetic tools has already provided insight into the orexin pathway
(Adamantidis et al., 2007; Zhang et al., 2007) In addition, inducible and tissuespecific gene expression, which will allow precise targeting of genetic
manipulations, will undoubtedly clarify the sleep function of genes whose role is
currently controversial. In an interesting merge of pharmacological methods and
genetic tools, viruses have been developed which can be introduced into specific
anatomic areas (Adachi et al., 2008; Fuller et al., 2008) .. The fly provides many
33

unique genetic techniques, some of which have been discussed in the course of
this review. Recently there has been an explosion of tools which allow scientists
to alter activity/signaling within a subset of neurons; this includes but are not
limited to expression of Na+ channels, K+ channels, Ca++ channels and vesicular
release blockers (for review see (Hodge, 2009)). This is a huge advance for
behavioral studies because electrophysiological stimulation of neurons to alter
behavior has to be done in a very artificial controlled environment in mammals,
but in flies since this is done genetically they are able to behave normally in an
unrestricted environment. cAMP monitors have also been developed that can be
specifically expressed in certain cells and do not rely on bath application or
injection (Shafer et al., 2008). Finally, in flies and mammals techniques have
been developed to specifically tag a subset of neurons in the brains and
determine their expression profile (Miller et al., 2009; Zong et al., 2005).

Conclusion
Genetics can tell us a lot about what sleep does for organisms, but the
potential of this approach has only just started to be recognized in the sleep field.
With the generation of conditional and anatomically restricted knock-outs (or
knock-ins) in mice, we are on the verge of answering many questions. These
include determining the roles of adenosine and BDNF in sleep and memory. In
flies anatomically and/or temporally-restricted expression of sleep-regulating
transgenes has already been performed. These approaches have provided great
insight into the role specific signaling pathways play in sleep. In the future this
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technology will be used to rescue sleep mutants in a region-specific manner
although some of these mutations, such as in ion channels, may turn out to have
global effects that cannot be rescued in specific areas. However, the real power
of the fly, worm and fish models lies in their amenability to unbiased genetic
screens. With a process like sleep, about which little is known, we suggest that
the best approach is one that is not associated with any preconceived
assumptions, since it allows the identification of completely novel mechanisms
and pathways. Thus far it appears that redundancy and/or compensation in
mammals will make it difficult to detect strong phenotypes through genetic
screens. The fly work, on the other hand, has already demonstrated that
mutants with strong phenotypes can be identified.
While forward genetic screens in mouse may not be realistic (or costeffective), QTL analysis and microarray approaches are yielding potential sleepregulating genes. The use of new genetic tools described above will allow
researchers to investigate whether or not these genes specifically affect sleep.
An example of this is provided by the Rarb story, where the gene was identified
through QTL mapping, and then specific targeted disruptions of this gene were
undertaken.
At this point, there is no evidence that a single gene or subset of genes
acting in specific subset of neurons is responsible for sleep. It is more likely that
a sleep is a network phenomenon. It is also likely that there will be many
hypotheses for why we sleep and strong evidence for each, since many of the
neurotransmitters and signaling pathways that keep us awake serve other
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functions. For instance, orexin is apparently involved in both feeding behavior
and maintaining wakefulness. Sleep deprivation results in several impaired
processes, some of which may turn out to reflect consequences of increased
wakefulness rather than indicating an actual function of sleep. With the
advancement of new genetic tools, it is likely that we will soon see experiments
directly testing some of these hypotheses such as cellular metabolic function and
synaptic scaling.
From the data discussed in this review it is likely that sleep is important for
overall homeostatic regulation of the entire organism, possibly down to within the
cell homeostasis. It is clear that sleep is a very basic process and that studying it
in model organisms will provide significant insight into why we sleep. In general,
advances in genetics in all model organisms will provide a wealth of knowledge
for the sleep field in the coming years.

Introduction Part 2: Octopamine
The focus of this thesis is on the neurotransmitter, octopamine, the insect
homolog of norepinephrine. I chose to work on octopamine because it is a major
invertebrate neurotransmitter and also because receptors for octopamine are
highly expressed in the Mushroom Body (an area known to regulate sleep and
wake) (Joiner et al., 2006; Roeder, 2005). In the fruit fly as well as other
invertebrates, octopamine is synthesized and regulated through pathways that
are distinct from those that produce dopamine, unlike in mammals where
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dopamine is a precursor in the synthesis of norepinephrine (Roeder, 1999).
Octopamine is known to play a role in memory formation, larval locomotion, wing
beating, ovulation and aggression (Cole et al., 2005; Hoyer et al., 2008; Lee et
al., 2003; Roeder, 2005; Saraswati et al., 2004; Schwaerzel et al., 2003), but its
effects on sleep have not been examined.

Octopamine Biochemistry:
Octopamine is synthesized through a series of enzymatic reactions
beginning with the molecule tyrosine. This is unlike the synthesis of mammalian
norepinephrine, which is synthesized from dopamine via the enzyme dopamine β
hydroxylase (Livingstone and Tempel, 1983; Roeder, 1999). In flies dopamine is
also synthesized from tyrosine, but through an enzyme known as tyrosine
hydroxylase, whereas the first step in octopamine synthesis is catalyzed by the
enzyme tyrosine decarboxylase 2 (Tdc2). Tdc2 synthesizes tyramine (the
precursor to octopamine), thus, disruption of Tdc2 results in low levels of
octopamine and tyramine (Cole et al., 2005). The second step involves an
enzyme known as tyramine β-hydroxylase (TβH) which results in the synthesis of
octopamine from tyramine. Loss of TβH reduces octopamine levels but increases
tyramine levels tenfold (Monastirioti et al., 1996). It is generally thought that TβH
is the fly homolog of mammalian dopamine β-hydroxylase (DbH). Since
synthesis of both amines (tyramine and octopamine) requires Tdc2, the cellular
distribution of Tdc2 should reflect cells that potentially produce both tyramine and
octopamine, but not dopamine.
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Octopamine Receptors:
In flies there are two classes of octopamine receptors, which are
categorized as either α or β receptors (Evans and Maqueira, 2005; Evans and
Robb, 1993; Han et al., 1998; Maqueira et al., 2005; Robb et al., 1994; Roeder,
1992; Verlinden et al., 2010). This classification stems from their homology to
mammalian α and β adrenergic receptors. Alpha receptors in both mammals and
in flies cause increases in Ca++. Increases in cytosolic Ca++ attributable to
activation of the octopamine α receptor results from the opening of channels in
the endoplasmic reticulum and the release of internal stores. This is
accomplished through activation of the phospholipase C (PLC) pathway (For
review see (Verlinden et al., 2010). Unlike their mammalian counterparts, the
Drosophila isoforms of the α receptors also couple to cAMP. This is true for the
OAMB receptor (octopamine receptor first found in the MBs) and the OA1
receptor. OAMB specifically has two isoforms: the K3 and the AS (Lee et al.,
2009). The K3 isoform couples to both Ca++ and cAMP and in some ways
behaves more like the octopamine β receptor than the α receptor. The AS
isoform only couples to Ca2+ and is a true octopamine α receptor. It behaves
similar to the α adrenergic receptor.
The octopamine β receptors known as octB1R (also OA2), OctB2R and
OctB3R, act like mammalian β receptors and all lead to increases in cAMP
(Maqueira et al., 2005). Interestingly, most octopamine receptors are also
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sensitive to tyramine, the other amine produced in Tdc cells, though at a much
lower affinity (Roeder et al., 1995). Tyramine also has its own class of receptors
which cause a decrease in cAMP when stimulated by tyramine, but an increase
in Ca2+ when stimulated by octopamine (Roeder, 2005). These receptors are all
thought to be G-protein-coupled receptors and support a role for agonist-receptor
trafficking schemes, where receptors change their conformations in response to
different agonists. This allows for signaling via different second messenger
pathways.

Actions of octopamine in invertebrates:
Octopamine has been extensively studied in invertebrates other than
Drosophila. Like norepinephrine in mammals, octopamine is implicated in stress,
aggression, locomotion, learning, memory and other behaviors (Chentsova et al.,
2002a; Saraswati et al., 2004; Schwaerzel et al., 2003; Sitaraman et al., 2010;
Zhou and Rao, 2008) (For review see (Verlinden et al., 2010). In mammals,
norepinephrine is an important contributor to stress (For review see (Goddard et
al., 2010). Norepinephrine is derived from specific cell populations in the Locus
Coeruleus (LC) and the brainstem groups known as A1 to A7 (Sara, 2009). The
LC neurons are important for coordinating the stress response, and a subgroup
of LC neurons along with the A1/A2 neurons regulate corticotrophin-releasing
neurons (CRH neurons) of the paraventricular nucleus. The CRH neurons are
important for mediating the metabolic and adaptive response to acute stress in
mammals (Lightman, 2008). In invertebrates, octopamine may play a similar
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role. Octopamine levels rise in response to many stresses, including immune
challenge, heat, starvation, mechanical stress and others forces, in honeybees,
locusts, cockroaches and Drosophila (Chen et al., 2008; Davenport and Evans,
1984; David and Coulon, 1985; Evans and Robb, 1993; Harris and Woodring,
1992; Hirashima and Eto, 1993; Orchard et al., 1993). Worker honeybees show
an increase in octopamine when their legs have been clamped to prevent
movement. This result demonstrates the sensitivity of this biogenic amine to
handling stresses during experimentation (Harris and Woodring, 1992). Studies
of stress in the cockroach employed vibrations, flashing lights or immersions in
60°C heat baths. Each of these stresses resulted in an increase in octopamine
levels (Hirashima and Eto, 1993). In locusts, the stress of long flights also
increases octopamine levels (Orchard et al., 1993). Interestingly, the two studies
that examined heat stress in Drosophila showed that TDC activity dramatically
decreases in females and only modestly decreases in males in response to heat
(Chentsova et al., 2002b; Gruntenko et al., 2004). This result is contradictory to
previous work showing an increase in octopamine in response to stress in other
invertebrates.
Octopamine in worker honeybees is also an important foraging signal, with
levels highest during the peak annual foraging season, June through September
(Harris and Woodring, 1992). Octopamine also regulates job position in the
honeybee hive colony (Schulz and Robinson, 2001b). Worker bees begin their
lives maintaining the hive and the Queen. Following increases in octopamine and

40

juvenile hormone (JH) levels, they transition to foraging outside the hive(Schulz
et al., 2002) .
Octopamine also modulates other basic biological functions such as
metabolism in invertebrates. In locust and crickets, octopamine affects global
metabolism, including the release of Adipokinetic Hormone (AKH), which is
activated in response to starvation and acts to liberate fat stores (for review see
(Roeder, 2005). Octopamine itself also acts on the fat body of these insects to
liberate fat stores synergistically with AKH. This effect has been observed
during the energy-demanding migratory flights of locusts(Orchard et al., 1993). A
similar situation is found in mammals where norepinephrine breaks down
glycogen and releases fat stores.
In many invertebrate species octopamine has been shown to induce
locomotion and arousal (Barron et al., 2002a; Roeder et al., 2003; Saraswati et
al., 2004). In fact, it is used in pesticides where it induces a ’walk off leaf’
phenotype and thereby promotes pest removal (Roeder et al., 2003). A recent
study showed how the venom of parasitic wasps acts on the octopamine system
in cockroaches to cause hypokinesia and prevent the cockroach from fleeing the
wasp (Rosenberg et al., 2007). This allows the wasp to lay its eggs inside the
cockroach. The hypokinesia caused by the venom can be rescued through
octopamine injections to the brain of the cockroach.
More recent research has demonstrated a role of octopamine in even
more complex behaviors such as aggression, learning and memory, and cocaine
sensitivity (Baier et al., 2002; Hardie et al., 2007; Hoyer et al., 2008; Schwaerzel
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et al., 2003; Sitaraman et al., 2010; Zhou and Rao, 2008). Indeed, there is a
current surge of studies on the role of octopamine in complex behaviors in
Drosophila. To this end, many octopamine-signaling mutants have been
generated, along with methods to target and modulate the neurons that produce
octopamine. These reagents have been used to demonstrate that octopamine
signaling in the mushroom body (the olfactory learning center in the fly) is
necessary for the fly to acquire appetitive (sucrose-associated) memories but not
place memories (Schwaerzel et al., 2003; Sitaraman et al., 2010). In addition, the
ventral unpaired medial group of octopaminergic neurons in the fly brain is
necessary for a male fly to show aggression (Zhou and Rao, 2008).
Prior to this thesis work, the role of octopamine in wakefulness in the fly
remained unknown.,
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Figure 1-1

Figure 1-1. Brain regions in the fly important for sleep–wake regulation. Many of
the major neurotransmitter systems within the fly have been analyzed for their
role in sleep. In the biogenic amine category, only octopamine has been localized
to a specific cell group relevant for its role in sleep–wake behavior (purple).
Dopamine and serotonin play a role in the regulation of sleep, but the specific
subgroups of cells have not been mapped, and thus the major cell groups that
produce these transmitters are shown in this figure (black and yellow). PDFproducing large ventral lateral neurons (LNv) are important for promoting arousal
in response to light and are shown in blue. Despite not knowing where the
neurotransmitter signals originate, areas that receive these signals have been
identified (PI neurons or mushroom body). Manipulation of intracellular signaling
pathways has also implicated these areas (PI neurons and mushroom body).
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Table 1-2
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Table 1-3
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Abstract
Sleep is a fundamental process, but its regulation and function are still not
well understood. The Drosophila model for sleep provides a powerful system to
address the genetic and molecular mechanisms underlying sleep and
wakefulness. Here we show that a Drosophila biogenic amine, octopamine, is a
potent wake-promoting signal. Mutations in the octopamine biosynthesis
pathway produced a phenotype of increased sleep, which was restored to wild
type levels by pharmacological treatment with octopamine. Moreover, electrical
silencing of octopamine-producing cells decreased wakefulness, where as
excitation of these neurons promoted wakefulness. Because protein kinase A
(PKA) is a putative target of octopamine signaling and is also implicated in
Drosophila sleep, we investigated its role in the effects of octopamine on sleep.
We found that decreased PKA activity in neurons rendered flies insensitive to the
wake-promoting effects of octopamine. However, this effect of PKA was not
exerted in the mushroom bodies (MB), a site previously associated with PKA
action on sleep. These studies identify a novel pathway that regulates sleep in
Drosophila.

Introduction
Sleep is a core process that spans genetically diverse eukaryotes from
mammals to arthropods (Allada and Siegel, 2008; Tobler, 2005) . Disrupting
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sleep in any of these organisms is detrimental to their performance, memory and
health (Rechtschaffen, 1998). Extreme loss of sleep can even lead to death
(Shaw et al., 2002). Thus, it must serve a very important function. Its
conservation over evolution supports this claim for another reason: the need to
sleep must outweigh selection pressure to eliminate it as a risk to predation.
However, the function of sleep is unknown and the molecular regulation
underlying it is poorly understood.
Sleep can be monitored through electroencephalograms (EEG) and
electromyograms (EMG), but when such electrophysiological recordings are
technically difficult, as in the case of Drosophila, it is monitored through analysis
of behavior. Drosophila show a sleep state characterized by changes in position,
increased arousal threshold, and periods of inactivity which can last several
hours (Hendricks et al., 2000a; Shaw et al., 2000). Although little is known about
the regulation of this sleep state, effects of some neurotransmitters have been
described. Thus, GABA and serotonin promote sleep, the latter by acting
through the 5-HT1A receptor expressed in the mushroom body (MB) (Yuan et al.,
2006). The only arousal-promoting signal identified in Drosophila is dopamine
(Andretic et al., 2005; Kume et al., 2005).
In mammals, dopamine and norepinephrine are associated with
states of arousal (Aston-Jones and Bloom, 1981). However, results regarding
the effects of norepinephrine on total sleep and wake amounts have been mixed
(Hunsley and Palmiter, 2003; Ouyang et al., 2004), in part because of differences
in experimental protocols and also perhaps attributable to the effects of
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norepinephrine manipulation on dopamine levels (Schank et al., 2006). The
insect equivalent of norepinephrine, octopamine, is synthesized and regulated
through pathways that are distinct from those that produce dopamine. However,
although octopamine is known to play a role in memory formation, larval
locomotion, wing beating, ovulation and aggression (Roeder, 2005), it has not
been examined for effects on sleep. Here we demonstrate a novel role for
octopamine in the regulation of sleep and wake in Drosophila. Feeding
octopamine to flies leads to a protein kinase A (PKA)-dependent decrease in
total sleep, whereas removal of octopamine from the food is followed by a sleep
rebound. In addition, flies mutant for octopamine show an increase in total sleep,
which can be restored to control levels with the administration of octopamine. We
show that electrical excitation of octopamine-producing cells decreases total
sleep, whereas electrical silencing of these cells increases sleep. Other
parameters of sleep such as sleep latency and arousal threshold are also
altered. Last, we demonstrate an activity-promoting role for the octopamine
precursor, tyramine, which is independent of the effects of octopamine.

Methods
Fly Strains Used
Wild-type fly strains include w;RC1;RC1 (isogenized chromosome 1 from
the w1118 stock; isogenized chromosomes 2 and 3 from the RC1 strain), w1118,
Canton S, Iso31 (Isogenic w1118 strain). Octopamine production mutants include
Tdc2RO54 (Tyrosine decarboxylase 2 mutant), TβHnM18/FM7 (Tyramine Β
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Hydroxylase mutant). Gal4 lines included Tdc2-Gal4 (neuronal Tdc2 expression
pattern), Tdc1-Gal4 (non-neuronal Tdc1 expression pattern), ElavGeneSwitch
(pan-neuronal expression during adulthood), MBSwitch (mushroom body specific
expression during adulthood). Upstream Activating Sequence (UAS) lines include
, UAS-B16B (NaChBac) (bacterial Na+ channel), UAS-Kir2.1(inward rectifying K+
channel), UAS-BDK33 (PKAr) (Drosophila inhibitory subunit of PKA with
mutated cAMP binding site), UAS-Tdc2, UAS-Tdc1. The following lines were
ordered from the Bloomington Stock center: Tdc2-Gal4 (9313), Tdc1-Gal4
(9312), UAS-NaChBac (9466), UAS-Tdc2 (9315), UAS-Tdc1 (9314), UASGFPnls (7032), Iso31 (5905). UAS-Kir2.1 and UAS-B16B were a gift from Dr. B.
White (National Institutes of Health, Bethesda, MD). ElavGeneSwitch
(Osterwalder et al., 2001), MBSwitch (Mao et al., 2004) and UAS-BDK33 (Rodan
et al., 2002) were used previously in the laboratory (Hendricks et al., 2001; Joiner
et al., 2006). The wild-type isogenic line w;RC1;RC1 was a gift from W. Joiner
(University of Pennsylvania, Philadelphia, PA). Tdc2RO54 lines and w1118
background line were a gift from Dr. G. Schupbach (Princeton University,
Princeton, NJ) and Dr. J. Hirsh (University of Virginia, Charlottesville, VA). The
TβHnM18/FM7, TβHm6/FM7, and Canton S background control were a gift from Dr.
E. Kravitz (Harvard University, Boston, MA).
All Gal4 and UAS lines were outcrossed 7 times into the w;RC1;RC1 or
Iso31 background. The w;RC1;RC1 background was chosen for the Tdc2-Gal4
expressing Kir2.1 because it shows lower levels of nighttime sleep (Table 2-1)
and thus affords the potential to avoid a ceiling effect.
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Sleep Analysis
Sleep analysis was performed as previously described (Joiner et al.,
2006). All flies were kept on a 12h light/dark (LD) cycle at 25˚C schedule unless
otherwise noted. Female and male flies 4-8 d old were placed in 65mm x 5mm
tubes containing 5% sucrose and 2% agar and entrained for 24-36 h before the
sleep recording. Baseline sleep was determined by monitoring activity for at least
3 d with no disruptions in an LD cycle. Locomotor activity was monitored using
the DAMS/Trikinetics system as described previously (Joiner et al., 2006). Sleep
was defined as a 5 m bout of inactivity as described previously (Joiner et al.,
2006; Shaw, 2003) . Latency to sleep was defined as the time in minutes from
the moment lights were turned off to the first bout of sleep. Sleep consolidation
scores were generated based on the amount of fragmentation seen in sleep, as
measured by brief awakenings and the length of sleep bouts.
Arousal Threshold
Arousal threshold was measured at three times of the night (2 h after
lights off, 6 h after lights off and 10 h after lights off). Increasing levels of
mechanical stimulation were applied to determine the minimum stimulus for
arousal. The levels were then labeled weak, medium, and strong, with weak
being the lowest level of stimulation and strong being the maximum. Animals
were scored based on their response to these three levels (Hendricks et al.,
2000a).
Feeding Octopamine and Tyramine
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Wild-type (w;RC1;RC1, Iso31) female animals were loaded into monitors
as described above and given 24-36 h to acclimate. One day of baseline data
were collected, and then, at the lights-on transition, the flies were transferred
either to tubes containing 5% Sucrose/2% Agar plus 10mg/ml octopamine or
onto sucrose- agar alone. Octopamine administered at 10mg/ml orally, was
shown previously to be optimal for rescuing egg-laying (Monastirioti et al., 1996).
A dose-response curve of Iso31 flies on octopamine is shown in Fig. 2-10a. The
animals were left for 3 d on or off octopamine and removed at the lights-on
transition. Rebound was determined and analyzed as previously described for
sleep deprivation (Joiner et al., 2006). The males were examined in the same
manner; however 10mg/ml octopamine was fatal for them over three d so the
octopamine concentration was reduced to 5mg/ml (data not shown). Other
concentrations of octopamine were tested, but 10mg/ml was found to be the
optimal amount for 3 d for wild-type females (Fig 2-10a). A blue food assay was
performed as described (Edgecomb et al., 1994) to ensure that the animals were
eating the food (data not shown). Because of the lethality seen with 10mg/ml
octopamine, the TβH nm18 females and controls were placed on 7.5mg/ml
octopamine.
Tyramine was also fed to wild-type flies. Similar to what was seen with
octopamine, tyramine at higher concentrations produced increased lethality so
wild-type male flies were fed 5mg/ml tyramine in 5%sucrose/2%agar. Females
were placed on 10mg/ml tyramine in 5%sucrose/2%agar. We tested other
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amounts of tyramine and determined that 10mg/ml was the optimal concentration
(data not shown).
Mianserin was also used to address octopamine signaling. Based upon
the work of Maqueira et al. (2005), who used this compound to block cAMP
increases attributable to octopamine in vitro (Maqueira et al., 2005), it was used
at 0.2mg/ml. All mianserin experiments were done with Iso31 control flies.
Following the same protocol outlined above for octopamine, we placed flies on
either mianserin alone, mianserin + 10mg/ml octopamine, control food or control
+ 10mg/ml octopamine.
Hydroxyurea Analysis
Ablation of mushroom bodies with hydroxyurea (HU) was performed as
described previously (de Belle and Heisenberg, 1994). First instar larvae of
Iso31 flies were collected and placed on either a yeast paste and water mixture,
or a yeast paste and 50mg/ml HU mixture for 4 h at 25˚C. They were then
washed with water and placed in regular food vials until adulthood. At 4-8 d after
eclosion, animals were loaded into monitor tubes as described above. They
were given three d of acclimation and then transferred onto 7.5mg/ml
octopamine, because high lethality was observed at 10mg/ml. After three d the
animals were then transferred back onto normal 5% sucrose agar tubes. Sleep
analysis was then performed as described above. Following the completion of
the sleep analysis fly heads were dissected in 4% paraformaldehyde and fixed
for 30 m, mounted on slides and analyzed for loss of the alpha and beta lobes of
mushroom bodies.
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PKA inhibition studies
For PKA inhibition studies, we crossed the ElavGeneSwitch transgene into
UAS-BDK33 flies. Octopamine at 10mg/ml was used as described above.
Because the GeneSwitch construct can be turned on during adulthood using the
drug RU486 (11β-(4-dimethylamino)phenyl-17β-hydroxy-17-(1-propynyl)estra4,9-dien-3-one), we placed half the animals on 5% sucrose/2% Agar tubes
containing either 500 µM RU486 dissolved in ethanol or ethanol alone (1%) for
three d. Half of each group was then transferred to octopamine-containing foodeither 5% sucrose/ 2% Agar + 500 µM RU486 + octopamine or 5% sucrose/2%
Agar + ethanol (1%) + octopamine. Both groups were also simultaneously fed 10
mg/ml octopamine for 3 days. At the lights-on transition at the end of this period,
animals were transferred off of octopamine onto 5%sucrose/2% agar containing
either 500 µM RU486 or ethanol (1%). Sleep analysis was performed as
described above.
Statistics
To compare multiple groups, 2-way ANOVA was used to determine
significance for total sleep, nighttime sleep, daytime sleep, sleep bout number
both day and night and latency to sleep. For non-Gaussian distributed data we
used the Kruskal-Wallis Test; this included sleep bout length (daytime and
nighttime), consolidation score, activity per waking minute and peak activity.
Statistical significance is denoted by asterisks. * = p≤ .01, ** = p≤ .001, *** = p≤
.0001.
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Results:
Mutants with reduced octopamine have increased sleep
To address a role for octopamine and its precursor, tyramine, in
Drosophila sleep, we analyzed two known genes that affect biosynthesis of these
amines (Certel et al., 2007; Cole et al., 2005; Monastirioti et al., 1996). As shown
in the flow diagram in Figure 2-1A, the Tdc2 enzyme synthesizes tyramine
(precursor to octopamine) from tyrosine; thus, its disruption results in low levels
of octopamine and tyramine (Cole et al., 2005). In contrast, TβH synthesizes
octopamine from tyramine and therefore its loss reduces octopamine, but
increases tyramine levels 10-fold (Fig.2-1a) (Monastirioti et al., 1996). Because
synthesis of both amines requires Tdc2, the cellular distribution of Tdc2 should
reflect cells that potentially produce both tyramine and octopamine. We
determined the expression pattern of Tdc2 by using the well-known UAS-Gal4
binary system to express green fluorescent protein (GFP) under the control of the
Tdc2 promoter (Fig. 2-1b). Expression of GFP was seen in discrete unilateral
subsets of cells located along the ventral medial line of the brain, as well as in
discrete bilateral clusters of cells in the lateral protocerebrum region and
surrounding the oesophagus cavity.
We then assayed sleep in flies mutant for each of the two genes in the
octopamine biosynthesis pathway. Baseline sleep levels were examined in flies
carrying a point mutation in the Tdc gene (Tdc2RO54) or a lesion, created by
imprecise excision of a P transposable element, in the TβH gene (TβH nm18).
Under baseline conditions, we found that male and female animals of both
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mutants displayed increased levels of sleep (Fig. 2-2a,b; Fig.2-3a,b ). All male
data are shown in Table 2-1 while female data are depicted in Figures 2-2 - 2-5.
The increase in sleep in Tdc2RO54 and TβH nm18 mutants occurred largely during
the day (Fig.2-2a,b; 2-3a,b), perhaps because flies are already sleeping
maximally during the night. The increase in total sleep was accompanied by a
decreased latency to sleep (the time from lights off until the animal’s first bout of
sleep) in the Tdc2RO54 mutants (Fig. 2-2c), suggesting an increase in homeostatic
drive to sleep. The TβH nm18 mutation did not have a significant effect on latency,
although there was a slight decrease in males (Table 2-1). The Canton S
background strain that the TβHnm18 mutants were crossed into displays rapid
onset of sleep compared to other wild type control lines used in this study (Table
2-1), which may occlude any decrease in latency caused by the mutation.
Analysis of sleep architecture indicated that the increase in sleep in
Tdc2RO54 mutants was attributable to an increase in sleep bout number (Table 22), whereas the increase in TβH nm18 mutants occurred from an increase in bout
length (Table 2-2). Because both mutants affect octopamine similarly, this
difference in sleep architecture is most likely attributable to differences in levels
of tyramine. We also determined the arousal threshold in both mutants by
measuring their response to a stimulus of increasing intensity. The arousal
threshold during sleep was higher in both sets of mutants than in wild-type flies
(Fig 2-2d and 2-3c). This suggests that these animals are in a deeper state of
sleep than their controls.
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An increase in sleep could result from the animals being sick and
unable to move. To address this possibility, we measured locomotor activity in
Tdc2RO54 and TβH nm18. We found that Tdc2RO54 and TβH nm18 had peak activity
levels that were not significantly different from those of controls (data not shown).
However, , the TβH nm18 flies showed significantly increased waking activity (Fig.
2-3d), as measured by total activity while awake; despite their increased total
sleep time, the TβH nm18 mutants showed a hyperactive phenotype when awake..
In contrast the average rate of movement was significantly decreased in
Tdc2RO54 flies compared with the wild type controls (Fig. 2-3d) Because activity in
the two mutants is affected in opposite directions, it is unlikely that the increased
sleep phenotype of the mutants is secondary to effects on activity. More likely,
the loss of octopamine (common in both mutants) underlies the decrease in
sleep, whereas differences in tyramine levels account for effects on locomotor
activity. In fact, our data are consistent with previously published data indicating
that the increased (10 fold) levels of tyramine in the TβH nm18 flies cause an
increase in locomotor behavior when awake (Hardie et al., 2007).
It was shown previously that expression of Tdc1 (the non-neuronal
form of Tdc) in Tdc2-producing cells rescues the Tdc2RO54 mutant locomotor
phenotype (Hardie et al., 2007). We found the same to be true for sleep. When
Tdc1 was expressed in Tdc2-producing cells in a Tdc2RO54 background, we found
that we were able to rescue the baseline sleep phenotype (Fig. 2-2E), as well as
sleep architecture and latency to sleep (data not shown).
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Altering excitability of octopamine/tyramine-producing cells affects
sleep
If octopamine and/or tyramine are released in the brain to regulate sleep,
then blocking or increasing their release should also affect sleep. Thus, we
sought to determine if electrical manipulation of the cells producing tyrosine
decarboxylase, which should affect the release of octopamine and tyramine,
produces a change in sleep. The Tdc2-Gal4 line mentioned above, which
expresses Gal4 in cells producing octopamine and tyramine, was crossed to flies
carrying transgenes for ion channels under the control of a UAS element
recognized by Gal4 (UAS-NaChBac or UAS-Kir2.1) (Baines et al., 2001; Cole et
al., 2005; Nitabach et al., 2005; White et al., 2001). The UAS-NaChBac
transgene is derived from a gene encoding a bacterial Na+ channel, which has
the characteristics of high open probability and low inactivation, thus driving
membrane voltage to a more depolarized and easily excited state. Expression of
the Na+ channel in Tdc2-positive cells resulted in a decrease in sleep of 56.5%,
corresponding to a loss of ~346 min (Fig.2-4a,b).

The loss of sleep was specific

to the nighttime, with no significant sleep loss during the daytime, which may be
indicative of normally high octopamine activity during the day. This hypothesis is
consistent with mammalian studies where the noradrenergic cells of the locus
coeruleus fire primarily during the active period (Aston-Jones and Bloom, 1981).
We also found a corresponding increase in sleep latency in these flies. They
took, on average, 74 min longer to fall asleep after lights off (Fig.2-4b). Flies
expressing NaChBac in Tdc2-positive cells also showed a decreased arousal
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threshold, suggesting that they are easily awakened during the night (Fig.2-4d).
Bout analysis indicated that nighttime sleep bouts were shorter in duration (Table
2-2). In addition, there was a significant increase in daytime bout number (Table
2-2), which may reflect increased homeostatic drive resulting from the reduced
sleep at night. However, the animals were unable to maintain long sleep bouts
even under these conditions.
We also expressed a hyperpolarizing K+ channel transgene under the
control of the Tdc2-Gal4 driver and found that this produced an increase in total
sleep (Fig.2-5a,b). Kir2.1 is an inward rectifying K+ channel that has a high open
probability and no inactivation. Expression of this channel hyperpolarizes
neurons and decreases membrane resistance, thus making it more difficult for
membrane potential to reach threshold for firing action potentials (Baines et al.,
2001). Consistent with a previous report, we found that locomotor activity
decreased when Tdc2-Gal4 was used to express the inward rectifying K+ channel
(UAS-Kir2.1) (data not shown). Analysis of sleep parameters, however, revealed
that it was actually an increase in sleep that accounted for the phenotype (Fig.25a,b). Flies expressing UAS-Kir2.1 in Tdc2 cells showed, on average, 174 min
increase in sleep and also displayed changes in several sleep measures such as
latency and arousal threshold. These flies also showed a decrease in latency to
sleep (Fig. 2-5c) and an increased arousal threshold during sleep, requiring more
stimulation to wake up compared with controls (Fig. 2-5d). In addition, they
showed a trend toward longer bouts of sleep during the night, although the major
increase in sleep came from the increased number of sleep bouts during the day
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(Table 2-2). The relative lack of an increase in nighttime sleep length may result
from a ceiling effect of sleep at night.
Although sleep levels and architecture are clearly affected in flies
expressing sodium or potassium channels in Tdc2 neurons, it is possible that
altered activity levels contribute to the overall phenotype. Thus, we also
examined peak activity levels and activity while awake. The Tdc2-Gal4 females
expressing NaChBac showed significantly lower peak activity (Table 2-1) as well
as decreased activity while awake compared with the outcrossed background
control (mean±SEM; w;Tdc2-Gal4/NaChBac;+, 1.7±0.06; Iso31,
2.09±0.06;p≤0.01, Kruskal-Wallis test). However, it is unlikely that a decrease in
waking activity underlies a reduced sleep phenotype. We also found significantly
reduced waking activity in animals expressing the K+ channel under the control of
the Tdc2 driver (Table 2-1). This decrease in waking activity is similar to the
decreased waking activity seen with the Tdc2RO54 mutant, in which levels of both
octopamine and tyramine are low (mean±SEM; w;Tdc2-Gal4/kir2.1;RC1,
2.14±0.06; w;RC1;RC1, 3.87±0.97;p≤0.0001, Kruskal-Wallis test). Thus, reducing
electrical activity in octopamine-producing cells has the same effect on activity
and sleep as a mutation (Tdc2R054) that decreases levels of octopamine.
To ensure that the effect on sleep caused by loss of octopamine signaling
is specific to neuronal Tdc2 and not to a global loss of Tdc, we made use of a
Tdc1-Gal4 driver that is expressed in non-neuronal cells. Expression of the
UAS-B16B transgene (NaChBac channel) under the control of this driver
produced no significant change in sleep (Fig.2-6). Thus, we conclude that the
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sleep phenotype observed in the Tdc2R054 mutant or produced by manipulations
of Tdc cells is specific to the neuronal form of Tdc, Tdc2. Unfortunately the UASKir2.1 channel proved to be lethal with Tdc1-Gal4.
Given that the NaChBac channel increases excitability of Tdc2 cells and
thereby presumably stimulates release of octopamine/tyramine, we asked
whether overexpressing Tdc2 would have the same effect. As predicted, we
found that overexpression of Tdc2 in Tdc2-producing cells resulted in a 300 min
decrease in nighttime sleep (Fig 2-7). As with the NaChBac channel this
appears to be a nighttime specific sleep loss. There was also a decrease in sleep
with the overexpression of Tdc1 in Tdc2-producing cells (data not shown).

Oral administration of octopamine reduces sleep in flies
Because the Tdc2RO54 and TβH nm18 mutants change levels of octopamine
and tyramine, it is important to dissociate the effects of the two to identify the
transmitter responsible for the sleep phenotype. As noted previously, Tdc2RO54
decreases levels of both tyramine and octopamine, whereas the TβH nm18
decreases octopamine but increases tyramine. To determine whether a change
in octopamine is sufficient to regulate sleep, we placed a wild-type isogenic line,
Iso31, on octopamine-containing food for three d. It was shown previously that
animals fed 10mg/ml octopamine have increased levels of this neurotransmitter,
particularly in the brain (Barron et al., 2007). Supporting this finding, ingested
octopamine rescues the egg-laying phenotype displayed by TβH nm18 and
Tdc2RO54 mutants (Cole et al., 2005; McClung and Hirsh, 1999; Monastirioti et
62

al., 1996). We found that flies fed 10 mg/ml octopamine had ~ 200 min less
nighttime sleep than control flies maintained on sucrose-agar alone (Fig.2-8a)
(Dose-response curve is shown in Fig 2-9a). Thus, similar to the UAS-NaChBac
effect, this was a nighttime specific effect. Following the removal of octopamine,
these flies showed a corresponding sleep rebound of ~70 min (mean±SEM;
control, 289.9 ±13.92, n=40; 10mg/ml octopamine, 367.53 ± 16.91, n=40;
p≤0.001, Two-way ANOVA)(Fig. 2-8c). In addition to the effect it had on wild
type flies, a lower concentration of orally administered octopamine (7.5mg/ml
octopamine) was able to restore the sleep phenotype of the TβHnm18 mutant to
control levels (Fig. 2-8c). This concentration of octopamine produced no
significant change in sleep in the Canton S strain, which is the background of the
TβH nm18 mutants.
To exclude the possibility that the sleep phenotype was attributable to
some non-specific toxicity associated with octopamine, we attempted to block the
effect by inhibiting octopamine signaling. Thus, we co-administered 0.2mg/ml
mianserin, which acts by inhibiting octopamine-induced cAMP increase (Fig. 28c) (Maqueira et al., 2005). Co-administration of mianserin almost completely
blocked the effect of feeding 10mg/ml octopamine to flies. This demonstrates
that the loss in sleep produced by octopamine feeding is attributable to the
ingestion of octopamine itself and not attributable to toxic, non-physiological
effects. In addition, these data suggest that the effects of octopamine on sleep
are mediated by β receptors.

63

Wild-type flies fed tyramine did not show significant changes in sleep
amount (Fig.2-9b). In addition, neither octopamine nor tyramine produced a
significant change in activity while awake (Fig. 2-9c).

Octopamine acts through neuronal PKA to decrease sleep
cAMP-dependent protein kinase (PKA) signaling plays an important role in
sleep in Drosophila (Hendricks et al., 2001) (Joiner et al., 2006). It is also known
to be coupled to some of the octopamine and tyramine G-protein coupled
receptors (Evans and Maqueira, 2005). Indeed, the blocker of octopamine used
above inhibits cAMP signaling. To directly address whether the effect of
octopamine on sleep is through PKA-dependent pathways, we expressed the
regulatory subunit of PKA (PKAr), which inhibits activity of PKA, under the
control of an ElavGeneSwitch driver (Joiner et al., 2006; Osterwalder et al.,
2001). The use of the ElavGeneSwitch driver allowed us to inducibly express the
regulatory subunit in all neurons. We found that expression of PKAr in adult
neuronal tissue rendered the flies insensitive to the sleep-reducing effects of
octopamine (Fig. 2-10a), supporting the idea that octopamine is acting through a
PKA-dependent pathway to promote arousal.
Because the MB is implicated in the effects of PKA on sleep (Joiner et al.,
2006), we sought to determine if this is also the site of octopamine action on
sleep. Thus, we ablated the mushroom bodies with hydroxyurea as described
previously (de Belle and Heisenberg, 1994) and then treated these flies with
octopamine. The sensitivity to octopamine was intact despite the absence of the
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MBs (Fig. 2-10b). As expected, the MB ablation itself reduced sleep, but there
was an additional decrease produced by feeding octopamine (Fig. 2-10b). The
decrease was 87 min, which was comparable to the amount of sleep lost when
Iso31 flies were fed 7.5mg/ml octopamine (82 minutes). To verify that the MBs
were ablated, we followed up the behavioral analysis of all flies with anatomical
analysis of the brain. All flies that still contained some α and β lobes were
eliminated from analysis.
We also examined the effects of octopamine on flies expressing PKAr
under control of an inducible mushroom body GeneSwitch driver (MBSwitch) and
found that these flies were still sensitive to octopamine (data not shown). Our
inability to block effects of octopamine on sleep by inhibiting PKA signaling in
MBs supports the finding that elimination of MBs by hydroxyurea does not block
the wake-promoting effects of octopamine.

Discussion:
Biogenic amines play many important roles in mammals, with several
having significant effects on sleep-wake states. Thus, dopamine, serotonin, and
norepinephrine are all important for regulating states of arousal. We
hypothesized that, like its counterparts in mammals, the invertebrate
neurotransmitter octopamine would be important for arousal in Drosophila. That
prediction was supported by the data reported here. We find that decreases in
levels of octopamine increase sleep, while increasing octopamine causes a
decrease in sleep. In addition, although the mammalian data have been
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contradictory with respect to the role norepinephrine plays in total sleep, we find
that octopamine decreases total sleep time. The mammalian data are
complicated in part because perturbations of the norepinephrine pathway result
in changes in the levels of dopamine (Ouyang et al., 2004). The use of
Drosophila allows us to examine specifically the role of octopamine without
perturbing dopamine signaling.
By modulating the excitability of octopamine-producing cells, we were able
to manipulate the output of these cells. In mammals, one can record from
specific cell populations to determine when the cells fire action potentials.
Although this assay is difficult to do in flies, we were able to electrically modulate
the cells through expression of K+ and Na+ ion channels. We found that when
octopamine-producing cells were more depolarized (expression of a Na+
channel), the animal was awake more and unable to stay asleep, whereas when
the cells were hyperpolarized (expression of a K+ channel), the animals slept
more.
Based primarily upon larval crawling assays, octopamine and tyramine
were implicated previously in locomotor behavior (Gong et al., 2004; O'Dell,
1994; Saraswati et al., 2004; Scholz, 2005). Specifically, larvae move slower
through quadrants when they have decreased octopamine levels (the TβH nm18
and Tdc2RO54 mutants). More recent work showed that adult Tdc2RO54 flies also
have a decrease in locomotor activity attributable to the lack of tyramine (Hardie
et al., 2007). Our data showing differences in activity in the Tdc2RO54 and the
TβH nm18 mutants support the claim that tyramine plays an important role in
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locomotion. Thus, whereas increased levels of tyramine in Tbh mutants increase
activity, decreased levels in Tdc mutants decrease locomotor activity. However,
both mutations increase sleep, which is most likely attributable to the loss of
octopamine. In addition to overall sleep, we find that other sleep parameters
such as latency to sleep and arousal threshold are affected in flies carrying these
mutations. We infer that tyramine plays a role in locomotion, but octopamine
specifically affects arousal states.
Studies of other invertebrate species support a role for octopamine in
arousal (Corbet, 1991a; Corbet, 1991b). In fact, octopamine agonists are
potential natural pesticides because they cause insect species to “walk off” the
leaves (Roeder, 1999). As in Drosophila, changes in octopamine levels affect
behavior in honey bees, as demonstrated through feeding and injection of
octopamine as well as through analysis of endogenous levels of octopamine.
Fussnecker et al. (2006) showed that injections of octopamine promote flying in
honeybees (Fussnecker et al., 2006). In addition, octopamine and tyramine
regulate other behaviors in honeybees such as hive maintenance and foraging
(Barron et al., 2002b; Schulz and Robinson, 1999, 2001a; Wagener-Hulme et al.,
1999) . Octopamine and tyramine also modulate sensory input in honeybees
(Kloppenburg and Erber, 1995a; Kloppenburg and Erber, 1995b; Scheiner et al.,
2002). In the locust, octopamine mediates heightened arousal in response to
new visual stimuli (Bacon et al., 1995). Bacon et al. found that a specific subset
of octopamine-producing neurons in the brain of the locust fires during the
presentation of new visual stimuli, causing dishabituation of the descending
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contralateral movement detector (DCMD) interneuron. Interestingly, application
of endogenous octopamine can mimic this state of heightened arousal. Our
study suggests that octopamine serves to promote arousal in Drosophila. It is
possible that the increased arousal we see with too much octopamine, or
decreased arousal with too little, is a result of improper gating of sensory stimuli,
but without electrophysiological data we are unable to draw any conclusions.
Note also that the Tdc2 cells important for sleep and arousal in the fly brain have
not been identified yet.
In previous studies, octopamine was fed to flies to rescue or verify a
phenotype of the TβH nm18 flies. The ability of octopamine to rescue egg laying in
TβHnm18 mutants was assayed in this manner, as TβH nm18 flies are unable to
release eggs. Animals were placed on different levels of octopamine, and
10mg/ml octopamine over a period of 6 d provided maximal rescue (Monastirioti
et al., 1996). Using the same concentration, we found that a steady increase in
octopamine levels led to a decrease in nighttime sleep. Based on the specific
effect on nighttime sleep, we speculate that octopamine levels are already high
during the daytime, thereby precluding any effects of an increase. This analysis
is supported by the Na+ channel data in which a significant decrease in total
sleep was found only during the nighttime sleep periods. We speculate that
normally, activity of these cells is low at night, and so expression of the Na+
channel causes them to fire more and release octopamine at an abnormal time,
thereby producing a decrease in sleep. Similar results, indicating nighttimespecific effects, were obtained with overexpression of Tdc2.
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Work in other

insects also supports the idea of modulated octopamine release. Pribbenow and
Erber (1996) demonstrated that honeybees who are already in a heightened
arousal state of antennae scanning, do not change scanning frequency in
response to octopamine administration, but in animals scanning at a low
frequency, injections of octopamine significantly increase scanning (Pribbenow
and Erber, 1996).
Our data suggest that the effects of octopamine are mediated through
PKA-dependent signaling. In mammals, there are 9 different adrenergic
receptors, some of which signal through PKA (Hoffman and Lefkowitz, 1996a;
Hoffman and Lefkowitz, 1996b). The α1 adrenergic receptor is the only receptor
associated with a wake-promoting effect in that the agonist methoxamine causes
an increase in waking (Hilakivi and Leppavuori, 1984; Monti et al., 1988).
However, the antagonist has no effect on total sleep (Benington et al., 1995;
Berridge and Espana, 2000). It is important to note that the α1 receptor in
mammals is thought to be coupled to phospholipase C and Gq (Ramos and
Arnsten, 2007). The β adrenergic receptors (which are coupled to cAMP and
PKA) probably do not have specific effects on sleep in mammals because,
contrary to known effects of norepinephrine, the agonist increases sleep and the
antagonist decreases sleep (Monti et al., 1988). Studies in Drosophila may be
better able to identify biogenic amine receptors relevant for sleep because of the
ease of genetic manipulation Many G-protein-coupled receptors in Drosophila
which display activity that allows their bona fide classification as octopamine
receptors (Evans and Maqueira, 2005). Our data here suggest that receptors
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sensitive to mianserin are likely to be involved in regulating fly sleep. Because
mianserin inhibits cAMP signaling, these data not only further support a role for
PKA, but also implicate β receptors in octopamine action. We note that none of
these receptors is known to display a circadian cycling profile.
Given that PKA was shown previously to regulate sleep in
Drosophila, we are starting to see a link between the various molecules that
affect Drosophila sleep. Interestingly, however, octopamine does not appear to
act through the MBs, a structure known to mediate effects of PKA on sleep and
also to express a class of octopamine receptors. Because flies lacking MBs still
have substantial amounts of sleep, it is clear that other parts of the fly brain can
drive sleep. The current study shows that even PKA can affect sleep in regions
outside the MB. Defining the site of action of sleep-regulating molecules such as
octopamine should help to identify these other brain regions.
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Figures and Tables
Figure 2-1

Figure 2-1. The octopamine biosynthesis pathway and its
distribution in the fly brain A. Octopamine and tyramine are derivatives of
tyrosine. Tyrosine is converted to tyramine by tyrosine decarboxylase (Tdc).
Tyramine is then converted to octopamine by tyramine β hydroxylase (TßH). B.
Expression pattern of the Tdc2-Gal4 line as visualized with a GFP reporter.
Octopamine is produced in a subset of neurons in the brain and thoracic
ganglion. Expression was characterized by crossing Tdc2-Gal4 with nuclear
UAS-GFPnls.
71

72

Figure 2-2. Baseline sleep phenotype of Tdc2RO54 mutants, which
have decreased levels of octopamine and tyramine. A, Three days of
baseline sleep recording inTdc2 females. The Tdc2RO54 line (gray dashed line)
shows significantly more sleep than its control w1118 (black solid line). Dark bars
and white bars on top indicate nighttime and daytime, respectively. n = 8
for Tdc2RO54 and w1118. CT, Circadian time; ZT, Zeitgeber time. B, Total sleep is
significantly increased inTdc2RO54 mutant females (mean ± SEM; Tdc2RO54, 1115
± 19, n = 23; w1118, 895 ± 32, n = 32; p 0.0001, two-way ANOVA). Latency to
sleep is significantly lower in Tdc2RO54 mutants (mean ± SEM; Tdc2RO54, 20.6 ±
4.6, n = 23; w1118, 47.5 ± 8.7, n = 32; p 0.001, two-way ANOVA). C, Arousal
threshold during sleep in the Tdc2RO54 mutants. The animals were given three
levels of stimulation to determine whether they were arousable. All animals that
responded to the first stimulation were also aroused on stronger stimulation.
Compared with wild type, the Tdc2 mutant line had a higher percentage of flies
that did not respond to any of the three levels of stimulation. In addition,
fewer Tdc2RO54 flies responded to the weaker stimuli (Tdc2RO54, n = 23; w1118, n =
32).D, Rescue of the baseline sleep phenotype in Tdc2RO54 with expression of
the Tdc1 gene. Total sleep was quantified, and Tdc2RO54 mutant females were
significantly different from both wild-type and rescued animals. There was no
significant difference between rescued animals and controls (mean ± SEM; w1118,
895 ± 33, n = 32; Tdc2RO54, 1238 ± 33, n = 16; p 0.0001; UAS–Tdc1; Tdc2–
Gal4, Tdc2RO54, 871 ± 33; n = 16).

73

Figure 2-3
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Figure 2-3. Baseline sleep phenotype of TβH nm18 mutants, which
have decreased levels of octopamine and increased levels of tyramine. A,
Five days of baseline sleep recording in TβH females. The TβHnm18 line (gray
dashed line) shows significantly more sleep than its control, Canton S (black
solid line). Dark bars and white bars on top indicate nighttime and daytime,
respectively. Sixteen animals are shown for each group. CT, Circadian time; ZT,
Zeitgeber time. B, Total sleep is significantly increased in the TbHnm18 mutants
(mean ± SEM; TβHnm18, 1176 ± 17, n = 46; Canton S, 884 ± 20, n = 52; p
0.0001, two-way ANOVA). C, Arousal threshold for the TβHnm18 mutants. The
animals were given three levels of stimulation to determine whether they were
arousable. All animals that responded to the first stimulation were also aroused
on stronger stimulation. Compared with wild type, theTbh mutant line had a
higher percentage of flies that did not respond to any of the three levels of
stimulation. In addition, fewer Tdc2RO54 flies responded to the weaker stimuli
(TβHnm18, n = 46; Canton S, n = 52). D, Activity per waking minute, which
quantifies activity during the time the animal is awake, was significantly increased
in the TβHnm18 mutants (mean ± SEM; TβHnm18, 1.84 ± 0.13; Canton S, 1.57 ±
0.05; p 0.01, Kruskal–Wallis test) but significantly decreased in
the Tdc2RO54 mutants (mean ±SEM; Tdc2RO54, 1.2 ± 0.09; w1118, 1.5 ± 0.08; p
0.01, Kruskal–Wallis test).
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Figure 2-4
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Figure 2-4. Baseline sleep phenotype produced by depolarizing
Tdc2-positive neurons. Female flies carrying a UAS-NaChBac transgene
under the control of TDC2-Gal4 were assayed for sleep. A, Six days of baseline
sleep recording of eight animals each. w;Tdc2–Gal4/NaChBac;+ flies (gray
dashed line) show significantly less sleep then Iso31 controls (black solid line).
Dark bars and white bars indicate nighttime and daytime, respectively. CT,
Circadian time; ZT, Zeitgeber time. B, Nighttime sleep is significantly decreased
in w;Tdc2–Gal4/NaChBac;+ flies (mean ± SEM; w;Tdc2–Gal4/NaChBac;+, 267 ±
31, n = 33; Iso31, 613 ± 9, n = 58; p 0.0001, two-way ANOVA). The latency to
sleep is significantly longer in w;Tdc2–Gal4/NaChBac;+ flies (mean ±
SEM; w;Tdc2–Gal4/NaChBac;+, 107 ± 20, n = 33; Iso31, 34 ± 3, n = 58; p 0.01,
two-way ANOVA). C, Arousal threshold in the w;Tdc2–Gal4/NaChBac;+ flies.
The animals were given three levels of stimulation to determine whether they
were arousable. All the w;Tdc2–Gal4/NaChBac;+ flies were more arousable at
each stimulation level, and there was a much lower percentage of animals that
did not respond at all (w;Tdc2–Gal4/NaChBac;+, n = 33; Iso31, n = 58).
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Figure 2-5
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Figure 2- 5. Baseline sleep phenotype produced by hyperpolarizing
Tdc2-positive neurons. Female flies carrying a UAS-Kir2.1 transgene under
the control of Tdc2-Gal4 flies were assayed for sleep. A, Four days of baseline
sleep recording of 16 animals for each group. w;Tdc2–Gal4/Kir2.1;RC1flies (gray
dashed line) show significantly more sleep then their controls, w;RC1;RC1 (black
solid line). Dark bars and white bars indicate nighttime and daytime, respectively.
CT, Circadian time; ZT, Zeitgeber time. B, Total sleep is significantly increased
in w;Tdc2–Gal4/Kir2.1;RC1flies (mean ± SEM;w;Tdc2–Gal4/Kir2.1;RC1, 829.19
± 14.14, n = 47; W+;RC1;RC1, 655.35 ± 15.30, n = 47; p 0.0001, two-way
ANOVA). The latency to sleep is significantly lower in Tdc2 x Kir2.1 flies (mean ±
SEM; w;Tdc2–Gal4/Kir2.1;RC1, 13.86 ± 1.19, n = 47; w;RC1;RC1, 45.68 ±
8.40, n = 47; p 0.001, two-way ANOVA). C, Arousal threshold in w;Tdc2–
Gal4/Kir2.1;RC1 flies. The animals were given three levels of stimulation to
determine whether they were arousable. All animals that responded to the first
stimulation were aroused on stronger stimulation. Compared with controls, an
increased percentage of w;Tdc2–Gal4/Kir2.1;RC1 flies did not respond to any of
the three levels of stimulation. At the strongest stimulation, more control flies
responded than w;Tdc2–Gal4/Kir2.1;RC1 flies (w;Tdc2–Gal4/Kir2.1;RC1, n =
47; w;RC1;RC1, n = 47).
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Figure 2-6:

Figure 2-6 (Supplemental Figure 1). Total sleep in Tdc1-Gal4 female
flies expressing UAS-NaChBac. A. Total sleep is not significantly different
between Tdc1-Gal4;NaChBac/+;+ flies and sibling controls. (Tdc1Gal4;NaChBac/+;+= 774 ± 48 S.E.M. N=32 Tdc1-Gal4;Cyo/+;+ (sibling controls)
= 886 ± 78 S.E.M. N=32 2-way ANOVA)
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Figure 2-7

Figure 2-7 (Supplemental Figure 2). Overexpression of Tdc2 causes
decreases in sleep. A. Female flies carrying a UAS-Tdc2 transgene under the
control of Tdc2-Gal4 were assayed for sleep. Baseline sleep was measured for
six days in 16 animals of each genotype and total nighttime sleep was quantified.
Tdc2 x Tdc2 flies (grey line) show significantly less sleep than controls (black
solid line) (w+;UAS-Tdc2/ Tdc2-Gal4;+ = 322 ± 69 S.E.M. N=16 w+;Tdc2Gal4/+;+ = 676 ± 6 S.E.M. N=16 p≤.0001 2-way ANOVA)
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Figure 2-8 Oral administration of octopamine decreases sleep in
Iso31 flies and TβH nm18 mutant flies. Female flies of the Iso31 strain were
treated with octopamine and assayed for sleep A, The sleep profile shows 1 d of
baseline sleep, followed by administration of 10 mg/ml octopamine (gray dashed
line) for 3 d. Octopamine was then removed and sleep was assayed for 2 more
days. Control flies (black line) were fed normal food during this time. Arrows
indicate the time when food was changed. The data are from 16 animals for each
group. There was a significant decrease in nighttime sleep for the Iso31 flies on
10 mg/ml octopamine (mean ± SEM; control, 612.04 ± 8.47, n = 40; 10 mg/ml
octopamine, 409.33 ± 19.77, n = 40; p 0.0001, two-way ANOVA). CT, Circadian
time; ZT, Zeitgeber time. B, Sleep in TbHnm18 mutant flies is restored to control
levels through the administration of octopamine. Before octopamine
administration, TβHnm18 flies showed a significant increase in total sleep time;
after administration of octopamine, sleep in TβHnm18 flies was not significantly
different from that of control (Canton S) flies not on octopamine (Canton S, 796 ±
55 min; Canton S plus 7.5 mg/ml octopamine, 792 ± 54 min; n = 16 for each
group). C, Coadministration of mianserin blocks the effect of octopamine on
nighttime sleep. When 10 mg/ml octopamine was administered along with 0.2
mg/ml mianserin, there was no longer a significant drop in nighttime sleep
(compare with columns on the right). Sleep in flies treated with mianserin alone
was not significantly different from that of controls [mean ± SEM; mianserin, 654
± 8, n = 32; mianserin plus 10 mg/ml octopamine, 627 ± 15, n = 32; Iso31
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(Control), 647 ± 22, n = 32; 10 mg/ml octopamine, 450 ± 35, n = 32; p 0.001,
two-way ANOVA].
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Figure 2-9 (Supplemental Figure 3). A. Dose response curve for
effects of octopamine on sleep. As the concentration of octopamine increases
there is a corresponding decrease in nighttime sleep. (0 oct. 647 ± 22 S.E.M.
n=18, 5mg/ml oct. 597 ± 19 S.E.M. n=8, 7.5 mg/ml oct. 514 ± 21 S.E.M. n=24,
10mg/ml oct. 420 ± 31 S.E.M. n=30, 12 mg/ml oct. 343 ± 33 S.E.M. n=21) B.
Effect of tyramine on nighttime sleep. 10 mg/ml tyramine did not significantly
alter nighttime sleep amounts in Iso31 flies. (Iso31 n=32, Iso31 + Tyramine n=32)
C and D. Waking activity was not significantly different in flies fed either
10mg/ml octopamine or 10mg/ml tyramine.
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Figure 2-10

Figure 2-10 Effects of octopamine are mediated by PKA and are
independent of the Mushroom Body. A, Total nighttime sleep in control (Iso31)
andElavGeneSwitch flies crossed with UAS–BDK33 (PKAr). The control on 7.5
mg/ml octopamine shows a significant decrease in nighttime sleep, whereas flies
expressing PKAr under the control of ElavGeneSwitch do not show a decrease in
sleep in response to octopamine [mean ± SEM; Control (Iso31), 623 ± 11, n = 24;
control plus octopamine, 489 ± 22, n = 24; p 0.001, two-way
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ANOVA; ElavGeneSwitch, 665 ± 7, n = 51;ElavGeneSwitch plus octopamine,
667 ± 11, n = 51]. B, Iso31 flies subjected to hydroxyurea treatment to ablate the
mushroom body still show sensitivity to the sleep-reducing effects of octopamine.
Hydroxyurea-treated flies show a significant decrease in sleep compared with
controls; they also show an additional decrease in sleep when placed on 7.5
mg/ml octopamine (mean ± SEM; control, 583 ± 11, n = 24; control plus 7.5
mg/ml octopamine, 491 ± 12, n = 24; p 0.01, two-way ANOVA; HU, 469 ±
32, n = 24; HU plus 7.5 mg/ml octopamine, 382 ± 30, n = 22; p 0.01, two-way
ANOVA).
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Table 2-1

Table 2-1. Sleep and activity in flies mutant for the octopamine pathway.
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Table 2-2

Table 2-2. Sleep bout analysis in flies mutant for the octopamine pathway
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Abstract:
An understanding of sleep requires the identification of distinct cellular
circuits that mediate the action of specific sleep:wake-regulating molecules, but
such analysis has been very limited. We identify here a circuit that underlies the
wake-promoting effects of octopamine in Drosophila. Using MARCM, we
identified the ASM cells in the medial protocerebrum as the wake-promoting
octopaminergic cells. We then blocked octopamine signaling in random areas of
the fly brain and mapped the post-synaptic effect to insulin-secreting neurons of
the pars intercerebralis (PI). These PI neurons show altered potassium channel
function as well as an increase in cAMP in response to octopamine, and genetic
manipulation of their electrical excitability alters sleep:wake behavior. Effects of
octopamine on sleep:wake are mediated by the cAMP-dependent isoform of the
OAMB receptor. These studies define the cellular and molecular basis of
octopamine action and suggest that the PI is a sleep:wake-regulating
neuroendocrine structure like the mammalian hypothalamus.

Introduction:
Although sleep occupies a large part of daily life for many organisms, it
remains a poorly understood phenomenon. Analysis of sleep regulation would
be facilitated by a focus on specific cellular loci, but knowledge of such loci is
limited (Kryger et al., 2005). Molecules known to affect sleep are expressed
widely and function in many different processes (Kryger et al., 2005; Saper et al.,
2005). Delineating the cellular basis of their effect on sleep is complicated in
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mammals because of the complexity of the brain structure (Hendricks et al.,
2000b). The fruit fly, Drosophila melanogaster, on the other hand, has a
relatively simple brain, making it a better model to address the cellular circuitry
underlying sleep (Hendricks and Sehgal, 2004). Similarities between mammalian
and fly sleep have been established and extend to the neurotransmitters
underlying the regulation of sleep (Agosto et al., 2008; Andretic et al., 2005;
Hendricks et al., 2000a; Shaw et al., 2000; Yuan et al., 2006).
We demonstrated recently that octopamine, the Drosophila equivalent of
norepinephrine, is a potent wake-promoting signal (Crocker and Sehgal, 2008) .
Octopamine is synthesized from tyramine by the action of tyramine βhydroxylase (Tβh), and tyramine is synthesized from tyrosine by tyrosine
decarboxylase (dTdc) (Roeder, 2005). Mutations in both Tβh and Tdc result in
an increased amount of sleep, and electrical manipulation of Tdc-expressing
neurons also has predictable effects on sleep (Crocker and Sehgal, 2008).
Likewise in mammals, norepinephrine promotes wakefulness. However, the
many targets of norepinephrine-producing cells and the existence of multiple
receptors have made it difficult to dissect the function of this pathway in sleep
(Insel, 1996; Sara, 2009). There are five different classes of adrenergic
receptors, with a total of nine receptors, both α and β, and conflicting data on the
roles these different receptors may play in sleep (Insel, 1996). Octopamineproducing neurons in Drosophila also project all over the brain and octopamine
can signal through several different receptors (Evans and Robb, 1993).
Nevertheless, the system is still simpler than in mammals with a total of 4 known
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genes for octopamine receptors: OAMB, Octβ1R (OA2), Octβ2R and Octβ3R
(Evans and Robb, 1993; Han et al., 1998). In addition, the gene for OAMB
encodes two isoforms, AS and K3, resulting in five possible receptor types (Han
et al., 1998; Lee et al., 2009).
Other neurotransmitters shown to affect Drosophila sleep are dopamine,
serotonin, and GABA (Agosto et al., 2008; Andretic et al., 2005; Kume et al.,
2005; Yuan et al., 2006). However, each of these is produced by many neurons
and the specific sub-group of neurons responsible for the effect on sleep is not
known for any neurotransmitter. Dopamine and serotonin exert at least some of
their effects through receptors expressed in the mushroom bodies (MBs), a
region previously implicated in the regulation of sleep (Andretic et al., 2005;
Joiner et al., 2006; Pitman et al., 2006; Yuan et al., 2006). However, the MBs
are a complex structure (Tanaka et al., 2008) and the specific neurons relevant
for the serotonin/dopamine phenotype were not identified The circadian large
ventral lateral neurons mediate effects of light and GABA on sleep, but the
source of the GABA is not known (Chung et al., 2009; Parisky et al., 2008;
Sheeba et al., 2008a). Finally, neurons in the pars intercerebralis (PI) region
promote sleep, but their neurochemical identity remains to be determined
(Foltenyi et al., 2007). Thus, little is known about the cellular basis of sleep in
Drosophila and there has been no concerted effort to dissect the cellular and
molecular circuit underlying the effect of any particular neurotransmitter.
In this study, we set out to map the octopamine pathway important for
sleep. Using a technique known as Mosaic Analysis with a Repressible Cell
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Marker (MARCM), we were able to map the wake-relevant octopamine-producing
cells to specific cells in the medial protocerebrum (Wu and Luo, 2006). We also
used an unbiased approach to map the octopamine target neurons that mediate
the effects on sleep:wake. Building upon the observation that the effects of
octopamine on sleep are protein kinase A (PKA)-dependent, we blocked PKA
signaling in various parts of the fly brain and assayed the behavioral response to
orally ingested octopamine. We find that a subset of neurons in the pars
intercerebralis (PI) mediates effects of octopamine on sleep. Consistent with
their identification as octopamine-responsive cells, these neurons in the PI
demonstrate changes in electrical activity, as well as, in cAMP levels, in
response to exogenous octopamine. Acting through the OAMB receptor on
these PI neurons, octopamine signals through cAMP and PKA to promote
wakefulness. Our data provide a molecular pathway as well as the cellular
circuitry that mediates the wake-promoting effects of octopamine. Because the
PI neurons implicated here are an integral part of the neuroendocrine PI, we
believe these findings highlight the similarity between the PI and the mammalian
hypothalamus. These findings may also provide insight into how the adrenergic
system works to influence sleep in mammals.

Methods:
Fly Stocks:
The following lines were ordered from the Bloomington Stock Center:
Tdc2–GAL4 (9313), UAS–NaChBac (9466), UAS–GFP syt(6925), UAS95

mCD8::GFP (5137), UAS–GFPnls (7032), P{neoFRT}19A, P{tubP-GAL80}LL1,
P{hsFLP}1, w[*]; Pin[Yt]/CyO (5133), y[1] w[1118] P{neoFRT}19A (1744), 18896
(OctB2R),and Iso31 (5905). MBGS, H24-GAL4, 17d-GAL4, c747-GAL4, c309GAL4, 1366-GAL4, MJ63-GAL4, c507-GAL4, 104y-GAL4, D42-GAL4, mai301GAL4 , ElavGeneSwitch, 30y-GAL4, Sep54-GAL4, 201y-GAL4, Dilp2-GAL4,
UAS-CD8-GFP and UAS-BDK33(PkaR) were used previously in the laboratory
(Crocker and Sehgal, 2008; Joiner et al., 2006; Zheng et al., 2007). OAMB 286,
OAMB 584 and UAS-K3;OAMB286 were a gift from Dr. K. Han, 50y-GAL4 was a
gift from Dr. R. Greenspan and Kurs58-GAL4 was a gift from Dr. U. Heberlein.
UAS-Epac1-cAMP50 was a gift from Dr. P. Taghert.

Generating flies for MARCM:
The MARCM method was used to generate flies in which different,
random subsets of Tdc2-expressing neurons expressed the sodium channel,
NaChBac (Lee and Luo, 1999). The crosses that created the MARCM flies are
shown in Fig 3-1. The original lines are: P{neoFRT}19A, P{tubP-GAL80}LL1,
P{hsFLP}1, w[*]; Pin[Yt]/CyO (5133)of the Bloomington stock Center (donated by
L. Luo) UAS–NaChBac(9466) line of the Bloomington stock Center (donated by
B. White) y[1] w[1118] P{neoFRT}19A (1744) line Bloomington Stock Center
(donated by L. Luo) Tdc2–GAL4 (9313) line Bloomington Stock Center (donated
by J. Hirsh) The final MARCM flies contain a Tdc2-Gal4, a UAS-NachBac (B16B)
a tubulin-Gal80 and a heat shock promoter-FLP recombinase transgene. In the
presence of the Gal80, Gal4 activity is suppressed and so NachBac is not
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expressed in any cell. However, the Gal80 can be randomly excised from
subsets of cells by the heat shock activated FLP recombinase. Crosses were
raised at 18°C and the parental generations were transferred to new vials
following egg laying for the times indicated in Fig. 3-1. To remove the GAL80,
animals received a heat shock at 37°C for 20-30 minutes between 1 and 2 days
of development.. P{neoFRT}19A, P{tubP-GAL80}LL1, P{hsFLP}1,
w[*]/P{neoFRT}19A ; UAS-NaChBac-EGFP/TDC2-Gal4 female flies were
selected for sleep and mapping analysis.

Sleep Analysis:
Sleep analysis was performed as described previously (Gilestro and
Cirelli, 2009; Joiner et al., 2006). All flies were kept on a 12 h light/dark (LD) cycle
at 25°C schedule. Female MARCM flies, 6–8 d old, were placed in 65 x 5 mm
tubes containing 5% sucrose and 2% agar and entrained for 24–36 h before the
sleep recording. Baseline sleep was determined by monitoring activity for at least
3 d with no disruptions in an LD cycle. Locomotor activity was monitored using
the DAMS/Trikinetics system as described previously (Gilestro and Cirelli, 2009;
Joiner et al., 2006). Sleep was defined as a 5 min bout of inactivity as described
previously (Shaw, 2003). Latency to sleep was determined for the octopamine
receptor mutants and is defined as the time in minutes from the moment lights
are turned off to the first bout of sleep.

Immunohistochemistry:
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Brains of adult female flies were dissected in cold PBS and fixed in 4%
paraformaldehyde in PBS at 4°C overnight. After four 10-min washes in 0.1%
Triton X-100 in PBS samples were permeabilized with 3% normal goat serum
(NGS) 2 h at room temperature. Samples were then incubated in a primary
antibody solution containing mouse anti-nc82 (1:50; Developmental Studies
Hybridoma Bank) and rabbit anti-GFP IgG (1:1000; no. A11122, Invitrogen) in
3% NGS at 4°C overnight. After four 10-min washes in 0.1% Triton X-100 in
PBS, brains were incubated at 4°C overnight in a secondary antibody solution
containing Alexa Fluor 568 goat anti-mouse IgG (1:1000, Invitrogen) and Alexa
Fluor 488 goat anti-rabbit IgG (1:1000, Invitrogen) in 3% NGS. After 4 10-minute
washes in PBS brains were mounted using Vectashield mounting medium
(Vector Labs) and covered with a no. 1 glass coverslip before imaging.
Immunolabeled adult brains were imaged with a 488 and 510 laser-scanning
confocal microscope (Leica) under 20x magnification. z stack images were
scanned at 1µm section intervals with a resolution of 1024 x 1024 pixels.

Analysis of MARCM data:
Following sleep analysis, and immunohistochemistry to detect GFP,
individual brains were analyzed to correlate the sleep phenotype with the cellular
expression of NaChBac-GFP. All mapping analysis was performed blind to the
sleep analysis. Each group contains flies with expression only in that subgroup,
with the exception of the ASM flies and PSM flies. Due to the low numbers of
flies that expressed NaChBac-GFP in these regions alone we included flies that
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also expressed in other areas. We had four flies that had expression only in
ASM neurons and an additional 8 flies which had expression in other areas in
addition to ASM, bringing the total number to 12. These 8 flies were not counted
in any other category. In the group showing expression in only a single ASM
neuron, we had 3 flies with only one such neuron labeled and another 8 lines
which had expression elsewhere, in addition to the single ASM neuron, to bring
the number to 11. These lines were not counted in any other category. The
number of flies indicated in the “no cells” category is probably an underestimate
since we stopped counting these flies at some point. Over 1,000 flies were
screened in this study, similar to the number Busch and colleagues screened to
map octopamine neurons (Busch et al., 2009).

Mapping the site of PKA action:
To map the site of PKA action, we crossed each of the following driversMBGS, H24-GAL4, 17d-GAL4, c747-GAL4, c309-GAL4, 1366-GAL4, MJ63GAL4, c507-GAL4, 104y-GAL4, D42-GAL4, mai301-GAL4, 50y-GAL4, ElavGS,
30y-GAL4, Sep54-GAl4, 201y-GAL4, Dilp2-GAL4, Kurs58-GAl4- into UAS–
BDK33 flies (Rodan et al., 2002). Female flies were used from these crosses for
all sleep and octopamine analysis. Octopamine at 10 mg/ml as previously
described was fed to each fly for 3 days following a 3 day baseline(Crocker and
Sehgal, 2008). The GeneSwitch construct in elavGS and MBGS can be turned on
during adulthood using the drug RU486 (11β-(4-dimethylamino)phenyl-17βhydroxy-17-(1-propynyl)estra-4,9-dien-3-one). We placed the animals on 5%
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sucrose/2% agar tubes containing either 500 µM RU486 dissolved in ethanol or
ethanol alone (1%) for 3 days. Half of each group was then transferred to
octopamine-containing food with either 5% sucrose/2% agar plus 500 µM RU486
plus octopamine or 5% sucrose/2% agar plus ethanol (1%) plus octopamine.
Both groups were also simultaneously fed 10 mg/ml octopamine for 3 days. At
the lights-on transition at the end of this period, animals were transferred off of
octopamine onto 5% sucrose/2% agar containing either 500 µM RU486 or
ethanol (1%). Sleep analysis was performed as described above.

Electrophysiology:
For in vivo patch recording from PI neurons, flies were anesthetized with
CO2 and glued ventral side down to a glass cover slip. The cover slip was placed
in a chamber containing extracellular solution (101mM NaCl, 3mM KCl ,4mM
MgCl2, 1mM CaCl2, 1.25mM NaH2PO4, 20.7mM NaHCO3, 5mM Glucose with pH
7.2) and then the cuticle was peeled off using fine forceps to expose the surface
of the brain. The chamber was placed on the stage of an Olympus BX51
fluorescent microscope, and PI neurons were identified by their location and
bright green fluorescence. Patch recording electrodes (WPI, Inc) were firepolished, and had resistances from 3 – 4 MΩ when filled with intracellular
solution (102 mM K-gluconate, 17mM NaCl, 0.085mM CaCl2, 4mM Mg-ATP,
0.5mM Na-GTP, 0.94mM EGTA, 8.5mM HEPES with pH 7.2). Standard
technique was used to record macroscopic currents in the whole-cell voltageclamp mode with an Axopatch 200A amplifier (Molecular Devices, Union City,
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CA). Data were digitized with a Digidata 1322A interface (Molecular Devices,
Union City, CA) and stored on a PC hard drive for further analysis with pClamp9
software (Molecular Devices, Union City, CA).

FRET Imaging:
The TDC2-GAL4 flies were crossed to flies carrying a UAS-Epac1cAMPs(50A) transgene (Shafer et al., 2008). Brains were dissected under icecold calcium-free fly hemolymph-like saline (HL3) containing 70 mM NaCl, 5 mM
KCl, 20 mM MgCl2, 10 mM NaHCO3, 5 mM trehalose, 115 mM sucrose, and 5
mM HEPES (pH 7.1). The brains were then laid at the bottom of a 35 × 10 mm
plastic FALCON Petri dish (Becton Dickenson Labware), given a few seconds to
adhere and covered with 1.6 ml HL-3 containing 1.5 mM CaCl2 (Shafer et al.,
2008).
Time course FRET imaging of Epac1-camps was performed on individual
brains using the Leica TCS SP5 confocal microscope using a HCX APO L
40x/0.80 dipping objective. We performed octopamine experiments by
administering 140ul of 125mg/ml of octopamine in dH2O into the dish making the
final concentration of octopamine 10mg/ml octopamine. In the water control, 140
ul of water was added to the well. For the mianserin experiments, initially
mianserin alone was added at a concentration of 0.25mM, followed by a second
application of 0.25mM mianserin along with 140 ul of the 125 mg/ml stock of
octopamine. Analysis of FRET was done using the Sensitized Emission FRET
wizard built into the Leica Application Suite for the TCS SP5 using Method 1 for
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FRET analysis. Images were taken every 5 seconds at 512 x 512 and line
averaged 3 times. A time series was taken for 5 minutes of baseline, followed by
octopamine administration and 15 minutes post octopamine administration. For
the mianserin experiments, the 5 minutes of baseline preceded the first
application of mianserin alone; this was followed 1 minute later by mianserin
plus octopamine. We then outlined the PI neurons and selected them as our
region of interest for analysis. Results are plotted as the minute prior to
octopamine administration followed by 240 seconds post octopamine
administration. Longer periods of time did not change the FRET levels. 12
brains were plotted for octopamine administration, 8 for the water control and 9
brains for the mianserin treatment.

Receptor Characterization:
RT-PCR was run according to previously published protocols (Ousley et
al., 1998). RT-PCR primers: OAMB primers were previously described (Lee et
al., 2009); we also generated new primers for the K3 and AS isoforms. New
primers are for K3: forward 5’-CTGCCGTGAGAACGACGAG-3’; reverse 5’GCGCAATATGAGCTGGGACT-3’. Primers for AS were: forward 5’CTGCCGTGAGAACGACGAG-3’; reverse 5’- ATGTATGCGCAATGTGAGGC-3’.
OctB2R receptor primers were: foraward 5’-ATGCTGATGCACCGACCAT-3’;
reverse 5’ AAGGCAGCCAGCAGAGGAT-3’.

Single cell RT-PCR:
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Whole-cell extracts were taken from Dilp2 neurons following electrical
recording. Ten cells were pooled and then RT-PCR was run on them with the
following modifications:10ul of buffer (150 mM sodium acetate, 50 mM Tris, pH
9.0, 5 mM EDTA, pH 8.0, 1% SDS containing 1/100th volume diethyl
pyrocarbonate) was used to place each recording pipette tip into, than those
were pooled to equal 100ul. Following PCR with K3 and AS primers, the K3
band was cut out of the gel and sent for sequencing to verify K3 band. We did
not see an AS band so that was not sequenced.

Results
Identifying the Octopaminergic Cells that Regulate Sleep
In mammals, the release of norepinephrine from a specific group of cells
in the Locus Coeruleus (LC) is known to regulate sleep (Sara, 2009). We set out
to determine whether a specific cell group in the fly is responsible for the effect of
octopamine on sleep. To address, this question we employed the MARCM
technique which allows one to restrict the expression of a transgene to a subset
of its normal pattern (Wu and Luo, 2006); (Agosto et al., 2008). We showed
previously that expression of a sodium channel (NaChBac) by a tyrosine
decarboxylase 2 (Tdc2) GAL4 driver, which expresses in tyramine- and
octopamine-producing cells, decreases sleep (Cole et al., 2005; Crocker and
Sehgal, 2008). The NaChBac transgene is derived from a gene encoding a
bacterial Na+ channel which has the characteristics of high open probability and
low inactivation, thus driving membrane voltage to a more depolarized and easily
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excited state (Luan et al., 2006; Nitabach et al., 2006). Thus, excitation of Tdc2positive neurons results in decreased sleep. However, Tdc2-GAL4 is expressed
in a number of cells in the fly brain (Figure 3-2a), any of which could be
responsible for the decrease in sleep. In the MARCM technique, a repressor of
GAL4 activity, GAL80, is co-expressed and then is excised in a random fashion
from groups of cells (see Figure 3-1). By driving this excision in populations of
developing Drosophila, one can generate large numbers of flies, each of which
expresses GAL4 in a different subset of the original pattern. Using MARCM, we
were able to reduce the number of octopamine cells expressing the Na+ channel
down to a single cell in some cases. We chose the Na+ channel in part because
it has a robust effect on sleep and also because it is tagged with green
fluorescent protein (GFP). The GFP marker allowed us to identify the cells
expressing the sodium channel.
Because each fly generated through MARCM expresses the
relevant transgene in a distinct pattern, we assayed each individual fly for sleep
and then for expression of GFP. Figure 3-2b shows the different cell populations
labeled by Tdc2-GAL4 in a schematic of the anterior and posterior sections of the
fly brain. The schematic is derived from the anatomical map generated by
Sinakevitch and Strausfeld (Sinakevitch and Strausfeld, 2006), whereas the
nomenclature is based upon the studies of Busch et al., 2009. We were unable
to discriminate some cell clusters as anterior or posterior and so grouped them
together, such as the ASM cells. We found that expression of the Na+ channel in
the ASM group of cells produced a decrease in sleep similar to that seen with the
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Tdc2-GAL4 driver expressing the Na+ channel in all neurons (Figure 3-2c,d,
Table 3-1). The sleep loss was approximately 320 min when the Na+ channel
was expressed in multiple cells of the ASM group, but was less when it was
expressed in only one cell in this group. Thus, the effect of this neuronal group
on sleep appears to reflect the cumulative contribution of multiple cells.
Expression of the sodium channel in other areas of the brain and thorax did not
result in a significant drop in sleep (Figure 3-3c).

Mapping Brain Regions that Mediate Post Synaptic Effects of
Octopamine
We showed previously that PKA is necessary for the relay of the wakepromoting octopamine signal (Crocker and Sehgal, 2008). In this study, we
attempted to localize the areas of the fly brain that respond to this signal. We
overexpressed the regulatory subunit of PKA (PkaR), which acts to block PKA
signaling, using a number of different GAL4 drivers (Figure 3-3a)(Rodan et al.,
2002). We found that many of the resulting lines showed increases in total sleep
as compared to the control line Iso31 (Isogenic w1118 line). This effect is
consistent with our previous work showing that an increase in PKA signaling
reduces sleep (Hendricks et al., 2001). In addition, a subset of the GAL4 lines
expressing PkaR were no longer sensitive to the decrease in sleep caused by
feeding octopamine (Figure 3-3a, Table 3-2). Although some of these lines
express GAL4 in many cell types, the one region of the brain where the
expression overlaps is the PI (Figure 3-3b). In fact, the Dilp2 GAL4 driver, which
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expresses GAL4 in cells producing Drosophila insulin like peptide 2 (Dilp2), is
expressed in only a subset of PI neurons (Rulifson et al., 2002) and expression
of PkaR by this driver has as robust an effect as any other. Although this line did
not show a significant increase in nighttime sleep relative to wild-type, it did show
a significant increase in sleep consolidation— decreased number of sleep bouts
with a corresponding increase in sleep bout length (Fig. 3-4). Interestingly,
expression of PkaR in the mushroom body, a region previously implicated in the
regulation of sleep, does not affect the response to octopamine.
We were interested in determining whether wake-promoting
octopaminergic cells project to the PI. To this end, we expressed a synaptically
tagged GFP under the control of the Tdc2-GAL4 and co-labeled the brains with
antibodies specific for the Dilp2 neurons. As shown in Figure 3c, synaptic
boutons of Tdc2 neurons are found in the vicinity of the Dilp2 neurons. In
addition, expression of a membrane bound GFP (CD8-GFP) in Tdc2-producing
cells indicates dorsal as well as lateral projections of ASM neurons. This is
similar to the findings of Busch et al, who examined whole-mount projections of
the octopamine-producing ASM neurons (Busch et al., 2009) . Together, these
data indicate that the Dilp2 neurons likely receive octopaminergic signals and
mediate wake-promoting effects of octopamine.

Modulation of Dilp2-Producing Neurons Alters Sleep
If octopamine signals through the PI to regulate sleep, then modulating the
firing of the relevant PI neurons should also affect sleep. Thus, we used the
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Dilp2–GAL4 driver to express either a depolarizing or a hyperpolarizing ion
channel (UAS–NaChBac or UAS–EkoIII) (Luan et al., 2006; White et al., 2001)
and examined effects on sleep. Expression of the Na+ channel in Dilp2-positive
cells resulted in an average decrease in daily sleep of 172 min (Figure 3-5)
(Table 3-5). The loss of sleep was more specific to the nighttime, similar to what
we see when Tdc2-producing cells are depolarized (Crocker and Sehgal, 2008).
A similar decrease in sleep was seen in male flies expressing the Na+ channel in
the Dilp2 neurons (Figure 3-5)(Table 3-3).
When UAS-EkoIII, a modified Shaker K+ channel, was expressed in Dilp2
neurons, there was an increase in sleep during both the night and the day
(Figure 3-5a, b) (Table 3-3). These data support the idea that excitation of the
Dilp2 neurons promotes wakefulness whereas silencing these neurons increases
sleep.

Octopamine Modulates a Potassium Current in PI Neurons
Because PI neurons are implicated in the wake-promoting effects of
octopamine, we asked whether octopamine application could influence their
electrical excitability. Accordingly, we generated flies in which the PI neurons
were labeled with green fluorescent protein (GFP) under the control of the Dilp2
GAL4 driver. The PI neurons are large and located close to the surface of the
brain, and so we were able to measure whole-cell currents by patch clamp
analysis, in the brains of living flies (Shahidullah et al., 2009). Voltage-dependent
outward currents were evoked by depolarizing voltage steps in the whole-cell
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recording mode (Figure 3-6a). In order to examine the outward current in the
presence of octopamine, we evoked currents by applying a repetitive
depolarizing pulse to +60 mV from a holding potential of -70 mV, and then added
1 mM octopamine to the bath solution. As shown in Figure 3-6b, 1 mM
octopamine reduces the total outward current by approximately 30%. Because
mianserin antagonizes effects of ingested octopamine on sleep:wake (Crocker
and Sehgal, 2008), we determined whether this antagonist (Maqueira et al.,
2005) could block the effects of octopamine on the whole cell outward current.
We applied the same protocol described above to evoke outward current, and
then added 0.25 mM mianserin to the bath solution followed by 1mM octopamine
(Figure 3-6c). Indeed, mianserin greatly reduces the effect of octopamine on the
outward current.
We next asked which component of the outward potassium current is
modulated by octopamine application. At low concentrations, the potassium
channel blocker tetraethylammonium (TEA) is highly selective for the calciumdependent potassium current carried by Slowpoke channels (Shen et al., 1994),
and we have demonstrated that 1 mM TEA selectively blocks Slowpoke current
in the PI neurons in vivo (Shahidullah et al., 2009). As shown in Figure 3-6d, 1
mM TEA has little effect on the outward current following octopamine application,
suggesting that octopamine inhibits the TEA-sensitive component of outward
current attributable to Slowpoke. Following washout of octopamine, the TEAsensitive current returns. These data demonstrate that octopamine selectively

108

inhibits the Slowpoke calcium-dependent potassium current in the Dilp2 neurons,
thereby increasing their excitability.

Octopamine Affects cAMP Signaling in PI Neurons
As mentioned above, we found that altering PKA levels in the PI neurons
blocks the flies’ response to octopamine, suggesting that octopamine increases
cAMP. Thus, we asked whether there is a change in cAMP signaling in Dilp2
neurons following application of octopamine. To monitor cAMP activity, we used
a recently described Epac-cAMP construct which reports the activation of Epac
by cAMP through a FRET-based assay (Shafer et al., 2008). An increase in
cAMP produces a decrease in the FRET associated with this construct. We
drove the UAS-Epac construct with a Dilp2 driver, dissected brains from the
resulting flies and measured FRET in response to octopamine. Figure 3-7a
shows that the FRET signal decreases following application of 10mg/ml
octopamine in the bath. The response is fairly rapid, similar to that seen when
Gs coupled receptors in other parts of the brain are stimulated (Shafer et al.,
2008). As one might expect, most of the changes in FRET are intracellular
(Figure 3-7b). We also determined if 0.25mM mianserin, a blocker of octopamine
receptors, could block the effects of octopamine application. The addition of
mianserin completely blocks the increase in cAMP activity seen with octopamine
administration alone (Figure 3-7d). Interestingly mianserin alone produces a
small decrease in cAMP activity. Together, these studies show that octopamine
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both depolarizes Dilp2 neurons and activates cAMP signaling in them, with a
similar time course.

The OAMB Receptor Acts in PI Neurons to Regulate Sleep
Mammals express many different norepinephrine receptors, and it has
been difficult to pinpoint those relevant for sleep. Because our previous work
indicated that effects of octopamine are mediated by PKA, we focused on the
octopamine β and OAMB receptors which signal through cAMP and are
homologous to the β adrenergic receptors. As noted above, the OAMB receptor
has two isoforms, K3 and AS. Activation of the K3 isoform results in increased
cAMP signaling and Ca2+ signaling whereas activation of the AS isoform only
increases Ca2+ (Lee et al., 2009).
OctB2R is an octopamine β receptor that is known to signal through cAMP
(Evans and Robb, 1993), but has not been characterized genetically in the fly.
We obtained flies carrying a P-element insertion in the 5th exon of the OctB2R
gene and analyzed them on molecular and behavioral levels. This P-element
disrupts the conserved 7th transmembrane domain of the predicted protein and
results in a loss of mRNA signal, as seen in Figure 3-8. To assay the effect of
the P-induced mutation on sleep, we first outcrossed it into an Iso31 background.
We found that disruption of the OctB2R gene did not affect nighttime sleep, but
produced a significant decrease in daytime sleep, resulting in an overall
decrease in sleep (Table 3-3). Since this P-element disrupts expression of the
OctB2R receptor and yet affects sleep in the opposite direction from octopamine,
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we did not consider it further as a candidate for mediating effects of octopamine
(Figure 3-9b)
We examined two previously characterized OAMB mutants, the OAMB
286 mutant and the OAMB 584 mutant (Lee et al., 2003), for effects on
sleep:wake. The OAMB 286 mutant is a known null (Figure 3-8) and the OAMB
584 mutant deletes the first 3 exons of the OAMB gene. Both OAMB 286 and
OAMB 584 disrupt the K3 and AS isoforms. Both mutants show increases in
sleep (Figure 3-9a), which manifest as longer sleep bouts at night and greater
numbers of sleep bouts during the day (Table 3-3). An effect on number and
duration of sleep bouts suggests that the mutants affect the initiation as well as
the maintenance of sleep. For the rest of our studies we focused on the null
OAMB 286.
OAMB is expressed in the mushroom body, thereby its name (octopamine
mushroom body receptor), but was not known to express in the PI neurons (Han
et al., 1998). To determine if OAMB is expressed in the PI, we collected extracts
from single Dilp2 neurons via the whole-cell recording electrode, prepared RNA
and ran RT-PCR experiments. We found that the K3 isoform of OAMB, which
couples to both cAMP and calcium, is expressed in the Dilp2 neurons. Indeed,
sequence analysis of the single band observed on the gel confirmed its identity
as the K3 isoform (data not shown). We did not detect the Ca2+ -only isoform, A3
(Fig. 3-10). To confirm the specificity of the RT-PCR experiments, we also ran
them on OAMB mutants. The Dilp2 neurons of these mutants did not express
the K3 isoform of OAMB (Fig. 3-10).
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We then asked whether restoring OAMB to the PI neurons would rescue
the sleep phenotype of the OAMB mutants. To address this question, we drove
expression of the K3 isoform in the Dilp2 neurons of OAMB 286 mutants.
Expression of K3, under the control of the Dilp2 driver, resulted in a significant
reduction in sleep in the 286 background, thus effectively rescuing the phenotype
(Figure 3-9a). These data support the conclusion that octopamine acts through
OAMB mediated cAMP signaling in Dilp2 neurons to modulate sleep.

The OAMB Receptor Mutants Act in PI Neurons to Mediate WakePromoting Effects of Octopamine
We then asked whether OAMB mutants are responsive to the wakepromoting effects of octopamine. Feeding 10mg/ml octopamine to OAMB 286
flies did not produce the decrease in nighttime sleep seen in wild-type controls
(Figure 3-11a). However, consistent with a role for the Dilp2 neurons in
mediating effects of OAMB on sleep:wake, the response of 286 flies to
octopamine was rescued by Dilp2-GAL4-driven expression of the K3 isoform
(Figure 3-11a).
We also recorded in vivo from Dilp2 neurons in the OAMB 286 flies and
found they are virtually unresponsive to octopamine (Figure 3-11b). To
determine whether the Slowpoke calcium-dependent potassium current is
present in Dilp2 neurons in the OAMB 286 mutant flies, we applied 1 mM TEA
after several attempts to modulate the current with octopamine (Figure 3-11b).
TEA blocks about 30% of the outward current, as it does in wild-type flies (Figure
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3-6), confirming that octopamine receptor deletion does not directly affect the
Slowpoke current, but eliminates its modulation by octopamine.

Discussion:
Most animals have evolved mechanisms to maintain alertness as well as
sleep states (Tobler, 2005). Here we identify a pathway through which
octopamine regulates arousal in the insect brain. This study is the first to our
knowledge to map the sleep:wake-regulating effect of a particular
neurotransmitter to specific cells in the fly brain. We show that a specific cell
group, known as the ASM cell group, comprises the octopamine-producing cells
important for the effects of octopamine on arousal. These cells are found in the
lateral protocerebrum region and are also known as the G1/G4a cells
(Sinakevitch and Strausfeld, 2006). Previously, these cells have only been
described in terms of anatomical location. Using MARCM to specifically express
a sodium channel in ASM cells, we were able to mimic the sleep phenotype seen
with Na+ channel expression in all octopamine-producing cells. We find that the
magnitude of the decrease in sleep depends upon the number of ASM cells
activated, although even the activation of a single cell produces a phenotype.
Thus, as in mammals, discrete cell populations encoding a specific
neurotransmitter regulate sleep and arousal in the fly.
We also demonstrate that the Pars Intercerebralis (PI) is an important
region of the fly brain for relaying the octopamine arousal-promoting signal.
Inhibiting PKA, a downstream signal of octopamine receptors, in specific PI
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neurons blocks the effect of ingested octopamine on sleep. Modulating the
electrical activity of these PI neurons also affects sleep. Although we have not
demonstrated actual synaptic contact between the ASM neurons discussed
above and the relevant PI neurons, there is reason to believe that these neuronal
groups are directly connected. Our work, and that of Busch et al, suggests that
Tdc2 neurons, including the ASM group, extend projections towards the dorsal
region of the brain (Busch et al., 2009). In fact, we show termini of Tdc2
projections in the vicinity of the PI (Figure 3-3).
Previous work identified sleep-promoting cells in the region of the PI, but
those appear to be distinct from the ones that mediate the effects of octopamine
(Foltenyi et al., 2007). When we decreased PKA signaling in cells labeled by
50y-GAL4 (which targets the sleep-promoting cells identified in the other study)
we observed a normal response to octopamine (Figure 3-3). Conversely, none
of the drivers that were effective in our studies were reported in the study that
identified the sleep-promoting neurons (Foltenyi et al., 2007). Also, the sleeppromoting neurons appear to be morphologically distinct from many of the other
PI neurons, in that they do not show long projections to the tritocerebrum. It
should be noted that the PI is a very heterogeneous structure composed of many
different cell types (Siegmund and Korge, 2001). Functionally, given that it
contains many neuroendocrine cells, it appears to be most analogous to the
mammalian hypothalamus (Toivonen and Partridge, 2009). The fact that both
sleep-promoting and arousal-promoting neurons can be found in the PI, as in the
hypothalamus, lends credence to this analogy. Interestingly, we have found that
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the PI is also important for circadian output, which suggests the possibility that it
integrates circadian and homeostatic signals (Jaramillo et al., 2004).
The PI neurons that mediate the effects of octopamine are the major
insulin secreting cells in the fly (Rulifson et al., 2002). This may have important
implications for the much-hypothesized link between metabolism and sleep
(Trenell et al., 2007). Recent work on human sleep indicates that sleep
deprivation modulates the insulin signaling pathway (Knutson and Van Cauter,
2008; Spiegel et al., 2009). On the other hand, disruptions in metabolism may
also cause changes in sleep (Laposky et al., 2008; Laposky et al., 2006; Trenell
et al., 2007). It is reasonable to assume that if sleep is conserved across species
then its most basic functions may also be conserved. We find that an arousal
pathway in flies includes the major neurosecretory cells in the PI (Toivonen and
Partridge, 2009). In mammals, growth hormone regulation more closely follows
the sleep wake cycle than the circadian cycle (Sassin et al., 1969; Takahashi et
al., 1968). It may turn out that similar hormones released from the PI or PI
projections closely match the sleep wake cycle. Indeed, insulin, produced by the
Dilp2 neurons, has growth-promoting effects in Drosophila (Brogiolo et al., 2001).
In mammals, it has been difficult to tease apart the adrenergic receptors
important for the arousal-promoting effects of norepinephrine. In this study we
show that the OAMB receptor coupled to Ca2+ and cAMP regulates arousal in
response to octopamine. Specifically. we demonstrate that the cAMP-stimulating
action of this receptor is required. In mammals, the Α-1 receptors are coupled to
Ca2+ or PKC, the Α2 receptors inhibit cAMP and the Β receptors stimulate cAMP
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(Insel, 1996). Given that cAMP also regulates sleep in mammals (Cirelli et al.,
1996; Kanyshkova et al., 2009; Zamboni et al., 1999) and CREB appears to be a
wake-promoting signal (Graves et al., 2003b), it is likely that mammalian β
receptors are responsible for the wake-promoting effects of norepinephrine.
Thus, the prediction is that A2 adrenergic receptors will be found to increase
sleep while β receptors decrease sleep. In mammals, the agonists of these
receptors, when focally applied to the medial preoptic area, do seem to follow the
hypothesis above such that the A2 agonists promote sleep and the β agonist
promotes wakefulness (Mallick and Alam, 1992). Finer injections of agonists and
antagonists specifically into the ventral lateral preoptic area (the major
mammalian sleep-promoting area (Saper et al., 2005), will likely provide stronger
support for this idea.
In the PI neurons identified here, the activation of cAMP by octopamine is
accompanied by an inhibition of the outward potassium current, measured by
whole-cell patch clamp in vivo. By using low concentrations of the highly
selective potassium channel blocker TEA, we identified the Slowpoke calciumdependent potassium current as the specific target of octopamine. Because
Slowpoke current contributes significantly to action potential repolarization (Shao
et al., 1999), a decrease in this current will lead to an increase in action potential
duration in the PI neurons (Shahidullah et al., 2009), thereby increasing the
activity of neural circuits in which these neurons participate. It is noteworthy that
calcium-dependent potassium channels have long been known to be modulated
by PKA-dependent phosphorylation and dephosphorylation (Chung et al., 1991;
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DePeyer et al., 1982; Ewald et al., 1985; Zhou et al., 2002). The present findings
provide an intriguing physiological and behavioral context for these earlier
cellular and molecular studies.
To map the octopamine target neurons relevant for sleep:wake, we
genetically decreased PKA levels in different brain regions and then monitored
the response to food supplemented with octopamine. In many subgroups of
neurons, dropping the level of PKA leads to death or very sick flies, making it
difficult to address their role in sleep behavior. Thus, there may be areas in
addition to the PI that are important for the regulation of sleep by octopamine.
Likewise, there are other brain regions that mediate effects of PKA on sleep and
wake. For instance, a screen to map the sleep-relevant site of PKA action
identified the mushroom body as an important sleep-regulating structure (Joiner
et al., 2006; Pitman et al., 2006). We found that over-expressing PKA in Dilp2
cells results in pupal lethality, which may explain why the PI neurons did not
show up in the screen that identified the MBs. In addition, because the
octopamine signal did not map to the mushroom body, there are as yet unknown
signals that increase PKA in the MB.
Clearly, the regulation of sleep in Drosophila is complex and likely involves
many sites and signaling molecules. As noted earlier, in addition to the MBs and
the PI, the circadian large ventral lateral neurons have a role in the regulation of
sleep (Parisky et al., 2008). How these different sites communicate with each
other and are ordered in a sleep-regulating circuit will be an important question to
address. We propose that the PI lies downstream of these other sites and
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integrates circadian and homeostatic signals to control sleep:wake. Consistent
with this idea, the PI is known to be a major output of the fly brain (Toivonen and
Partridge, 2009). In addition, we know that some projections of the central clock
neurons are in the vicinity of the PI (Jaramillo et al., 2004) and that the PI
contains wake-and sleep-regulating cells. We hypothesize that the decrease in
sleep produced by the ablation of mushroom bodies (Joiner et al., 2006; Pitman
et al., 2006) is due to the imbalance of inputs to the PI neurons, resulting in an
increase of wake-promoting signals over sleep-promoting signals. This is
supported by our data showing that flies lacking MBs are more sensitive to
octopamine feeding (Crocker and Sehgal, 2008), implying that the MBs normally
exert a moderating influence.
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Figure 3-1

Figure 3-1 (Supplemental Figure 1) : MARCM Methods.
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A. Outline of the crosses performed to generate the female flies for MARCM
analysis. We used flies with the FRT (Flp recombination target) site as well as
the FLP recombinase and the Gal80 driven by a tubulin promoter on the 1st
chromosome,. The second chromosome carried the Tdc2-GAL4 and UASNaChBac transgenes. B. Outline of the heat shock regime to induce expression
of FLP recombinase. Parents of the final offspring were allowed to lay eggs for
the times indicated before being removed from the vial; eggs/larvae were then
heat pulsed at 37 degrees. Note that each population was only subjected to one
treatment; induction of the recombinase at different stages in different
populations resulted in a wide range of “mosaic” progeny, from those that
expressed the sodium channel in many cells to those that showed expression in
only one cell.
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Figures 3-2

Figure 3-2: Cells in the medial protocerebrum mediate wake-promoting
effects of octopamine
A. Expression pattern of the Tdc2–Gal4 line as visualized with a GFP
reporter. Octopamine is produced in a subset of neurons in the brain. Expression
was characterized by crossing Tdc2–Gal4 with UAS–GFPnls. B. A schematic of
the different octopamine neurons, labeled according to Sinakevitch and
121

Strausfeld (Sinakevitch and Strausfeld, 2006). Cell groups are clustered
according to color, with similar colors indicating cells that could not be
distinguished from each other in our analysis. C. Total sleep amounts for each
cell population indicated in B. The colors of the graph correspond to clusters of
the same color in B. The ASMs were the only cell group that showed a
significant decrease in sleep compared to the other cell groups. The graph
depicts mean sleep ± S.E. and * is p≤0.01 using 2 way ANOVA. Values are
found in Table 3-1. D. Sleep data for single flies. Sleep over 24 hours is shown
for two flies, one expressing Na+ channel in 4 cells in the ASM region (Black
line) and one for a fly expressing the Na+ channel in about 8 VUMS (Blue line).
Day and night are depicted by the black and white lines respectively. Pictures
below are of those individual fly brains stained for nc82 (pink) and GFP (green).
The generation of the MARCM flies is outlined in Figure 3-8.

Figure 3-3
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Figure 3-3. Octopamine signals through cells in the pars intercerebralis
(PI). A. Sleep in flies expressing the regulatory subunit of protein kinase A
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(PkaR) in different regions of the fly brain. Progeny obtained by crossing each of
the 18 GAL4 driver lines indicated to w1118;UAS-BDK33 (PkaR) were analyzed
for sleep. w1118 (Iso31), the background for all the lines, was used as control
line. Sleep values were determined for the night prior to the initiation of 10mg/ml
octopamine feeding and then the third night after providing octopamine. Grey
bars represent sleep prior to octopamine; black bars, sleep following 10mg/ml
octopamine. Sleep values are found in Table 3-2 and are plotted as mean ±
s.e.m. Nighttime sleep values for each line is depicted in Table 3-2 and sleep
parameters during nighttime sleep for expression of PkaR in Dilp2-producing
neurons is shown in Figure 3-4. B. Expression of a nuclear-targeted GFP
(GFPn) under the control of the following GAL4 drivers; Dilp2-GAL4, Sep54GAL4, 30y-GAL4, 201y-GAL4. The PI region is denoted by the white square in
each image. C. Expression of a synaptically targeted GFP (syt-GFP) under the
control of Tdc2-GAL4. PI neurons were stained with anti-Dilp2 and are shown in
red. An enlarged image of the PI region is shown in the right hand panel. D.
Expression of a membrane bound GFP (CD8-GFP) Tdc2-producing cells using
the Tdc2-GAL4 driver. A single confocal image through the ASM neurons is
shown on the left. On the right is an enlarged image of a 5 m thick stack through
the ASM neurons, which appear to show dorsal as well as lateral projections.

Figure 3-4
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Figure 3-4 (Supplemental Figure 4 ). Expressing PkaR in Dilp2 neurons
consolidates sleep. A. The average length of sleep bouts is significantly longer in
flies expressing UASBDK33 (PkaR) in Dilp2 neurons using the Dilp2-GAL4
driver. Control flies (Iso31) have an average sleep bout length at night of 83.86 ±
7.27 minutes while the Dilp2-GAL4;UAS-BDK33 flies have an average night-time
bout length of 233.1 ± 21.21 minutes. Sleep bout length is plotted as mean ±
s.e.m. Asterisk= P < 0.01 by 2-way Anova. B. The average number of sleep
bouts is significantly less in flies expressing UASBDK33 (PkaR) in Dilp2 neurons
using the Dilp2-GAL4 driver. Control flies (Iso31) have on average 10.6 ± 0.47
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sleep bouts at night while the Dilp2- GAL4;UAS-BDK33 flies have 6.85 ± 0.56
sleep bouts. Sleep bout number is plotted as mean ± s.e.m. Asterisk= P < 0.01
by 2-way Anova.
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Figure 3-5

Figure 3-5. Sleep is altered by manipulations of the electrical activity of PI
neurons. A 24 hour profile of sleep in w1118 flies (black line), and Dilp2-GAL4
flies expressing either 3xUAS-Eko (Blue line) or UAS-NaChBac (orange line).
Top panel shows female data and bottom panel male data. Total sleep amount
for females and males of each genotype is shown below the profiles. Actual
values are in Table 3-3. Total sleep is plotted as mean ± s.e.m. Asterisk= P <
0.01 by 2-way Anova.
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Figure 3-6
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Figure 3-6. Octopamine modulates outward potassium current in PI
neurons. The Dilp2 neurons were identified by expressing GFP under the control
of a Dilp2-Gal4 driver, and voltage-dependent outward current was recorded in
the whole cell patch recording mode. A. Whole-cell outward currents evoked by
150 ms depolarizing voltage steps from -60 mV to +70 mV in 10 mV increments,
from a holding potential of -70 mV. The scale bars apply to all portions of this
figure. B. Repetitive pulses to a single voltage, +60 mV, were used to examine
the effects of octopamine (OA) on the outward current. 1 mM OA was added to
the bath solution during the recording after which the outward current at +60 mV
decreases as a function of time (B, left). Peak current amplitudes are plotted
against time and the application of octopamine is shown by an arrow (B, right).
C. The same voltage protocol as in B was used to evoke outward current, and
0.5 mM mianserin (MI) was added to the bath solution followed by the application
of 1 mM OA (C, left). Peak current amplitudes are plotted against time; the
applications of mianserin and OA are shown by arrows (C, right). D. The same
voltage protocol was used to evoke outward current, and 1 mM OA was added to
the bath solution. After the modulation by octopamine, subsequent addition of
TEA does not block the residual outward current (D, left). Following washout of
the octopamine and TEA, the current returns to baseline levels (D, middle).
Subsequent addition of TEA blocks about 30% of the outward current (D, right),
suggesting that octopamine selectively modulates the TEA-sensitive component
of the current. The arrows illustrate the direction of current change over time
after drug addition or withdrawal.
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Figure 3-7

Figure 3-7. Octopamine increases cAMP signaling in PI neurons
A. The response of Dilp2 neurons to 1 mM Octopamine. A FRET-based
cAMP sensor was expressed in Dilp2 neurons and the FRET signal was
measured in dissected brains following the application of octopamine. In all
graphs the red arrow indicates the start of bath application of octopamine or
vehicle. The lower panel shows the response of Dilp2 neurons from 8 brains to
vehicle (water). B. A pseudocolored time course of Epac1-camps FRET loss in a
cluster of 3 Dilp2 cell bodies in response to 1 mM octopamine. The black bar
represents the addition of octopamine. The time course is outlined below the
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images. The table values on the right represent raw YFP/CFP ratios. C.
Quantification of the data in A showing the average YFP/CFP value for each time
point over 300 seconds. Error bars indicate the standard error of the mean.
Through one-way repeated measures ANOVA, all time points following
octopamine administration were significantly different from vehicle with p<.001;
prior to octopamine administration there was no difference between vehicle and
octopamine groups. D. Effects of mianserin on the response to octopamine. The
plot shows the average YFP/CFP value for each time point over 300 seconds
following application of 0.25mM mianserin and then 0.25mM mianserin plus
10mg/ml octopamine. Error bars indicate the standard error of the mean.
Through one-way repeated measures ANOVA, all time points following
octopamine administration were not significantly different from previous time
points, despite there being a trend towards an increased ratio.

Figure 3-8
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Figure 3-8 (Supplemental Figure 2). Molecular analysis of the OAMB and OctB2
receptors A. Schematic of the OctB2R gene showing the P-element insertion (red
arrow). Primers were designed to flank this insert and to span an exon (blue lines
under exon) and then RT-PCR was conducted to assay expression of OctB2R.
Representative gel showing lack of a product in OctB2R flies as compared to the
control lane, implying that these flies are mutant for the OctB2R gene. B.
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Verification of the OAMB 286 mutant. RT-PCR was run on control flies and
OAMB 286 mutants using the new K3 and AS primers to both verify primer
specificity and to verify that OAMB 286 is a true null.

Figure 3-9
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Figure 3-9. Mutations in the OAMB receptor affect sleep levels. A. Sleep
amounts for females of the following genotypes- w1118 (white),
w1118;;OAMB286/OAMB 286 (black), w1118;;OAMB 584/OAMB 584 (grey),
UAS-K3;Dilp2-GAL4;OAMB 286/OAMB286 (white), UAS-K3;;OAMB
286/OAMB286 (light blue), and w1118;Dilp2-GAL4;OAMB 286/OAMB286 (blue) .
Total sleep is plotted as mean ± s.e.m. Asterisk= P < 0.01 by 2-way Anova.
Actual values and male data are in Table 3-3. B. Sleep amounts for the OctB2R
(18896) outcrossed into the w1118 (Iso31) background. Total sleep is shown as
in part A for Iso31 (control) in white and 18896 in black. Actual values and male
data are in Table 3-3. Verification of loss of OAMB transcript in OAMB 286
mutant and OctB2R transcript in the OctB2R mutant is shown in Fig. 3-8.
Expression of OAMB transcript in Dilp2 -producing neurons is shown in Figure 310.
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Figure 3-10

Figure 3-10 (Supplemental Figure 3) . The OAMB receptor is expressed in Dilp2
neurons Single cell RT-PCR of control flies showing that only the K3 isoform is
present in Dilp2-producing neurons. B. Representative gel for single cell RT-PCR
of control Dilp2 neurons and OAMB 286 mutant Dilp2 neurons. In the OAMB 286
mutant the K3 isoform is no longer present.
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Figure 3-11
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Figure 3- 11. The OAMB mutant shows an attenuated response to
octopamine. A. Sleep amounts prior to treatment with 10mg/ml octopamine
(white bar) and post octopamine (black bar) for females of the genotypes w1118,
w1118;;OAMB286/OAMB286, and UAS-K3;Dilp2-GAL4;OAMB286/OAMB286.
Sleep is plotted as mean ± s.e.m. Asterisk= P < 0.01 by 2-way Anova. Nighttime
sleep values are shown in Figure 3-9. B. Whole-cell outward current in PI
neurons in OAMB 286 flies. Current at +60 mV (as in Figure 4) is modulated only
slightly by two successive applications of 1 mM octopamine (OA). Subsequent
application of 1 mM TEA blocks about 30% of the outward current (B, left). Peak
current amplitudes are plotted against time, and the applications of octopamine
and TEA are shown by arrows (B, right).
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Table 3-1

Table 3-1 (Supplemental Table 1). Sleep data for flies generated through
MARCM Table depicts total sleep, daytime sleep and nighttime sleep for each
group of TDC2 positive cells.
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Table 3-2

Table 3-2 (Supplemental Table 2) : Effects of octopamine on sleep in different fly
lines The first part of the table shows effects of octopamine on sleep in flies
expressing PkaR under the control of different GAL4 drivers. The bottom part
shows effects on octopamine receptor mutants.
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Table 3-3
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Table 3-3 (Supplemental Table 3) : Sleep in octopamine receptor mutants and in
flies with altered excitability of Dilp2 neurons. In the tables above Dilp2 refers to
Dilp2-GAL4, NaChBac to UAS-NaChBac and 3xEko to UAS EkoII;UAS-EkoI.
The w1118 background for OAMB 286 and OAMB 584 is different from the
isogenic w1118 strain, termed Iso31, we used in other experiments. All tables
depict mean ± SEM *= p<.01 relative to wild-type control line (w1118 or Iso31, as
the case may be). All “†” for w1118;NaChBac, w1118;3xEkoII,
w1118;Dilp2/NaChBac and w1118;Dilp2/3xEkoII are relative to each respective
GAL4 and UAS control. The “**” for rescue experiments indicate the rescue is
significantly different from each control- wild type, mutant and mutant with either
UAS or GAL4 alone. Dilp2/NaChBac females are significantly different from all
controls for total sleep, daytime sleep, nighttime sleep, sleep bout length night
and sleep bout number night. Dilp2/NaChBac males are significantly different
from all controls for total sleep, daytime sleep, nighttime sleep, and sleep bout
length night. Dilp2/3xEkoII females are significantly different from all controls for
total sleep, daytime sleep, and daytime sleep bout length. Dilp2/3xEkoII males
are significantly different from all controls for total sleep, daytime sleep, nighttime
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sleep, daytime sleep bout length, nighttime sleep bout length, daytime sleep bout
number and nighttime sleep bout number.
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Chapter IV:

Effects of octopamine on metabolism in Drosophila
Amanda Crocker, Justin DiAngelo, Renske Erion, Alexis Gerber, Adam
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Abstract
Why we sleep is one of the major unanswered questions in science.
While in the last 100 years many people have devoted their careers to this, we
still do not understand this phenomenon. Recent work on sleep in humans
indicates deficits in normal metabolic function due to loss of sleep (Knutson and
Van Cauter, 2008; Spiegel et al., 2009; Van Cauter et al., 2008). Studies show
that normal healthy individuals develop early clinical signs of type-3 diabetes
when their sleep is disrupted (Knutson and Van Cauter, 2008). In addition, many
metabolic syndromes are accompanied by disrupted sleep (Bopparaju and
Surani, 2010; Lisk, 2009; Nixon and Brouillette, 2002; Shipley et al., 1992).
While this research points to a link between sleep and metabolism, it is difficult in
mammals to address whether these reciprocal effects are a consequence of
overlapping pathways or actually reflect mutual regulation. Mammals and
Drosophila (flies) share many signaling pathways, including those involved in
sleep and metabolism (Crocker et al., 2010; DiAngelo and Birnbaum, 2009;
Rulifson et al., 2002). Of the pathways that affect both processes, octopamine is
a good example. Octopamine is known to regulate sleep in Drosophila and in
other invertebrate species has been implicated in metabolism(Crocker and
Sehgal, 2008; Roeder, 2005). Likewise, the mammalian homolog of octopamine,
norepinephrine, is implicated in both physiological processes (Berridge, 2008;
Harik et al., 1982; Sara, 2009). Here we show that flies with less sleep due to
increased neuronal octopamine signaling have increased triglycerides.
Conversely, mutants in the octopamine receptor OAMB showed decreased
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triglycerides. The increase in triglycerides seen with increased octopamine
signaling does not appear to be due to the loss of sleep, since other shortsleeping flies do not show consistent increases in triglyceride levels. To address
whether the effect of octopamine on metabolism drives the loss of sleep, we
tested whether changes in insulin signaling, a likely cause of altered triglyceride
levels, directly affect sleep. We find that alterations in the insulin pathway,
independent of manipulations in octopamine, have only minor effects on sleep.

Introduction
While trying to address why we sleep, it is important to address the
question of what keeps us awake. In a world where people are driven to
maintain wakefulness for longer and longer periods of time and forego the normal
8 hours of sleep, it is important to understand the consequence of this behavior.
Many neurotransmitters and neuropeptides that are necessary for normal
wakefulness, such as dopamine, norepinephrine and orexin, are also important
for proper metabolic functioning (Berger et al., 2009; Charmandari et al., 2005;
Ford et al., 2005; Saper et al., 2005). Serotonin and norepinephrine are also
important for proper stress regulation (Berger et al., 2009; Charmandari et al.,
2005; Goddard et al.; Leonard, 2005). These factors are important, considering
that during sleep deprivation these neurotransmitter systems may be more active
then normal.
In humans, sleep deprivation leads to early symptoms of type-2 diabetes
(Knutson and Van Cauter, 2008). These signs include reduction in the ability to
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regulate blood sugar levels during a glucose tolerance test, decreased release of
insulin, and increases in cortisol levels (Spiegel et al., 2009). In addition, patients
who suffer from sleep disorders that cause severe fragmentation of sleep, such
as sleep apnea and severe restless leg syndrome, display impaired glucose
tolerance tests (Keckeis et al., 2010). Just as people who suffer sleep disorders
have impaired metabolic functioning, people who suffer from metabolic disorders
(including patients with diabetes) have abnormal sleep (Bopparaju and Surani,
2010; Lisk, 2009; Nixon and Brouillette, 2002; Shipley et al., 1992). Mice that are
resistant to leptin, a hormone that regulates appetite and glucose and lipid
metabolism, show a high degree of sleep fragmentation (Laposky et al., 2008).
These findings beg the question of whether sleep is required for normal
metabolic function and/or normal metabolic function is required for normal sleep.
To best address this question we need a molecule that overlaps in both
metabolic and sleep function. In mammals, this molecule might be
norepinephrine, which regulates the fight or flight response and is responsible for
heightened arousal and the breakdown of fat stores (Berridge, 2008; Harik et al.,
1982). Interestingly, a subset of norepinephrine neurons in the locus coeruleus
(LC) also make neuropeptide Y (NPY) which promotes fat storage and feeding
behavior, although the primary nucleus that produces NPY is the arcuate nucleus
(Holets et al., 1988; Leibowitz, 1991). The function of the co-expression of
norepinephrine and NPY is unclear. It may be that increased action of
norepinephrine underlies both metabolism and disrupted sleep.
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Drosophila have many of the same metabolic and sleep pathways as
mammals and provide an ideal model for addressing the mutual regulation of
metabolic function and sleep. We have also recently found a potential tool with
which to ask these questions. Octopamine, which is the mammalian homolog to
norepinephrine, appears to be an ideal candidate for linking sleep and
metabolism. Through the experiments described in Chapters 2 and 3, I have
demonstrated that octopamine is necessary in flies to maintain normal arousal
(Crocker and Sehgal, 2008; Crocker et al., 2010). This arousal signal in part
comes from the action of octopamine on neurons in the Pars Intercerebralis (PI),
the neurosecretory cells that produce the fly homolog of insulin (Rulifson et al.,
2002). In addition, there are reports of strong correlations between octopamine
signaling and metabolic function; however, most come from other insects, and
not flies (Roeder, 2005). Nevertheless, this potential interaction between the
octopamine and insulin systems provided us an opportunity to address whether
sleep affects metabolism and/or metabolism affects sleep.
We hypothesized that octopamine alters insulin signaling in the PI and that
changes in insulin signaling underlie the sleep phenotype. However, this is not
what we found. Consistent with the idea that octopamine stimulates the insulin
pathway, we found that triglyceride levels (a readout of insulin signaling in the
adult fly) are increased in flies with increased octopamine signaling and
decreased in flies with reduced octopamine signaling. This is not the case
across all short sleeping flies though. While some sleep mutants show
alterations in metabolic function, the changes are not consistent across different
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sleep mutants/conditions. To address whether insulin is part of the wakepromoting pathway we examined sleep in flies with altered insulin signaling. We
found that alterations in the insulin signaling pathway do not produce the
dramatic decreases in total sleep seen with octopamine activation. In fact
increases in Dilp2 (Drosophila insulin like peptide) showed only a minor increase
in total sleep. Other alterations in the insulin pathway also produced only minor
changes in sleep. These data do not rule out octopamine action on insulin, but
strongly support the idea that insulin is not the octopamine mediated wake signal
in flies.

Methods:
The following fly strains were used in this study: UAS-dInR CA, UASmyrAKT, UAS –AKT RNAi (Vienna stock collection 2907) yolk-GAL4, elav-GAL4,
elav-GeneSwitch, MB-GeneSwitch, UAS-mc* (constitutively active PKA), OAMB
286

, Tdc2-GAL4, UAS-B16b (NaChBac channel), UAS-TrpA1, sssp1, Fumin, and

Iso31 (isogenic w1118 stock).
Flies were grown on standard cornmeal-molasses medium as described
previously, and were grown at 25°C unless otherwise noted (Crocker and
Sehgal, 2008). To control for background and growing conditions, crosses were
performed to compare driver alone, transgene alone and animals carrying both
transgene and driver. In some cases, the driver alone flies or transgene alone
flies carried balancers, which could have independent effects on growth and
nutrient storage; in these cases, we used separate crosses as controls. For
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instance, since the OAMB286 mutation is maintained over a Tm6,tb, balancer we
used background w1118 flies grown in a separate vial as controls. For TrpA1
experiments, flies were raised at 21°C, shifted to 28°C when they were 0-3d old
and then tested after 4 days at 28°C to activate the channel (Hamada et al.,
2008). We verified that expression of TrpA1 by Tdc2-GAL4 caused loss of sleep,
as expected from previous work (Crocker and Sehgal, 2008; Crocker et al.,
2010). For experiments utilizing the GeneSwitch system, animals were placed
on 500 uM RU486 in 1% EtOH in standard medium for 4 days to activate
GeneSwitch activity.
Triglyceride assays: Adult female flies aged 4 to 5 days were taken for the
following flies: OAMB286, Tdc2-GAL4/UAS-B16b (NaChBac), Tdc2-GAL4/UASTrpA1, sssP1 (sss), Fumin (Fmn), MB-GeneSwitch/UAS-mc* and respective
control lines. All triglyceride assays were done as described by DiAngelo et al.
(2009).(DiAngelo and Birnbaum, 2009).

Results:
Decreasing sleep in multiple ways does not lead to a similar change
in metabolic function.
Since octopamine has actions on metabolism in other invertebrates and its
wake-promoting actions are mediated through the insulin-producing neurons of
the brain, we hypothesized that octopamine regulates metabolic function in
Drosophila. Thus, we measured triglycerides in the fat bodies of flies with
increased or decreased octopamine signaling. We found that an increase in
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neuronal specific octopamine, through the use of the TrpA1 channel or a
bacterial Na+ channel driven by Tdc2-GAL4 (GAL4 expressed in octopamine
and tyramine-producing neurons), increases triglycerides (Fig. 4-1a).
Conversely, flies carrying a mutation in the octopamine OAMB receptor have
decreased triglycerides (Fig. 4-1a).
Since sleep deprivation is implicated in obesity and increased fat storage
and flies with increased neuronal octopamine signaling sleep significantly less, it
is possible that sleep loss accounts for the increased triglycerides. In order to
address this issue, we examined triglycerides in other short sleeping flies. We
looked at 5 different genotypes previously shown to result in decreased sleep:
Tdc2-GAL4 driving the bacterial Na+ channel or the TrpA1 channel (Na+/Ca2+
channel activated by heat), the sleepless (sss) flies, Fumin (fmn) flies, and flies
expressing a constitutively active protein kinase A (PKA) transgene in the
mushroom body (Crocker and Sehgal, 2008; Joiner et al., 2006; Koh et al., 2008;
Kume et al., 2005). Preliminary data show that, similar to Tdc2-GAL4 driven
expression of either excitatory channel, the fumin mutants showed a trends
towards increases in triglycerides (Fig. 4-1a,b). However, the sss flies have
decreased triglyceride levels. A similar trend towards decreased triglycerides
was observed in the flies that express constitutively active PKA in the mushroom
body. (Fig. 4-1b). Together, these data imply that the simple loss of sleep does
not lead to a consistent increase or decrease in metabolic activity. We suggest
that many factors that alter sleep also alter metabolism independent of sleep.
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Altering insulin signaling does not alter sleep.
In Drosophila, as in mammals, fat storage and normal metabolic function
and growth are dependent on insulin (DiAngelo and Birnbaum, 2009). In
Drosophila, there are 7 different insulin like peptides (dilp) but only 3 (dilps 2, 3
and 5) are found in the octopamine-sensitive PI neurons (Brogiolo et al., 2001;
Broughton et al., 2010; Ikeya et al., 2002). However, there is only one receptor
for all the Dilps in flies, known as the Drosophila Insulin Receptor (dInR)
(Garofalo, 2002; Oldham and Hafen, 2003). Whether this receptor is expressed
in the adult brain is controversial, but it is known to be highly expressed in an
area of the fly known as the fat body (Garofalo and Rosen, 1988; Hwangbo et al.,
2004). The fat body is equivalent to the mammalian liver and adipose tissue in
mammals and is the major site of triglyceride storage. In flies, upregulation of the
insulin-signaling pathway leads to increases growth throughout development,
while the opposite phenotype is observed when the pathway is inhibited. It is
thought that the main action of insulin in flies is to regulate growth throughout
development, with less action in adulthood. However, insulin does cause some
increase in fat cell mass in the adult stage (DiAngelo and Birnbaum, 2009).
Since octopamine has actions through the insulin-producing neurons of
the brain and demonstrate increased triglyceride levels, we asked whether
alterations in insulin signaling led to the changes in sleep seen with octopamine
modulation. Specifically, if the decrease in sleep seen with Tdc2-GAL4 driving
the Na+ channel is due to increased Dilp protein, then increasing the insulin
signaling pathway should lead to decreases in total sleep while downregulation of
151

this pathway should lead to increases in total sleep. To address this question,
we first overexpressed Dilp2 in Dilp2 neurons. Dilp2 was chosen since it has the
highest homology to human insulin and its expression can rescue the growth
phenotype observed by partially ablating PI neurons (Rulifson et al., 2002).
Expression of Dilp2 in the PI neurons led to a minor, non-statistically significant
increase in sleep. (Fig. 4-2a).
Since Dilp2 is very tightly regulated by nutrient conditions, we thought we
might see a greater effect if we altered other parts of the insulin pathway. Thus,
we expressed a constitutively active form of dInR in either the adult fly fat body
(the center for fat storage and a major site of action of insulin in the fly) or in the
brain. Previous work has shown that expression of this in the fat body leads to
increases in triglyceride levels (DiAngelo and Birnbaum, 2009). In both cases
(fat body and brain) we only saw minor effects on total sleep (Figure 4-2b). This
was also true when we expressed an RNAi construct to decrease levels of dAKT,
an enzyme essential for insulin signaling, in either the fat body or the brain (Fig.
4-2b). When insulin signaling is active it leads to myristylation of AKT. We also
expressed a constitutively active form of AKT, that is always myristylated and
targeted to the plasma membrane (myrAKT), in either the fat body or the brain.
In the fat body this active form of AKT had little effect on total sleep, but in the
brain we were unable to measure any effects because these flies only lived about
5 days and showed severe developmental defects (Fig. 4-2b). However, when
this construct was expressed specifically in adulthood using the GeneSwitch
system in the brain there was no effect on total sleep (Fig. 4-2b).
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Discussion
A state of wakefulness or consciousness is necessary to sustain life, so it
is reasonable to assume that many neurotransmitters and redundant anatomical
pathways in the brain are devoted to this. This is true from mammals to flies
where multiple pathways have been implicated in maintaining arousal. Since the
brain has limited space, it is also likely that there is overlap between these
pathways and pathways important for other behaviors or functions such as
metabolism. Only a small number of neurons are responsible for producing the
necessary neurotransmitters and so it is highly likely that when we are looking at
one behavior/process we will also see an effect on another. This is important in
thinking about the experiments which record activity of norepinephrine-producing
neurons in the LC. These data show that during heightened arousal there is
increased firing of these cells (Sara, 2009). Since we do not know the entire
connectivity of the LC, we have to assume that these cells project to more than
just the wake-promoting areas of the brain. In fact, the LC is known to activate
the stress pathway and coordinate the brain’s response to stress (Goddard et
al.). Thus, it is likely that in human sleep deprivation studies there are effects of
norepinephrine on the stress pathway in addition to the arousal pathway.
Similarly in flies, overlapping circuitry may be responsible for the diverse
phenotypes caused by sleep loss. The preliminary and ongoing studies reported
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in this chapter on the role of octopamine signaling in the fly may shed new light
on the intricate workings of the LC in mammals.
Here we addressed whether sleep and metabolism are dependent or
independent when they converge on a similar cell type. We find that the wakepromoting and metabolic roles of the PI neurons are independent of each other.
While Dilp2 neurons are activated by octopamine to promote wakefulness, the
effect seems to be independent of Dilp2, as manipulating downstream insulin
signaling in the brain or the fat body does not have major effects on sleep. In
addition it is not the increase in wakefulness that causes changes in triglycerides
in these animals since other short sleepers do not show the same increases in
triglycerides. This result implies that octopamine has its own independent action
on triglycerides through a currently unknown mechanism. The mechanism may
still involve Dilp2, since we have not shown any data to the contrary. This action
is most likely strongest during development, because increasing octopamine
signaling in adulthood (with TrpA1) led to less fat storage than if the octopamine
pathway was activated throughout development. Ongoing studies are
addressing whether the effect of octopamine on triglyceride levels is insulin
dependent or not.
Recent work on insulin in the fly suggests that it is a sleep-promoting
molecule (Broughton et al., 2010). We find that there is a trend towards
increases in total sleep, but these are very minor and most likely not biologically
relevant in adult flies. This leaves the question of what in these dilp-producing
neurons is the wake-promoting signal. We show here that it is not Dilp2. We
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have not ruled out dilp3 and dilp5, which are also expressed in these neurons,
but these are also unlikely signals as they would act through the same
downstream insulin signaling which is not affected by changes in octopamine. A
more in depth characterization of these neurons will be needed to address this
question. Finally, metabolic signaling has also been implicated in homeostatic
sleep rebound (the ability of an animal to recover sleep lost during a period of
deprivation) (Chikahisa et al., 2009; Peterfi et al., 2006). This aspect of metabolic
control of sleep was not addressed in this chapter and may also be a product of
overlapping circuitry.
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Figure 4-1
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Figure 4-1: Triglyceride levels in different sleep mutants. A. Triglyceride levels
following alterations in octopamine signaling. Triglyceride/ protein ratio of female
whole animals 4-5 days old from: Tdc2-GAL4<UAS-TrpA1, and its control lines:
Tdc2-GAL4/Cyo or Sco and UAS-trpA1/ Cyo or Sco; Tdc2-GAL4<UASNaChBac, and its controls: Tdc2-GAL4/Cyo and UAS-NaChBac/ Sco; and
OAMB286 mutants and w1118 background control line. N>12 for each line for total
experiment. B. Triglyceride levels in short sleeping flies. Triglyceride/ protein ratio
of whole animals from: Fmn control lines (w1118) (n>16), Fmn (n>16) and Fmn
heterozygous animals over Cyo from the same vial (n>16); MBGeneSwitch
driving UAS-mc* (constitutively active PKA) with or without RU486 (n=5) ; SSS
control lines (Iso31) (n=3), SSS (n=4) and SSS heterozygous animals over Cyo
from the same vial (n=4). Error bars represent ± SEM. * = p<.01 unless stated
otherwise.
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Figure 4-2:

Figure 4-2: Baseline sleep in flies with altered insulin signaling. A. Average total
sleep over 24 hr period in female animals overexpressing UAS-Dilp2 in Dilp2
neurons, compared to Dilp2 driver alone (Dilp2-GAL4 < UAS-nGFP) and UASDilp2 alone. N=32 for each group. B. Total sleep in female flies expressing UAS158

dAKT RNAi, UAS-myrAKT and UAS-dInRCA. Total sleep in UAS-dAKT RNAi
expressed in Fat body (yolk-GAL4) and brain (elav-GAL4) compared to controls
yolk-GAL4<Iso31, elav-GAL4<Iso31 and Iso31<UAS-dAKT RNAi (n=32 for each
group). Total sleep in UAS-myrAKT expressed in Fat body (yolk-GAL4) and brain
during adulthood (ElavGeneSwitch activated by RU486 in 1%EtOH for 4 days)
compared to controls yolk-GAL4<Iso31, Iso31<UAS-myrAKT, ElavGeneSwitch <
UAS-myrAKT on 1% EtOH. (n=32 for each group). Total sleep in UAS-dInRCA
expressed in Fat body (yolk-GAL4) and brain (elav-GAL4) compared to controls
yolk-GAL4<Iso31, elav-GAL4<Iso31 and Iso31<UAS-dInRACA (n=32 for each
group). Error bars represent ± SEM. * = p<.01 unless stated otherwise.

159

Appendix:
Other regulators of Drosophila sleep
Part 1: Sleep in Drosophila is regulated by adult
mushroom bodies
William J. Joiner, Amanda Crocker, Benjamin H. White and Amita Sehgal
Joiner, W.J., Crocker, A., White, B.H., and Sehgal, A. (2006). Sleep in Drosophila
is regulated by adult mushroom bodies. Nature 441, 757-760

Part 2: Caffeine changes global levels of cAMP
Extracted from Wu, M.N., Ho, K., Crocker, A., Yue, Z., Koh, K., and Sehgal, A. (2009).
The effects of caffeine on sleep in Drosophila require PKA activity, but not the adenosine
receptor. J Neurosci 29, 11029-11037.
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Part 1: Sleep in Drosophila is regulated by adult
mushroom bodies
William J. Joiner, Amanda Crocker, Benjamin H. White & Amita Sehgal

Sleep is one of the few major whole-organ phenomena for which no
function and no underlying mechanism have been conclusively demonstrated.
Sleep could result from global changes in the brain during wakefulness or it could
be regulated by specific loci that recruit the rest of the brain into the electrical and
metabolic states characteristic of sleep. Here we address this issue by exploiting
the genetic tractability of the fruit fly, Drosophila melanogaster, which exhibits the
hallmarks of vertebrate sleep (Hendricks et al., 2000a; Nitz et al., 2002; Shaw et
al., 2000; van Swinderen and Greenspan, 2003). We show that large changes in
sleep are achieved by spatial and temporal enhancement of cyclic-AMPdependent protein kinase (PKA) activity specifically in the adult mushroom
bodies of Drosophila. Other manipulations of the mushroom bodies, such as
electrical silencing, increasing excitation or ablation, also alter sleep. These
results link sleep regulation to an anatomical locus known to be involved in
learning and memory.
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Sleep duration is inversely related to PKA activity in flies (Hendricks et al., 2001).
To determine whether specific brain loci regulate sleep, we used the GAL4/UAS
(upstream activating sequence) system (Brand and Perrimon, 1993) to express a
catalytic subunit of PKA in various regions of the fly brain. We first expressed
PKA under the control of the RU486-inducible pan-neuronal driver
elavGeneSwitch (Osterwalder et al., 2001). Restricting the expression of PKA to
adult neurons decreased daily sleep, supporting earlier studies with mutants
such as dunce (Hendricks et al., 2001) that increase PKA levels, and showing
that PKA directly regulates sleep rather than a developmental process that might
affect sleep (Fig. A-1a). We next expressed PKA under the control of different
GAL4 drivers and examined the changes in total daily sleep in the different
driver/transgene combinations relative to driver/background and
background/transgene controls (Fig. A-1b). When both controls were taken into
account, the expression of PKA by only two drivers led to changes in sleep that
exceeded 2 s.d. These were 201Y, which increased sleep by 75 ± 3% and 93 ±
4% respectively, and c309, which decreased sleep by 46 ± 11% and 43 ± 14%
per day compared with the two sets of controls. Changes in sleep caused by all
other GAL4 drivers remained within 1s.d. of the mean.
We next examined whether activity levels during wake periods were
affected by the 201Y and c309 drivers. Many GAL4 driver/UAS–PKA lines were
hypoactive, but line 201Y had normal waking activity (Fig. A-1c). Similarly,
activity normalized to waking time in c309 was not significantly higher in PKAdriven animals than in either control (Fig. A-1c), indicating that c309 was not
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hyperactive. We conclude that the sleep phenotypes of animals expressing PKA
under control of the 201Y and c309 drivers are not associated with abnormal
waking activity. Interestingly, both these drivers are known to be expressed in the
mushroom bodies (MBs) (Joiner and Griffith, 1999), a brain region implicated in
associative learning.
Given the strong, yet opposite, effects that 201Y and c309 had on sleep,
we further characterized their expression patterns in the fly brain by crossing
them into animals bearing a UAS transgene for green fluorescent protein (GFP).
We found that 201Y is expressed largely in the γ lobes and the core region of the
α/β lobes of the MBs, whereas c309 is expressed in the α/β and γ lobes but not
in the core region of the α/β lobes (Fig. A-2a, b, and Fig. A-3). This differential
expression pattern within the MBs indicates that PKA might affect the regulation
of sleep by the MBs in both a positive and a negative fashion by using
anatomically distinct classes of neurons. Consistent with this notion of
heterogeneous cell types within the MBs (Armstrong et al., 1998; Crittenden et
al., 1998; Zhu et al., 2003), some MB drivers, such as 30Y and 238Y, promoted
sleep during the day but inhibited sleep during the night, leading to only marginal
overall changes in daily sleep (Fig. A-1, and Fig. A-4). This effect was not
observed with any driver that was expressed exclusively outside the MBs (Fig. A2c and Table A-1). A small increase in daytime sleep was also frequently
produced by the pan-neuronal elavGeneSwitch driver, which decreased overall
sleep (data not shown, and Fig. A-1a). The expression patterns of 238Y and 30Y
overlap those of 201Y and c309, supporting the idea that 238Y and 30Y are
163

expressed in both sleep-promoting and sleep-inhibiting areas (see Table A-1 and
Fig. A-3 for expression patterns of drivers used in this study).
To test the hypothesis that PKA expression in MBs regulates adult sleep,
we expressed the PKA transgene under the control of an RU486-activatable MB
GAL4 driver, P{MB-Switch} (Mao et al., 2004). We confirmed selective
expression of this driver in the MBs by coupling it to a GFP reporter, and found
inducible expression in the MBs (Fig. A-2d, e, and Fig. A-3). Sleep was
significantly reduced in response to RU486 in MB-Switch/PKA animals (Fig. A5a, b) but was unaffected by the drug in control animals harboring either the
driver or the transgene alone (Fig. A-5c). Thus, PKA overexpressed preferentially
in specific neurons of adult MBs is sufficient to reduce sleep.
Next we compared sleep structure in the hyposomnolent animals with that
of controls. In both MB-Switch/PKA animals and c309/PKA animals, loss of sleep
was caused by a shortened sleep bout duration without a concomitant increase
in the sleep bout number (Fig. A-5d, e, and Fig. A-6a, b). The underlying cause
of reduced sleep in both sets of animals therefore seems to be impaired sleep
need, because the alternative—normal sleep need, but an inability to maintain
the sleep state—would be expected to produce an increase in sleep bout
number. In contrast, in 201Y sleep bout duration remained unchanged (Fig. A-6c,
d).
We then asked whether the reduction of sleep in MB-Switch/PKA animals
was due to an impaired accrual of a sleep-inducing signal. If this were so, then a
hallmark of sleep, homeostatic rebound—sleep that exceeds baseline to
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compensate for lost sleep—should not occur on relief of induced PKA
expression. However, when RU486 was withdrawn after about three days of
sleep deprivation, an average rebound of 156 ± 38 min was observed (Fig. A-5a,
f). This is a robust rebound, comparable to that produced when genetically
identical but uninduced flies were submitted to a standard 12h of mechanical
deprivation (137 ± 26 min; Fig. A-7). Behavioral rebound was also observed in
animals expressing elavGeneSwitch-driven PKA, after withdrawal of RU486
(data not shown), and was accompanied by a decrease in PKA activity in fly
heads (Fig. A-5g). Rebound after withdrawal of RU486 indicates that PKA might
not prevent the accrual of sleep-promoting signals but might suppress
homeostatic output.
To determine whether PKA affects sleep by regulating synaptic output in
MB neurons, we inducibly expressed either of two K+ channels, Kir2.1 (Baines et
al., 2001) or EKO (White et al., 2001), under the control of the MB-Switch driver.
Such transgenic expression should suppress action-potential firing by
hyperpolarizing neurons and decreasing membrane resistance, thus leading to
reduced synaptic transmission. We found that induction of either Kir2.1 or EKO
caused a significant increase in sleep (Fig. A-8a, b, and Fig. A-9). Because the
opposite was observed with PKA expression in the same neurons, it indicates
that PKA might decrease sleep by increasing either excitability or synaptic
transmission. To address this issue further, we inducibly expressed a sodium
channel (NaChBac), which depolarizes neurons and increases excitability (Luan
et al., 2006). When expressed under the control of the MB-Switch driver, the
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sodium channel caused a decrease in sleep (Fig. A-8c, d), similar to that
produced by PKA, confirming that PKA increases the output of these neurons.
The MB-Switch driver is expressed in a subpopulation of MB neurons
similar to those labeled by c309 (Fig. A-3), and both drivers had sleep-inhibiting
effects. As noted above, this pattern of expression differed from that of other
drivers (Fig. A-3), which had sleep-promoting or bidirectional effects on sleep
(Fig. A-1b, and Fig. A-4), thus leading us to propose that the MBs contain sleepinhibiting and sleep-promoting neurons. To determine the overall effect of MBs
on sleep, we ablated them with hydroxyurea and examined sleep and activity in
adult flies. Consistent with previous reports (Helfrich-Forster et al., 2002; Martin
et al., 1998) was our observation of an overall increase in activity (Fig. A-10a).
However, normalization of this activity to waking time indicates that the
phenotype derives less from hyperactivity than from a reduction in sleep (Fig. A10b, c). Even so, the reduction in sleep was much less than that seen with other
manipulations of the MBs (see above) or in short-sleep mutants such as
minisleep (Cirelli et al., 2005a). This supports our conclusion that MBs exert both
positive and negative influences on sleep that are integrated to produce the overt
behavioral state. Our model (Fig. A-11) takes into account our results; notably
the integrator downstream of the MBs promotes activity in the default state. Thus,
when MBs are ablated the overall effect is increased wakefulness.
Opposing effects of the c309 and 201Y drivers are also observed in a
different behavioral model. They parallel MB-dependent changes in brain activity
during the sleep/wake cycle that are associated with salience, a behavioral trait
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that may correspond to arousal. Consistent with our data was the observation
that reducing synaptic transmission using the c309 driver inhibited salience,
whereas the 201Y driver in the same type of experiment yielded no change. We
would predict increased arousal with 201Y, but in those experiments the animals
were already awake (van Swinderen and Greenspan, 2003).
Because MBs receive and transduce considerable sensory, particularly
olfactory, input to the fly brain, we speculate that they promote arousal or sleep
by allowing or inhibiting the throughput of sensory information. In addition, given
the major function that MBs have in regulating plasticity in the fly brain, it is likely
that this is linked to their role in sleep. In mammals, sleep deprivation suppresses
the performance of learned tasks, and sleep permits memory consolidation
(Walker and Stickgold, 2004). Sleep and sleep deprivation also differentially
affect cortical synaptic plasticity (Frank et al., 2001). In Drosophila, MBs
participate in the consolidation or retrieval of memories involving olfactory cues
(de Belle and Heisenberg, 1994; Dubnau et al., 2001; McGuire et al., 2001; Zars
et al., 2000), courtship conditioning (Joiner and Griffith, 1999; McBride et al.,
1999) and context-dependent visual cues (Liu et al., 1999; Tang and Guo, 2001)
by mechanisms that include cAMP signaling. Distinct anatomical regions of the
MBs have been shown to be important for at least some forms of memory
(McGuire et al., 2001; Pascual and Preat, 2001), as we have now also shown for
sleep. Thus, memory and sleep may involve similar molecular pathways (cAMP
signaling) and anatomical regulatory loci (MBs).
METHODS:
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Sleep assays
Female flies 3–7 days old were placed in 65mm × 5mm glass tubes
containing 5% sucrose/2% agarose with or without 500µM RU486. Flies were
acclimated for about 36h at 25°C in 12h light/12h dark (LD) conditions.
Locomotor activity was collected in LD with DAMS monitors (Trikinetics) as
described previously (Hendricks et al., 2000a; Hendricks et al., 2001). Sleep was
measured as bouts of 5min of inactivity, as described previously (Huber et al.,
2004), using a moving window over 30-s intervals. In some experiments RU486
was removed at the time points indicated in figure legends.
Localization of GAL4 expression
Many of the GAL4 lines from Fig. A-1 were crossed to a fly line with a
transgene encoding GFP fused to a nuclear localization signal (GFPn). Brains
were dissected and fixed for 20–30min in 4% paraformaldehyde in PBS before
photography of serial z-sections of whole mounts with the use of confocal
microscopy. In some cases, images were deconvolved to allow virtual transverse
sections to be taken through MB peduncles.
PKA assays
After 1 week in LD, elav-GeneSwitch/UAS-mc* females were switched at
ZT0 from drug to drug, from no drug to no drug or from drug to no drug. After 2h,
heads were isolated and homogenized on ice in buffer consisting of (in mM): 10
HEPES pH7.5, 100 KCl, 1 EDTA, 5 dithiothreitol, 5 phenylmethylsulphonyl
fluoride, 10% glycerol, 0.1% Triton X-100 and one tablet of Complete (Promega).
Debris was pelleted for 5min at 4°C in a microcentrifuge and discarded. A protein
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assay ( Dc kit; Bio-Rad) was performed on supernatant from each sample, and
homogenization buffer was added as necessary to make each sample equal in
concentration. PKA activity was measured as ATP-dependent quenching of
fluorescent kemptide in accordance with the manufacturer's instructions ( IQ
assay; Pierce) and normalized to values determined for animals maintained on
RU486 throughout the experiment.
Hydroxyurea-dependent ablation of MBs
Mated Canton-S flies were placed on standard grape juice/agar plates to
induce egg-laying over a 1-h period. On the next day, first-instar larvae were
collected within 1h of hatching and placed in 50% yeast paste in the presence or
absence of 50mg/ml hydroxyurea for 4h before being transferred to standard
food vials, as described previously (de Belle and Heisenberg, 1994). After
eclosion, adult male flies were aged for one week and then placed in glass tubes
to measure sleep/activity patterns over a three-day period in LD.
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Figure A-1

Figure A-1: Expression of PKA in various regions of the fly brain affects sleep
differentially. a, The pan-neuronal driver elavGeneSwitch7 was used to express
UAS-mc*, which contains a constitutively active subunit of PKA downstream of
an upstream activating sequence (UAS)30. Sleep, defined as 5 min of immobility,
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was assayed in flies in which expression of PKA was induced with 500
mMRU486 (dashed line) and in uninduced controls (solid line). b, Progeny were
collected from crosses between 21 GAL4 drivers and y w;UAS-mc*. For controls,
each GAL4 line was crossed to y w flies (the background for the UAS-transgenic
line), and yw;UAS-mc* was crossed to w1118 (the background for the GAL4
drivers). Daily sleep was averaged over 4 days. Sleep from control animals was
subtracted from the experimental group, then divided by the amount of control
sleep to calculate net percentage changes. Grey bars, sleep in w1118/yw flies
carrying UAS-mc* and a GAL4 transgene relative to sleep in w1118/y w flies
carrying the respective GAL4 transgene alone; white bars, sleep in w1118/y w
flies carrying UAS-mc* and a GAL4 transgene relative to sleep in w1118/y w flies
carrying only UAS-mc*. c, For each of the crosses in b, average daily activity
(beam crossings) was divided by average total wake time. Differences in waking
activity between GAL4/UAS-mc* and control flies were calculated as in b. For
each group, n = 25. Where errors are shown, they are s.e.m.
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Figure A-2

Figure A-2: Localization of GAL4-dependent brain expression. A nuclear targeted
GFP (GFPn) was expressed under the control of different GAL4 drivers. a,
c309/GFPn; upper arrows refer to a lobes and lower arrows to b lobes of MBs. b,
201Y/GFPn; upper, middle and lower arrows point to a, g and b lobes,
respectively, within MBs. c, 104Y/GFPn; the fan-shaped body of the central
complex and cells rimming the optic lobes and anterior brain are illuminated. d,
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P{MB-Switch}/GFPn with RU486 in the food; labeling is as in b. e, P{MBSwitch}/GFPn without RU486 in the food.

Figure A-3
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Figure A-3: (Figure S1). Expression patterns of eight GAL4 drivers within the MB
peduncle. (a) Expression of a nuclear-targeted GFP reporter was driven by each
of eight MB GAL4 drivers. Confocal images of brain whole mounts were
deconvoluted, and virtual cross-sections were reconstructed through the MB
peduncle proximal and distal to Kenyon cell bodies. See (b) for a schematic
representation of the structures labeled. Based upon the plane of the section
and proximity to the Kenyon cell bodies, all four fiber tracts may not be visible in
the proximal sections. Examples of alpha/beta expression are denoted by
arrowheads in the MB-Switch and c309 panels. Note that the core region within
each tract shows at best weak expression in MB-Switch and appears absent in
c309. (b) Schematic of MB peduncle anatomy proximal and distal to Kenyon cell
bodies1. Axons extend from Kenyon cell bodies through the peduncle, where
they form four main tracts. Proximal to the Kenyon cell bodies these can be
identified in transverse sections of the peduncle as: four bundles of fibers that
extend to the core region of alpha/beta lobes, four groups of fibers surrounding
each of the core bundles that also extend to alpha/beta lobes, a diffuse group of
fibers surrounding the previous two groups that extend to the alpha’/beta’ lobes,
and an outer ring of fibers that extends to the gamma lobes. Distal to Kenyon cell
bodies the four tracts of core and alpha/beta fibers merge into two groups, and
fibers destined for the alpha’/beta’ and gamma lobes become more
distinguishable in cross-sections of the peduncle1. (c) Summary of the expression
patterns of MB GAL4 drivers. Expression patterns are denoted with “++” for high
levels of fluorescence, “+” for moderate levels of fluorescence, “+/-“ for low to
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barely detectable levels of fluorescence and “-“ for no detectable fluorescence.
Since alpha/beta and alpha’/beta’ fibers could not always be distinguished, we
have grouped them here for simplicity. Expression of 201Y in the alpha/beta
core has previously been documented2. Lack of expression of c309 in the core
region has also previously been described3. The pan-neuronal elavGeneSwitch
driver (Fig A-1) also expressed weakly in the core region and strongly in
alpha/beta-alpha’/beta’ fibers (data not shown).
1.
Strausfeld, N.J., Sinakevitch, I. & Vilinsky, I. The mushroom bodies of Drosophila melanogaster: an
immunocytological and golgi study of Kenyon cell organization in the calyces and lobes. Microsc Res Tech. 62, 151-69
(2003).
2.
Wang, J., Zugates, C.T., Liang, I.H., Lee, C.H. & Lee, T. Drosophila Dscam is required for divergent
segregation of sister branches and suppresses ectopic bifurcation of axons. Neuron 14, 559-71 (2002).
3.
Connolly, J.B., Roberts, I.J., Armstrong, J.D., Kaiser, K., Forte, M., Tully, T. & O’Kane, C.J. Associative learning
disrupted by impaired Gs signaling in Drosophila mushroom bodies. Science 20, 2104-7 (1996).
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Figure A-4:

Figure A-4:( Figure S2.) Expression of constitutively active PKA with the 238Y or
30Y GAL4 drivers leads to suppression of sleep at night and enhancement of
sleep during the day. (a,b) 238Y/UAS-mc*, 30Y/UAS-mc* and control driver/y w
females were raised as in Fig A-1. Sleep profiles are means of n=15-16 animals.
Data from experimental groups and controls are represented by stippled and solid
lines, respectively. (c,d) GAL4 expression profiles from 5-9 day old females
carrying both the driver and UAS-GFPn transgene. Brains were prepared as in Fig
A-2.
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Figure A-5
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Figure A-5: Inducible expression of PKA in the MBs leads to decreased sleep
bout duration and accumulation of sleep debt. a, Sleep was monitored in
w1118/y w;UAS-mc*/+;P{MB-Switch}/+ females in the presence (dashed line) or
absence (solid line) of 500 mM RU486 (n = 16 for each group). At the end of day
3, animals were transferred to tubes lacking RU486 (arrow). Grey bars represent
12-h dark periods. b, Sleep was measured for females in LD (n = 61 or 62) and in
constant darkness (DD, n = 28–30), and for males in LD (n = 45 or 46) and in
DD(n = 15 or 16). Black bars represent animals fed RU486; white bars are
controls. Plotted values represent averages over three days. c, w1118/yw;;P{MB
Switch}/þ or w1118/y w;UAS-mc*/+ female controls were placed in LD for 3 days
with (black bars) or without (white bars) RU486 in their food. d, Sleep bouts in LD
were binned according to duration for P{MB-Switch}/UAS-mc* females with
(black bars) or without (white bars) RU486 (n = 43–45 for each group). e, Sleep
bout number in LD is similar for P{MB-Switch}/UAS-mc* females treated with
RU486 (black bars) to that in genotypically identical uninduced animals (white
bars). n = 43–45 for each group. f, Flies were monitored for four days in the
presence or absence of 500 mMRU486 and then transferred to tubes with no
drug at diurnal time 0 (ZT0; when the light was turned on). Rebound sleep during
the following 12 hours was determined by subtracting sleep in the ‘no drug to no
drug’ group from sleep in ‘drug to no drug’ animals. n = 64 for w1118/y w;UASmc*/+;P{MB-Switch}/+ experimental animals; n =30 for w1118/yw;;P{MB
Switch}/+ and w1118/yw ;UAS-mc*/+ controls. g, elav- GeneSwitch/UAS-mc*
females were switched at ZT0 from drug to drug (black bar), from no drug to no
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drug (white bar) or from drug to no drug (that is rebound conditions, grey bar).
After 2 h, PKA activity was measured in heads from each group. Significance
was determined with a one-way analysis of variance. Asterisk, P ≤0.05; two
asterisks, p ≤ 0.01; n.s., p . 0.05 by unpaired t-test. Where errors are shown, they
are s.e.m.
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Figure A-6:

Figure A-6: (Figure S3). Sleep architecture of animals expressing PKA under the
control of c309 and 201Y drivers. Animals were prepared as in Fig A-1 and
analyzed as in Figs A-5d,e. (a) Sleep bout distribution shifts leftward to reflect
overall shorter sleep bouts in c309/UAS-mc* female flies compared to controls.
Black bars represent w1118/y w;c309/UAS-mc*; white bars represent w1118/y
w;c309/+; grey bars represent w1118/y w;UAS-mc*/+. (b) Average daily number of
sleep bouts is similar between w1118/y w;c309/UAS-mc* (black bar), w1118/y
w;c309/+ (white bar) and w1118/y w;UAS-mc*/+ (grey bar). (c) Sleep bout
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distribution in 201Y/UAS-mc* female flies compared to controls. Black bars
represent w1118/y w;201Y/UAS-mc*; white bars represent w1118/y w;201Y/+; grey
bars represent w1118/y w;UAS-mc*/+. (d) Average daily number of sleep bouts in
w1118/y w;201Y/UAS-mc* (black bar) compared to w1118/y w;201Y/+ (white bar)
and w1118/y w;UAS-mc*/+ (grey bar) controls. N = 30-61 female flies in each
group. All calculations are plotted as averages + SEM. n.s. is not significant and **
p<.01 by 1-way ANOVA. In the case of the latter, posthoc comparison between
w;201Y/UAS-mc* and w1118/y w; UAS-mc*/+ showed a significant difference while
the difference between w;201Y/UAS-mc* and w1118/y w;201Y/+ was marginally
insignificant.
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Figure A-7:
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Figure A-7: Figure S4. MBSwitch/UAS-mc* female flies show homeostatic
rebound sleep following 12 hours of mechanical sleep deprivation that is similar in
magnitude to PKA-induced rebound. MBSwitch/UAS-mc* animals were prepared
as in Fig A-5. After 1.5 days of acclimation, activity and sleep profiles of
uninduced animals were measured for 2.5 days in LD. Beginning at day 2.5 (lights
off) and ending at day 3 (lights on), experimental animals were shaken for 2
seconds at randomized intervals with a mean inter-shake interval of 20 seconds.
Control animals were undisturbed. (a) During the shaking period, marked in the
figure as “dep”, activity was elevated in experimental animals (dotted line), but not
in genotypically identical control animals (solid line). (b) Sleep in the experimental
group was virtually abolished during the shaking period, while a normal sleep
profile was maintained in control animals. For approximately 8 hours after the
deprivation period, the experimental group slept substantially more than the
control group. (c) Sleep in the control group was subtracted from sleep in the
experimental group and integrated over time to keep a running tabulation of
cumulative change in sleep. During the deprivation period, experimental animals
lost ~500 minutes of sleep compared to controls. Following the deprivation period,
the experimental animals recovered 137 + 26 min relative to controls before
resuming a sleep profile with little net change in sleep relative to controls. Plotted
values are derived from means of 21 experimental animals and 25 control
animals.
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Figure A-8

Figure A-8: Decreasing and increasing excitability in a subset of MB neurons
have opposite effects on sleep. a, In P{MB-Switch}/UAS-Kir2.1 animals in
which K+ channel expression in the MBs was induced by RU486 (dashed
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line), sleep exceeded that of control animals of identical genotype (solid
line). b, RU486 significantly increased sleep in MBSwitch/Kir2.1 females
(black bars); white bars are uninduced controls. From left to right: for
w1118/y w;;MBSwitch/Kir2.1, n = 34–47; for w1118/yw;;MBSwitch/+,
n = 30 or 31; for w1118/y w;;UAS-Kir2.1/+, n = 11–26. c, In P{MB-Switch)/
UAS-NaChBac flies in which Na+ channel expression in the MBs was
induced by RU486 (dashed line), sleep was significantly suppressed in
comparison with control animals of identical genotype (solid line). d, RU486
significantly suppressed sleep in MBswitch/UAS-NaChBac females. From
left to right: for w1118/y w;UAS-NaChBac/+;MBSwitch/+, n = 46 or 47; for
w1118/y w;;MBSwitch/+, n = 31; for w1118/y w;UAS-NaChBac/+, n = 59 or
60. Two asterisks, P ≤ 0.01 by unpaired t-test. Where errors are shown, they
are s.e.m.
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Figure A-9:

Figure A-9: (Figure S5). Decreasing excitability in a subset of MB neurons using
the EKO transgene increases sleep. Animals were prepared and assayed for
sleep as in Fig 4. RU486 suppressed sleep slightly in female flies bearing either
the MBSwitch driver or 3 copies of the transgene for UAS-EKO but significantly
increased sleep in females carrying the driver/transgene combination. Black bars
represent animals that were fed RU486; white bars are controls. From left to right:
for w1118/y w;2xUAS-EKO/+;MBSwitch/1xUAS-EKO n = 45; for w1118/y
w;;MBSwitch/+ n = 30-31; for w1118/y w;2xUAS-EKO/+;1xUAS-EKO/+ n = 29-49.
Plotted values represent averages + SEM. ** p<.01; n.s. is not significant by
unpaired t-test.
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Figure A-10:

Figure A-10: Figure S6. Ablation of mushroom bodies with hydroxyurea leads to
increased activity and decreased rest. (a) Daily locomotor activity of HU-treated
(black) vs untreated (white) animals, averaged over 3 days. (b) Average daily
locomotor activity divided by waking time for HU-treated (black) vs control (white)
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animals. (c) Average daily sleep for HU-treated (black) vs control (white) animals.
N=59 and 53 for drug and no drug, respectively. All panels depict averages +
SEM. ** p<.001; * p<.05 by unpaired t-test.
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Figure A-11:

Figure A-11: (Figure S7). Model of sleep-regulating circuitry involving MBs. We
propose that within the MBs, sleep-promoting neurons (e.g. 201Y) are normally
most active at night, and wake-promoting/sleep-inhibiting neurons (e.g.
c309/MBSwitch) are normally most active during the day (diurnal influences are
indicated by upward and downward deflections in sinusoids). Antagonistic signals
from these two sets of cells are integrated to generate sleep/wake activity cycles.
Dashed arrows indicate possible influences of MB neurons on each other.
Constitutive expression of PKA in a single set of relevant MB neurons leads to
increased sleep or waking at temporally ectopic times of day. When PKA is
constitutively expressed in both sets an increase in daytime sleep accompanies a
decrease in nighttime sleep with little net change in total daily sleep (Fig A-4).
When MBs are ablated the excitatory influence of the integrator increases waking
and locomotion.
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Table A-1: The GAL4 drivers used are listed alongside their published expression
patterns.
GAL4 driver
c309

Major pattern of expression within the brain
optic lobe neurons, antennal lobe interneurons, a
subset of central complex neurons, mushroom bodies
201Y
mushroom bodies and a small cluster of cells located laterally
85b
antennal lobes, one lateral cell body, mushroom bodies
104Y
fan-shaped body of the central complex, optic lobe neurons,
small number of neurons diffusely distributed across the brain
103Y
mushroom bodies, small number neurons diffusely distributed
across the brain
GMR
eye
c747
antennal lobe interneurons, central complex and
mushroom bodies
238Y
large optic lobe neurons and projections, subset of the
central complex, mushroom bodies
30Y
subsets of the ellipsoid body and antennal lobes, mushroom
bodies, small number of neurons diffusely distributed across
the brain
C507
ellipsoid body of the central complex
MBSwitch
mushroom bodies
elavGeneSwitch pan-neuronal
H24
antennal lobes, ellipsoid body of the central complex,
mushroom bodies
17D
median bundle, mushroom bodies
pdf
lateral neurons
per
cells expressing the clock gene period
129Y
antennal nerve, suboesophageal ganglion
1366
various areas of the anterior, medial and posterior brain
c739
ellipsoid body and fan-shaped body of the central complex,
antennal lobes, mushroom bodies
MJ286
lateral protocerebrum
MJ63
lateral protocerebrum
c232
ellipsoid body of the central complex
c492b
antennal lobes, ellipsoid body of the central complex,
mushroom bodies
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Part 2: Caffeine changes global levels of cAMP
Mark N. Wu,Karen Ho, Amanda Crocker, Zhifeng Yue, Kyunghee Koh,
and Amita Sehgal

Caffeine is one of the most widely consumed stimulants in the world and
has been proposed to promote wakefulness by antagonizing function of the
adenosine A2A receptor (Huang et al., 2005). Work from our laboratory
demonstrates that chronic administration of caffeine reduces and fragments sleep
in Drosophila and also lengthens circadian period (Wu et al., 2009). However,
these effects are not mediated by the caffeine target thought to be relevant for
sleep, the adenosine receptor. On the other hand, the effects of caffeine on
sleep and circadian rhythms are mimicked by a potent phosphodiesterase
inhibitor, IBMX (3-isobutyl-1-methylxanthine). Using in vivo fluorescence
resonance energy transfer imaging, we find that caffeine induces widespread
increase in cAMP levels throughout the brain. We suggest that chronic
administration of caffeine promotes wakefulness in Drosophila, at least in part, by
inhibiting cAMP phosphodiesterase activity.

Methods:
Fluorescent resonance energy transfer imaging of cAMP levels.
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Brains from elav-Gal4/+; UAS-Epac1-camps (50A)/+ (Shafer et al., 2008)
flies were dissected in ice-cold calcium-free saline containing 46 mM NaCl, 180
mM KCl, and 10 mM Tris, pH 7.2. The brains were then laid at the bottom of a 35 x
10 mm plastic FALCON Petri dish (Becton Dickenson Labware), given a few
seconds to adhere and then covered with 1.6 ml of hemolymph-like saline (HL3)
containing 70 mM NaCl, 5 mM KCl, 1.5 mM CaCl2, 20 mM MgCl2, 10 mM NaHCO3, 5
mM trehalose, 115 mM sucrose, and 5 mM HEPES, pH 7.1 (Shafer et al., 2008 ).
Time course fluorescent resonance energy transfer (FRET) imaging of
pan-neuronally expressed Epac1-camps was performed on individual brains
using a Leica TCS SP5 confocal microscope using a HCX APO L 40x/0.80
dipping objective. 60 µl of 10 mg/ml caffeine was added into the dish for a final
concentration of 0.375 mg/ml following 3 min of baseline imaging. In the water
control, 60 µl of water was added. To quantify yellow fluorescent protein (YFP)
(525 nm)/cyan fluorescent protein (CFP) (475 nm) peak values, spectral analysis
was used, taking images from 470 nm to 599 nm in 10 nm increments at 256 x
256 pixels, 700 Hz, and a line average of two every 20 s. Regions of interest
(ROIs) on the brains were selected and examined for changes in YFP/CFP peak
height value on the spectral analysis.

Results:
Caffeine causes widespread increase in cAMP levels.
If caffeine does not act on sleep by antagonizing dAdoR (adenosine receptor)
signaling, how else might it act? Caffeine, like other methylated xanthines, inhibits
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cAMP PDE in mammalian cells, and indeed cAMP/PKA signaling is implicated in
the regulation of sleep in Drosophila and mammals (Hendricks et al., 2001;
Graves et al., 2003; Joiner et al., 2006). Biochemical data have suggested that
the concentration of caffeine required to inhibit phosphodiesterases (PDEs) is
higher than would be physiologically relevant in mammals (Fredholm et al., 1999)
, but recent data suggest that at least some of the effects of caffeine on human
immune function may involve inhibition of cAMP PDE (Horrigan et al., 2006).
Thus, we sought to investigate a role for the cAMP-PKA pathway in the effects of
caffeine on sleep.
If caffeine acts as a cAMP phosphodiesterase (PDE), one would expect
the presence of caffeine to elevate cAMP levels in widespread areas throughout
the fly brain. To assess this, we conducted in vivo FRET imaging with recently
described UAS-Epac1-camps flies, which can be used to overexpress Epac1camps, a FRET-based cAMP sensor (Nikolaev et al., 2004; Shafer et al., 2008).
In this system, the presence of cAMP causes a reduction in FRET from donor
(CFP) to recipient (YFP) chromophores. In brains where Epac1-camps is
expressed pan-neuronally, we find that addition of caffeine leads to an increase in
cAMP levels (as measured by a decrease in YFP/CFP signal) in widespread
areas throughout the brain, including areas previously implicated in sleep
regulation such as mushroom bodies (Joiner et al., 2006; Pitman et al., 2006) and
pars intercerebralis (Foltenyi et al., 2007) (Fig. A-12).
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Figure A-12:

Figure A-12: Caffeine reduces Epac1-camps FRET. Average FRET plots, as
measured by YFP/CFP peak signals, for different regions of interest (ROI)
following bath application of 0.375 mg/ml caffeine on elav-Gal4/+; UAS-Epac1camps/+ brains. Decreasing YFP/CFP reflects increasing cAMP levels. Arrow
represents the start of caffeine exposure. For each ROI, the following number of
brains were analyzed as follows: mushroom body (n =7), subesophageal
ganglion (n=8), antennal lobe (n=6), pars intercerebralis (n=3), deutocerebrum
(n=6), lateral protocerebrum (n=4), central complex (n=2). The brain ROIs in the
five water-treated brains were pooled. YFP/CFP peak signals pooled in 6 min
bins were statistically different from water (at least p<0.05) in all regions and all
bins, except central complex, which was statistically different only for minutes
21–27, and subesophageal ganglion, which was statistically similar for minutes
15–21.
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Summary and Perspectives.

An understanding of both the anatomical and cellular signaling pathways
underlying a particular behavior is expected to provide insight into the basis of
the behavior. For my thesis I set out to understand the mechanisms that underlie
sleep in Drosophila. I approached this question from many angles, which include
analysis of anatomy, investigation of a specific neurotransmitter, octopamine
,and characterization of the intra cellular signaling important for wake behavior in
flies.
Octopamine is a very prominent neurotransmitter in invertebrates (Roeder,
2005). Prior to this work octopamine had only been alluded to as an arousal
signal, but with the use of Drosophila as a model organism to study sleep, we
were able to conclusively demonstrate its wake-promoting actions. We show that
there is a decrease in sleep in mutants that do not produce octopamine. We also
show that flies with octopamine signaling altered through genetic changes in the
membrane potential of octopaminergic neurons display significant changes in
sleep, such that depolarization causes less sleep and hyperpolarization
increases sleep. These effects are all independent of the overall activity of the
animals because they either do not have defects in their ability to generate
movement or manifest excessive movement.
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We then addressed the anatomical pathway important for octopamine
regulation of sleep.

We demonstrate that a subset of octopamine-producing

cells is necessary for generating the wake-promoting actions of octopamine.
This signal is then relayed to an area of the brain known as the Pars
Intercerebralis (PI), specifically the Drosophila insulin (Dilp2)-producing neurons
within the PI. Effects of octopamine are mediated specifically by the K3 isoform
of the OAMB receptor present in Dilp2 neurons. Activation of the OAMB receptor
results in increases in cAMP and closing of the slowpoke K+ channel, thereby
causing a prolonged action potential in these neurons. Interestingly the wakepromoting effects of octopamine are independent of Dilp2 and seem to be
mediated by other pathways in Dilp2 neurons.

Putting these findings in the context of our general understanding of
sleep: While there have been many studies addressing why we sleep, we are
only just beginning to approach this question in a controlled fashion. Sleep is a
fundamental phenomenon with many complexities. Dr. Jerome Siegel postulates
that many of the functions we attribute to sleep are due to evolutionary pressure
for those activities, such as cellular repair, to occur during sleep but that sleep
itself is not necessary for these activities (Siegel, 2005). While this is not a
commonly held opinion, it is important to consider when thinking about the
function of sleep and the work in this thesis. In this thesis work I have focused
on the underlying circuitry and regulation of sleep/wake in Drosophila. While I
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have not directly addressed function, my work provides correlative evidence for
and against different functions of sleep.
The use of Drosophila as a model organism for sleep has led to the
identification of many anatomical areas and cellular pathways that turn out to be
important for other behaviors, thereby creating a resurgence of many old theories
for why we sleep (Cirelli, 2009; Crocker and Sehgal, 2010). For instance, we
found that specific cells in the pars Intercerebralis (PI), an area important for
metabolic regulation, are important for promoting wakefulness. It has long been
thought that sleep and metabolism are intimately associated, but until recently it
has been difficult to address whether these two processes are mutually
dependent.

The fly model allows for more straightforward approaches to these

questions than does the mammalian model. We have the ability to manipulate
sleep and/or metabolic pathways in a time and anatomical specific manner. In
doing so, we can address the role of each biological function and examine
interdependencies. The difficulty of such approaches in mammals arises, in
part, from the fact that major changes in baseline sleep are seldom detected.
There are very few if any mouse mutations that abolish sleep to the extent seen
in some fly mutants. In addition, the developmental effects of many of these
mutations on the sleep pathway and/or the metabolic pathway may prevent them
from developing to adults. Tissue and time specific knockouts can now be
generated in mammals, but not with the ease possible in flies.
Our recent work in trying to understand the overlap of the metabolic and
sleep pathways suggests that each biological function is independent of the
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other. Despite being independent, the functions overlap in a key
neurotransmitter known as octopamine. We find that octopamine regulates
triglyceride levels and promotes wakefulness. One theory is that the
wakefulness is what causes the changes in triglyceride levels. But this does not
appear to be the case, because many short-sleeping mutants have different
effects on triglycerides and short sleep does not always result in high
triglycerides. In fact, overexpressing PKA in the mushroom body (an area with
no known metabolic effect) results in short sleep and lowered triglycerides. This
may be closer to a more pure effect of sleep loss, in flies but since the mushroom
body is a main site of olfactory integration we cannot rule out the effects it may
have on sensing food. These studies highlight the importance of looking at the
whole picture when dealing with sleep and its functions. It is highly likely that in
humans there are metabolic effects of sleep deprivation, but they may be a
consequence of the pathways activated to elicit the sleep deprivation. This
concept was recently shown in stress and insomnia models in mammals where
overlap in stress and arousal systems (specifically the locus coeruleus and
paraventricular nucleus in the hypothalamus) results in stress induced insomnia
(Cano et al., 2008).
The idea that metabolic function affects the homeostatic regulation of
sleep is an interesting concept. While this question is not addressed in this
thesis ,it could be easily examined by sleep-depriving animals with altered
metabolic function. However, It is unclear whether these studies would actually
address the function of sleep but they could identify somnogens. If a metabolic
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signal, such as insulin or AMP activated kinase (AMPK), is a somnogen then
alterations in this signal would only affect the drive to sleep. It would not address
sleep function. In order to address this, one would need to show that normal
sleep is required for changes in these pathways. This has not been done and
may be very hard to do.
Recent work In mammals has tried to address the homeostatic regulation
of sleep by cellular metabolic signals. A widely held belief is that sleep has a
restorative function (Benington and Heller, 1995). Whether this is actually a
sleep function or is postulated based upon the restriction of cellular repair
processes to times of rest is unknown, but it is clear that sleep disruption in
mammals leads to disrupted metabolism (Spiegel et al., 2009). The idea is that
the build-up of adenosine in wake-promoting areas, due to high activity of AMPK,
results in these neurons turning off and going off-line to restore normal ATP
levels (precursor to ADP and adenosine)(Dworak et al., 2010). A major piece of
evidence supporting this model came from data suggesting that caffeine reduces
sleep by blocking the adenosine signal (Huang et al., 2005). This presents a
congruent story, where reduced sleep further increases adenosine levels; when
effects of increased adenosine levels, which would normally lead to sleep, are
blocked, the animal extends its wakefulness. Recent work of Dr. Mark Wu in our
lab has addressed this question in flies (Wu et al. 2009).
Since sleep is a highly conserved behavior, it is likely that its purpose is
similar across species. If this is the case, in flies there should also be a buildup
of adenosine telling the animal to sleep. In both flies and mammals, caffeine is an
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important wake-promoting signal and in mammals it inhibits the A2a adenosine
receptor (Huang et al., 2005). Unfortunately, in both flies and in mammals, the
evidence for a role of adenosine receptors in regulating sleep is not strong, so
analysis of other caffeine targets is important to understand its effects on sleep
and wake. cAMP phosphodiesterase is another well-known target of caffeine and
we show here that caffeine treatment leads to overall increases in cAMP across
multiple brain regions. In addition, the behavioral data reveal that caffeine
promotes global arousal independent of adenosine (Wu et al., 2009), calling into
question whether decreased adenosine signaling actually decreases sleep.
Another prevalent theory for sleep function is its role in learning and
memory (Walker and Stickgold, 2004). We have shown that the mushroom body,
a site of learning and memory in flies, is an important area for sleep regulation. It
is reasonable to assume that an area important for integrating sensory signals
such as the mushroom body would be wake-promoting. Many sensory systems
in mammals when stimulated will produce wakefulness. What is more interesting
about this work is the possibility that a subset of this structure is a sleeppromoting area. This effect is likely to be separate from the learning areas of the
mushroom body since it does not seem feasible to learn a task while one is
asleep. However, the sleep-promoting region may turn out to be important for
the consolidation of memory. Evidence for this idea exists in mammals where
sleep deprivation impairs consolidation of specific types of memory (Graves et
al., 2003a; Walker and Stickgold, 2004).
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Despite this work, it is clear we do not have a good understanding of why
we sleep. Many current theories are based on correlative data such as what is
described in this thesis. As we look closer at some of the main theories for why
we sleep we are finding that they may be independent of sleep itself. This
brings us back to Dr. Siegel’s theory on sleep—that it actually serves no purpose,
and that, through evolution and the optimization of both brain and body function,
certain biological processes just happen to occur during sleep. Unfortunately, if
this is the case it may be impossible to prove, because sleep deprivation would
always be associated with the deleterious loss of these processes, thereby
making it appear as if they are functions of sleep. But in a society that is
perpetually sleep deprived, whether a process is a function of sleep or not is
irrelevant; if sleep deprivation causes memory impairment and metabolic
changes due to alterations in normal biological functioning, it remains prudent
that we avoid loss of sleep.
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